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Aim of the thesis
The overall aim of this PhD thesis is to evaluate the feasibility of Blood Oxygen Level Dependent 
(BOLD) magnetic resonance imaging (MRI) as a non-invasive method for estimating changes in 
fetal and placental oxygenation.
The specific aims of this PhD thesis were:
 In ewes 
1. To estimate the association between changes in the BOLD signal and changes in fetal 
liver oxygenation during maternal hyperoxia and hypoxia. (Paper 1)
2. To investigate fetal and placenta oxygenation changes during maternal hyperoxia and 
hypoxia by BOLD MRI. (Paper 1+2)
 In healthy human pregnancy 
1. To investigate fetal oxygenation changes during maternal hyperoxia by BOLD MRI. 
(Paper 3)
2. To investigate placenta oxygenation changes during maternal hyperoxia by BOLD MRI. 
(Paper 4)
3. To investigate the reproducibility of placental T2* and the hyperoxic response (Paper 
5)
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Introduction
A normal placental function ensures adequate supply of oxygen and nutrients for the developing 
fetus. Impaired placental function leads to fetal growth restriction (FGR) and increased risk of 
neonatal morbidity and mortality because of hypoxia and acidosis. One of the main purposes of
fetal monitoring is to identify the growth restricted fetus in order to plan adequate monitoring 
intervals and ensure timely delivery. In each case of FGR the time of delivery will be determined by
a balance between excessive intrauterine fetal stress and neonatal complications due to 
prematurity. In modern obstetrics fetal monitoring is based on various methods, such as
cardiotocography (CTG), biophysical profile and ultrasound Doppler measurements of fetal and 
umbilical blood flow. These techniques are integrated in a focused strategy as a timeline of 
changes is associated with the progression of fetal hypoxia into acidosis and stillbirth. Current
methods focus on fetal wellbeing and thus only indirectly estimate placental function. The only 
method available for direct estimation of placental oxygen transport is cordocentesis. However, 
this invasive procedure is not used because of an associated risk of fetal loss. In neuroscience 
Blood oxygen level dependent (BOLD) magnetic resonance imaging (MRI) provides non-invasive 
information about oxygenation changes of the brain, as changes the BOLD signal is closely related 
to changes in the saturation of hemoglobin. Over the last decade, BOLD MRI has become the main 
method for mapping brain function in cognitive studies. However, in fetal medicine the method is 
only briefly described. In this thesis the feasibility of BOLD MRI as a non-invasive method for 
estimating fetal and placental oxygenation is investigated in healthy pregnancies.
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Background
This section contains three parts. The first part describes basic information about the BOLD MRI 
technique followed by a brief review of the literature previously published on fetal BOLD MRI. The 
second part summarizes the current methods in fetal monitoring. Finally, the third part is 
dedicated to the physiology of the fetus and the placenta.
Magnetic resonance imaging (MRI)
Basic MRI physics
In atoms the positively charged nucleus is surrounded by negatively charged electrons. Most atom 
nuclei contain an equal number of protons and neutrons. These pairs of subatomic particles spin in 
opposite directions, and therefore the nucleus itself has no net spin. However, MR active nuclei 
have an uneven number of protons and neutrons, and these nuclei therefore exhibit net spin. 
Because of the spin and the positive charge the MR active nuclei acquire a magnetic moment. The 
body contains several MR active nuclei; however, the hydrogen nucleus is the one used in clinical 
MR because of its high natural abundance in human tissue. Furthermore, the solitary proton of the 
nucleus produces a relatively large magnetic moment. In the absence of a magnetic field the 
hydrogen nuclei are randomly orientated in the body; however, when placed in an external 
magnetic field (B0) the magnetic moments of the hydrogen nuclei will align with the magnetic 
field. Some nuclei align parallel (low energy) with the field while others align anti-parallel (high 
energy). The longitudinal magnetization reflects the relative balance between the numbers of 
nuclei in each alignment group as slightly more protons align parallel to B0. At higher magnetic 
fields greater proportions align in parallel therefore, the longitudinal magnetization is increased.
The hydrogen nucleus is spinning on its axis. Furthermore, the influence of an external magnetic 
field B0 produces an additional spin around B0, which is called precession (Figure 1).
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Figure 1 A hydrogen nucleus spinning around its axis and around B0
In this secondary spin each MR active nucleus has a specific speed called the precessional 
frequency. When the hydrogen nucleus is exposed to a radio frequency (RF) pulse of energy at 
exactly its precessional frequency, the nucleus gains energy, it is excitated. This phenomenon is 
known as resonance. The results of resonance are as follows: 
 An increasing number of nuclei join the high energy population orientated antiparallel to 
B0, which decreases longitudinal magnetization. 
 The magnetic moments of the nuclei move into phase, as they move to the same position 
on the precessional path. This is known as coherence, which generates transversal
magnetization.
When the RF-pulse is stopped the hydrogen nucleus releases its energy. It continues to precess, 
and the net magnetic vector (the sum of the longitudinal and the transversal magnetic vectors) 
follows a spiraling path.
According to Faraday’s law of induction, voltage is induced in a receiver coil when placed close to a 
moving magnetic field. The precessing NMV induces an electric oscillating current in the receiver 
coil of the MR scanner, also known as the free induction decay (FID) signal. This process is the 
basis of the MRI signal. The MRI signal intensity is related to the magnitude of the NMV, which 
depends on the tissue relaxation properties, magnetic field strength, proton density etc. 
The release of energy following the RF-pulse is also known as relaxation and it is characterized by
two parallel but independent processes T1 and T2 relaxation (Figure 2).
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Figure 2 A) T1 recovery curve. B) T2 decay curve
 T1 recovery: Recovery of the longitudinal or spin-lattice magnetization. The T1 relaxation 
time is defined as the time when 63% of the original longitudinal magnetization is reached.
 T2 decay: Decay of the transversal or spin-spin magnetization (spin coherence). The T2 
relaxation time is defined as the time when the transversal magnetization is reduced to 
37%. T2 relaxation time is faster than T1 (Figure 3). 
Figure 3  T2 decay curve with demonstration of the transversal vectors loosing coherence.
 T2* decay: T2* decay is the sum of the T2 decay as described above and the effect of local 
magnetic field inhomogeneities, which can be caused by machine imperfections, the 
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presence of iron (e.g. implants) or contrast agents such as deoxyHgb. T2* relaxation time is 
faster than T2 (Figure 4).
Figure 4 A comparison of T2 and T2* decay curves. T2* decay is faster than T2 decay.
Each tissue has a specific and characteristic T1, T2 and T2* relaxation time depending on the 
interaction between the protons and their surrounding environment. Tissue specific relaxation 
times are very important for image contrast. Image contrast is determined by differences in signal 
intensity, which depends on tissue relaxation times. Weighting of an MRI image allows one 
mechanism of relaxation to dominate the other (1). For instance, in the T2* weighted image, the 
difference in signal intensity between tissues (tissue contrast) is dominated by differences in the 
T2* relaxation time. However other mechanisms such as tissue proton density will also contribute 
to tissue contrast at least to some extent. The weighting of image contrast is determined by 
selecting specific timing parameters of the RF pulse sequence. The sequence parameters and their 
effect on the contrast weighting are outlined below: 
Time of repetition (TR): The time from the application of one RF-pulse to the next RF-pulse. The 
TR determines the amount of T1 weighting. When the TR is short (<50 ms) T1 weighting is 
increased.
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The echo time (TE): The time from the application of the RF-pulse to the peak FID in the receiver 
coil. The TE is dependent on the timing of the re-phasing pulse. The TE determines the amount of 
T2 weighting. When the TE is long (>15-20 ms) T2 weighting is increased.
Flip angle: The RF excitation pulse tips the NMV and transverse magnetization occurs. The flip 
angle determines the amount of longitudinal magnetization that is moved to the transversal plane. 
If the TR is short and the flip angle is large, the image is T1 weighted because of NMV saturation.
Spin echo pulse sequence: Following the RF-pulse an additional 180° pulse at time=TE/2 is used to 
refocus the dephasing protons at time TE. The 180
°
pulse rotates the protons 180° which makes 
them process in the opposite direction. The slower protons catch up with the faster ones and 
come into phase. Therefore, the spin echo compensates for the T2* dephasing due to local or 
intrinsic magnetic field inhomogeneities. The spin echo contains predominantly T1 and T2 
information as the effect of T2* dephasing has been neutralized.
Gradient echo pulse sequence: In a gradient echo two gradients are applied – a dephasing and an 
opposite rephasing gradient (Figure 5). The magnetic field inhomogeneities persist in a gradient 
echo, as the gradient refocuses only the protons that have been de-phased by the gradient itself.  
The gradient echo is predominantly T1 and T2* weighted. When compared to the spin echo the 
gradient echo is faster, however the signal loss is greater because of the magnetic field 
inhomogeneities.
Figure 5 A gradient echo pulse sequence
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BOLD MRI
Different MR applications have been developed for assessing tissue function and physiology as 
opposed to conventional structural imaging. BOLD MRI represents one of these functional MRI 
techniques. The BOLD effect was discovered in 1990 when Ogawa et al. demonstrated that the 
oxygenation of the blood had a measurable effect on the MRI signal of blood in vitro (2) and in the 
rodent brain (3). These publications were followed by BOLD MRI studies of the human brain during 
visual stimulation, and a close relationship between brain activation and changes in BOLD signal
was demonstrated (4). During the last decades BOLD MRI has become the most important tool in 
cognitive studies of the human brain (5), and the number of publications has increased 
exponentially (4,6). However, in fetal medicine the method is only briefly described.
The BOLD signal should be obtained in a T2* weighted MRI scan as the BOLD contrast depends on 
differences in T2* relaxation. T2* weighting is obtained by a gradient echo pulse, a long TE and a 
long TR. The basis of the BOLD signal relies on the magnetic properties of hgb, which depend on 
the oxygenation state of the heme group. The paramagnetic effect of deoxyHgb is caused by the 
unpaired electrons of the heme groups which produces currents and thereby generates internal 
magnetism that affects the surounding protons (1). The binding of O2 alters the structure of the 
hgb dramatically. The iron bindings are changed from ionic to covalent, and this is believed to
explain why the paramagnetic effect is lost in oxyhemeglobin (7). Because of its paramagnetic 
effect deoxyHgb can be regarded as an intrinsic T2* contrast agent. It increases the local magnetic 
field surrounding it and reduces the T2* relaxation time of the neighboring protons. During 
hypoxia the amount of deoxyHgb is increased, so is the T2* decay, and following the BOLD signal 
intensity is reduced giving a darker appearance of the BOLD image. Likewise, during hyperoxia the 
amount of deoxyHgb is decreased, which decreases T2* decay and so the BOLD signal intensity is 
increased. When referring to BOLD MRI in this thesis, it includes the relative BOLD response 
obtained by an BOLD scan as well as the absolute T2* relaxation time obtained by a single 
measurement. Each of these estimates will be described separately in the following section.
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A BOLD scan usually consists of an initial basal state followed by an activated state due to some 
kind of stimulation for instance visual stimulation. The BOLD response indicates the change in 
BOLD signal during activation (Figure 6).
Figure 6 A functional MRI study of the human brain. Brain activation in the visual cortex is demonstrated 
during visual stimulation (open eyes) by an increase in the normalized BOLD signal (left) An anatomic 
map of the BOLD response demonstrates the location of the activation (right) (5).
The absolute BOLD signal (S) depends on the following parameters
(1) S = S0e
-TE/T2*
The baseline BOLD signal (S0) depends on 1) technical factors, such as the magnetic field strength, 
the pulse sequence, the distance to the receiver coil, and the shimming effects and 2) baseline 
tissue physiology such as heamatocrite and oxygen (Figure 7) (8-10).
Because of baseline signal variation the absolute BOLD signal tends to vary between individuals 
even when the oxygenation level of the blood is the same. For this reason only relative changes in 
BOLD signal can be directly compared between individuals, and a normalization of the BOLD signal 
is usually performed.
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Figure 7 The complexity of the cerebral BOLD response during visual stimulation. The BOLD response 
depends on blood volume (CBV) and blood flow (CBF) and metabolism (CMRO2). The maximum BOLD 
response is determined by baseline physiology, such as haematocrit (Hct), resting O2 extraction (E0) and 
blood volume (10).
As indicated by Formula (2) the initial basal state absolute BOLD signal is used as a reference and 
at any given time x, the normalized BOLD signal will be expressed as a percentage of the reference 
level.
(2) Normalized BOLD signal (x) = (SX – SBasal)SBasal x 100%
SX and SBasal indicate the absolute BOLD signals at time x and at basal state. 
The relative change in BOLD signal during activation, also known as the BOLD response (∆BOLD),
can be expressed by the following formula
   (3) ∆BOLD = (SActivated - SBasal)/SBasal X 100%
SActivated and SBasal indicate absolute BOLD signal of the steady state level in the activated and the 
basal state. 
As indicated in Figure 7 the BOLD response is closely related to physiological factors such as blood 
flow, blood volume and oxygen metabolism. These factors will influence the BOLD signal and 
therby the BOLD response in different ways. Any increase in blood flow would decrease the 
amount of deoxyHgb and thereby increase the BOLD signal. An increase in blood volume would 
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increase the amount of deoxyHgb, and thereby decrease the BOLD signal. An increase in tissue 
metabolism would increase the amount of deoxyhemglobin and thereby decrease the BOLD signal. 
All of these factors need to be taken into consideration when interpreting the BOLD response
(10,11). In its traditional use BOLD MRI provides information about brain activation in cognitive 
studies (4). These studies have demonstrated a rather surprising increase in BOLD signal during 
brain activation. This finding was rather unexpected as the amount of deoxyHgb is supposed to 
increase during activation and as a result of this increase, the BOLD signal was expected to 
decrease. However, the increase in cerebral BOLD response can be explained when taking the 
changes in cerebral blood flow into consideration. During brain activation a compensatory 
increase in the cerebral perfusion exceeds the metabolic demand and thus, the cerebral 
oxygenation is actually increased (12-14).
In a BOLD experiment curves of tissue T2* decay can be drawn at basal and activated states by 
performing a gradient echo sequences with multiple readouts. For each echo-time the mean MRI 
signal of the region of interest (ROI) is plotted and an exponential decay curve is formed for the 
basal as well as the activated state.
Figure 8  T2* decay curves demonstrating the resting and activated state of a specific tissue. The optimal 
echo-time (TEopt) where the curves are the most distant is indicated in the figure.
At any given echo-time the BOLD response will be determined by the difference between the two 
curves. As shown in Figure 8, the optimal TE would be the time where the curves of the basal and 
activated state are the furthest apart and where the BOLD signal intensity is still above the 
background noise level.
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The tissue specific T2* relaxation time can be calculated from the mono exponential T2* decay 
curve by fitting the formula 1 using a non-linear least squares fitting algorithm.
The hgb molecule has an intravascular localization, with deoxyHgb present predominantly in the 
veins and to some degree in the capillaries. DeoxyHgb creates magnetic field gradients around the 
red blood cells and these gradients extend into the surrounding tissue, also known as blooming. 
Therefore the BOLD response has an intravascular as well as extravascular component. In the 
brain only 4% of the tissue volume consists of vessels; however, at 1.5 Tesla the intravascular 
component contributes with 50% of the total BOLD response (15).
In summary, the presence of the paramagnetic deoxyHgb reduces tissue T2* relaxation time and 
thereby the T2*-weighted BOLD signal. The BOLD response is determined by the amount of 
deoxyHgb present in the basal and the activated state. In BOLD MRI either the relative BOLD 
response (ΔBOLD) or the absolute tissue T2* relaxation time can be estimated. 
Fetal BOLD MRI
To date 19 studies have been published on fetal and placental BOLD MRI. The studies are listed in 
the Review Table of the Appendix. The studies differ in several ways. The studies have been
conducted either in the human fetus or in an animal model such as the sheep or the rat fetus. The 
kind of stimulation varies from in utero acoustic and visual stimulation to changing the oxygen 
content of the maternal breathing air. The studies estimate the BOLD response by relative changes 
in the BOLD signal or absolute changes in the T2* value of the fetal organs and the placenta.
The very first fetal BOLD MRI study was published in 1999. In this study human fetal brain activity 
was demonstrated during acoustic stimulation in utero (16). This study was followed by three
other studies demonstrating fetal brain activation during vibroacustic and visual stimulation in 
utero (17-19). In 2001 a pilot study demonstrated increasing liver oxygenation during maternal 
hyperoxia in the human fetus (20); but unfortunately, this finding could not be reproduced in a 
larger group (21). The human studies were followed by studies investigating the oxygenation 
changes of the sheep fetus. Oxygenation changes were induced by changing the oxygen content of 
the maternal ventilation gas. The fetal oxygenation was estimated invasively by fetal arterial blood 
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samples (22-24) and fetal oxygen sensors (25), and a strong association between changes in the 
BOLD signal and changes in fetal oxygenation was demonstrated. Just recently, a few studies have 
demonstrated increasing oxygenation of the human fetus and the placenta during maternal 
hyperoxia when using the BOLD MRI method (26-28), and placental T2* relaxation time has been 
estimated for the healthy human pregnancy (26). By unilateral ligation of the left uterine artery a 
model of FGR has been created in the rat, and the hyperoxic BOLD response has been investigated 
in the fetoplacental unit. This model allows direct comparison of the BOLD response in the normal 
fetus (the non ligated uterine horn) and the FGR fetus (the ligated uterine horn) within one rat, 
and according to the rat model, the BOLD response of the fetoplacental unit is significantly 
reduced in the FGR fetus (29,30).
Safety in MRI
Safety is a major issue when scanning fetuses. Since MRI does not involve any form of ionizing 
radiation, it is considered safer than imaging modalities based on X-Rays and Computerized 
Tomography (CT). The American College of Radiology (ACR) states that fetal MRI is an established 
modality for evaluating fetal abnormalities that are not well assessed with ultrasound. The 2010 
guidelines from ACR recommend that fetal MRI is performed at 1.5 Tesla only, and preferably in 
the second and third trimester without the use of intravenous contrast agents (31). There is no 
evidence that MRI poses a risk to the developing fetus. Fetal MRI is still a new modality, so the lack 
of evidence is the main reason for the clinical guidelines being rather conservative. The main areas 
of concern discussed below.
Static magnetic fields
The natural magnetic field of the earth is approximately 50µT, and most clinical MRI procedures 
are performed in the range of 0.15 – 3T; however, experimental MRI systems of 10T are in use. 
The static magnetic field interacts with the living tissue in three ways: 1) magnetic induction of 
electric currents caused by moving electrocytes, 2) magneto-mechanical effects causing 
reorientation of macromolecules, and 3) electron spin interactions (32). Based on in vitro, animal
and human studies there is no evidence of cancer induction or any adverse effects induced by 
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static magnetic fields. Animal studies of repetitive fetal exposure to magnetic field strength up to 9 
Tesla have not demonstrated any adverse morphological, cognitive or behavioral effects (33).
Tissue heat
RF-pulse excitation generates tissue heat. This effect is related to different factors such as the 
magnetic field strength, the type of RF-coil used and the duration of the MRI scan. The fetal effects 
of tissue heating have been extensively investigated in relation to fetal ultrasound examination
(34,35). The fetus lives in a well insulated environment in which heat dissipation is restricted to 
two pathways conduction through the amniotic fluid and most importantly convection through 
the placental blood flow (36). In normal pregnancy fetal core temperature typically exceeds 
maternal temperature by 0.5°C because of accumulated heat generated by fetal metabolism. The
compromised fetal heat loss mechanism needs to be taken into consideration when estimating 
induced heat during MRI examination (37). Experimental animal studies have demonstrated an 
exponential relation between temperature and tissue damage. Proliferating cells are particularly 
sensitive to elevated temperature, and the teratogenic effect is mediated by reduced mitotic 
activity and cell death (38). It is generally accepted that a threshold value of temperature elevation 
of 1.5°C should be considered safe for the fetus (34). For every MRI scan a specific absorption rate 
(SAR) value can be calculated, which correlates to the tissue heat deposited. It has been estimated 
that at 1.5T the peak SAR value of the fetus is approximately 50% of that generated in the mother 
(39). According to the recommendations by the International Commission on Non-Ionizing 
Radiation Protection (ICNIRP) the whole body SAR value should be kept below 2 W/kg during a 
one hour scan equivalent to a rise in adult and fetal tissue temperature of 0.5C and 0.3C,
respectively (40).
Acoustic noise
During acquisition of images the MRI machine generates noise in the range of 80 to 120 dB (41). It 
is recommended that adults wear ear protection to reduce sound levels. The fetus is protected by 
the maternal abdomen and by the amniotic fluid, which reduces fetal noise by at least 30 dB (42).
It has been demonstrated that daily fetal exposure to noise > 99 dB increases the risk of specific 
hearing loss, prematurity and FGR (43). However, the noise generated during an MRI examination 
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is of short duration and the intensity should be well below 99 dB. A marked increase in fetal 
movements during MRI examination has been demonstrated (44). It is generally accepted that the
transient increase in fetal movements is a response to the sudden noise arising from the MRI 
machine.
Current methods in human fetal monitoring
The purpose of antenatal care is identification of the growth restricted fetus in order to ensure 
rational monitoring intervals and timely delivery. In modern obstetrics assessment of fetal well 
being is based on various methods; CTG, biophysical profile, and the ultrasound Doppler 
measurements of fetal and umbilical blood flow. For optimal fetal surveillance these methods
should be integrated into a focused strategy. As demonstrated by Figure 9 a certain timeline of 
changes is associated with the progression of fetal hypoxia into acidosis and stillbirth (45). In each 
case of FGR the time of intervention will be a balance between the risk of intrauterine stress due 
to hypoxia and acidosis and the risk of neonatal complications due to prematurity.
Figure 9 Fetal cardiovascular and behavioral response to placental insufficiency. A timeline of changes is 
associated with the progression of fetal hypoxia into acidosis and stillbirth. Umbilical artery (UA), middle 
cerebral artery, umbilical vein (UV), and ductus venosus (DV). End-diastolic velocity (EDV). 
Cerebroplacental ratio (CPR). Reversed or abscent atrial forward velocity (RAV). Biophysical profile score 
(BPS) and fetal heart rate (FHR) (45).
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CTG
Antepartum CTG includes registration of the fetal heart rate (FHR) by an external ultrasound 
transducer placed on the mother’s abdomen and simultaneous registration of uterine 
contractions. The following components of the FHR pattern can be assessed: baseline rate, 
baseline variability, accelerations and decelerations. The latter should be categorized according to 
the relationship with the uterine contractions. FHR pattern is a product of the central nervous 
system’s sympathic and parasympathic outflow, and it could be considered a measurement of 
central nervous system performance. During initial hypoxia the fetal chemoreceptor is stimulated,
and bradycardia occurs as a result of increased parasympathic activity. These decelerations are 
rapid and their depth is directly related to the degree of hypoxia (46). These variable decelerations 
are easy to detect, but unfortunately their diagnostic value is unclear. This is in contrast to 
decreasing variability and late prolonged decelerations, which are considered pathological. This 
abnormal FHR is related to chronic hypoxia, acidosis and placental insufficiency (47). The latter 
indicates an increased risk of antenatal neural injury because of reduced cerebral oxygenation
(48). Despite the widespread use of CTG in obstetric clinics, the benefit of CTG as a predictor of 
fetal hypoxia and neurological injury still needs to be proven (49). The reassuring CTG almost 
always predicts a well oxygenated fetus. In contrast, the nonreassuring CTG is complicated by a 
high false positive rate as it is very often associated with a well oxygenated fetus (50). An 
additional tool for the interpretation of the non-reassuring CTG is analysis of the ST-segment of 
the fetal electrocardiogram (ECG) and the combined analysis is known as STAN. Fetal hypoxia 
affects the fetal cardiac metabolism, which leads to significant changes in the ST-segment and in 
the ratio of the T-wave and the QRS amplitude of the fetal ECG (51). The fetal ECG is obtained 
from a scalp electrode; therefore, this method is available for intrapartum surveillance only.
Biophysical profile
The biophysical profile combines CTG (20 minutes) with ultrasound assessments of fetal 
movements, tone, breathing and amniotic fluid volume. It is well known that the fetus adapts to 
hypoxia by decreasing fetal activity, probably to reduce oxygen consumption (52). Furthermore,
fetal hypoxia causes redistribution of fetal renal blood flow towards the central organs, which 
leads to oligouria and oligohydramnious (53). The biophysical profile as a test of fetal hypoxia is 
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also complicated by a high false positive rate as fetal movements are often transiently reduced in 
well oxygenated fetuses and the amount of amniotic fluid has broad limits even in healthy fetuses. 
It has been documented that including the biophysical profile does not reduce perinatal mortality 
and morbidity when compared to CTG only, and unfortunately the biophysical profile has been 
shown to increase the rate of caesarean section and induction of labour (54).
Umbilical and fetal Doppler ultrasound
By Doppler ultrasonography fetal and umbilical blood flow velocity can be measured. Arterial 
Doppler waveform reflects downstream vascular resistance (Figure 10). However, venous Doppler 
waveform reflects cardiac forward function; thus, the forward flow in the venous system is 
determined by cardiac function (compliance, contractility and afterload). The complicated 
calculation of absolute blood flow volume requires accurate measurements of both the vessel 
diameter and blood flow velocity. Given these difficulties, reproducible angle independent indices 
of blood flow velocity such as pulsatility index (PI) have been developed for clinical use. The PI is 
calculated as the difference between the peak systolic velocity and the minimum diastolic velocity 
divided by the mean velocity through the cardiac cycle (55). 
Figure 10 Arterial Doppler waveform demonstrating the blood flow velocities of the cardiac cycle.
Specific changes in fetal, umbilical and placental circulation are important indicators of impaired 
placentation and fetal redistribution of blood flow due to hypoxia and acidosis (45). The effect of 
the implementation of ultrasound Doppler flow in fetal surveillance on fetal outcome is difficult to 
estimate. In 2010 reviews by Cochrane have addressed this question in normal (56) and high risk 
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pregnancy (57). Both reviews are limited by poor methodological quality of the included trials 
because of insufficient data included and possible publication bias. In normal pregnancy, it is
suggested that the use of fetal and umbilical Doppler does not improve fetal outcome or increase 
obstetrical interventions (56). However, in high risk pregnancies fetal mortality is reduced without 
any increase in obstetrical interventions when Doppler examination is compared to no Doppler 
examination or CTG only (57). The GRIT study (58), a randomized controlled trial, evaluated the 
effect of immediate versus delayed delivery in FGR fetuses, when the obstetrician was uncertain 
about when to deliver the fetus. The GRIT study demonstrated a trend towards a better short-
term (2 year) outcome in the delayed group of fetuses in regard to neonatal morbidity (59). 
However, with long-term (6-9 years) outcome no differences were demonstrated between the 
two groups in regard to motor and intellectual disabilities (60). The GRIT study did not evaluate 
specific monitoring strategies, but the study highlights the importance of gestational age in
regards to neonatal outcome in cases of very early onset FGR. A large multicenter randomized 
controlled trail, the TRUFFLE trial (61), is designed to evaluate specific monitoring strategies (CTG 
versus ductus venosus Doppler) in regards to fetal outcome, and the results of this trial still needs 
to be published. In general neonatal outcome will be determined by 1) neonatal complications due 
to prematurity and 2) intrauterine hypoxia and acidosis due to impaired placental function. The 
decision of when to deliver the growth restricted fetus will be a balance between the two. At early 
gestational age, the major determinant of neonatal outcome is gestational age as demonstrated 
by the GRIT study. At later gestation, when the prematurity-related morbidity decreases, 
intrauterine hypoxia and acidosis become the major determinants of neonatal outcome. Abnormal 
ductus venosus Doppler flow is the only Doppler finding that is directly related to fetal acidosis 
and stillbirth independent of gestational age (62,63). The association between brain sparing and 
fetal hypoxia is well known (64); however, studies indicate that fetal outcome in late onset FGR is 
compromised even before brain sparing can be observed by Doppler ultrasound examination (65).
This finding suggests that even with optimal fetal Doppler ultrasound surveillance fetal morbidity
cannot be prevented.
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In the following sections the physiology of the placenta and the fetus is described, and Doppler 
examination of placental, fetal and umbilical blood flow is mentioned when relevant.
Placental physiology
The main function of the placenta is the transport of gases and nutrients between the mother and 
the fetus. Moreover, the placenta serves as an important endocrine organ as placental hormones
are released to the maternal as well as the fetal circulation (66).
Placental structure and development
Placentation begins in the early first trimester, and this process is a major determinant of 
pregnancy outcome. The placenta consists of a maternal region (the basal plate) and a fetal region 
(the chorionic plate) and the space in between these two regions (the intervillous space). The 
latter contains the extensively branched fetal villous tree. On the maternal side of the placenta
blood of the uterine arteries enter the intervillous space via the low resistance spiral endometrial 
arteries. The transformation of the spiral arteries into low resistance vessels should be complete 
within 24 weeks of gestation, and it is mandatory for adequate maternal perfusion and 
development of the placenta. The waveform of the uterine artery reflects the resistance in the 
spiral arteries, and placentation abnormalities can be detected by uterine artery Doppler 
ultrasound examination (67). The maternal blood bathes the villous tree in the intervillous space
and drains back through the endometrial veins.
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Figure 11 Morphology of the normal human placenta. A) Cross section of the placenta demonstrating the 
chorionic and basal plate. B) A villous tree, the functional unit of the placenta. C) An electron micrograph 
of the placental exchange barrier consisting of the syncytiotrophoblast, the villous matrix and the fetal 
capillary endothelium (68).
Anatomically the human placenta is classified as a hemochorial placenta in which maternal blood 
is in direct contact with the fetal trophoblast (69). This is in contrast to the sheep placenta, an 
epitheliochorial placenta, in which the distance between maternal and fetal blood is increased by 
the epithelium of the maternal vessels. The functional unit of the placenta is the villous tree, and it 
is in the terminal villi are the major sites of maternal-fetal exchange (Figure 11). Fetal capillaries 
within the terminal villi are separated from the maternal blood in the intervillous space by only a 
small layer of syncytiotrofoblast.
The development of placental villi from trophoblasts starts around gestational week 4 followed by 
hypoxia stimulated angiogenesis of fetoplacental capillaries in gestational week 5-6 (70). At 
gestational week 12 maternal arterial blood enters the intervillous space, and the increase in 
oxygen stimulates further growth and maturation of the villus tree (71). By the end of the second 
trimester the formation of terminal villi occurs exponentially to meet the increasing metabolic 
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demand of the growing fetus. The thickness of the placental membrane is decreased and the 
surface area of the villous three increased, at term reaching 13m
2
(70). This placental maturation 
of normal the pregancy increases placental oxygen transport capacity by approximately 40% (72). 
The directions of maternal and fetal vessels are of major importance for the efficiency of exchange 
functions. There are two main types of arrangements (73); the counter current system, in which 
the pO2 of the umbilical vein equilibrates with the uterine artery, and the concurrent system, in 
which the pO2 of the umbilical vein equilibrates with the uterine vein. The human placenta is 
considered a multivillous system, which is a combination of the two. This arrangement should 
ensure the pO2 of the umbilical vein to equilibrate at least with the uterine vein (74,75). 
The vascular resistance on the fetal side of the placenta is determined by the architecture of the 
villous tree, and in normal pregnancy the resistance decreases gradually throughout pregnancy 
(76-78). Abnormalities of the placental villous tree can be detected by Doppler ultrasound 
examination of the umbilical artery (79). The vascular resistance of the maternal side of the 
placenta is determined by the resistance of the uterine arteries (80,81). Abnormal placentation 
can be detected by Doppler ultrasound examination of the uterine arteries, and increased 
resistance of the uterine arteries is a predictor of FGR and preeclampsia (82,83).
Placental function
The placenta is responsible for any feto-maternal exchange of nutrients and respiratory gases. 
Furthermore, the placenta serves as an important endocrine organ, and placental hormones are 
released into maternal as well as fetal circulation (66). The placenta is not innervated by the 
autonomic nervous system, and so any communication between the fetus, the mother and the 
placenta is regulated by blood borne substances. Examples of well known endocrine factors 
produced by the placenta are progesterone, human chorionic gonadotrophin (hCG), pregnancy-
associated plasma protein A (PAPP-A), human placental lactogen and placental growth hormone 
(66,84). Through very complicated interactions placental hormones regulate placental function, 
fetal growth and maternal adaption to pregnancy.
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The placenta is a highly active metabolic organ. In the third trimester the uterine arteries receive
30% of maternal cardiac output, and about 40% of the uterine oxygen supply is consumed by the 
placenta itself (85). This rather high oxygen consumption of the placenta is mainly  a consequence 
of protein synthesis (30%) and active transport mechanisms via the Na
+
-K
+
-pump (30%) (86). 
Placental exchange function is determined by feto-maternal concentration differences, uterine 
and umbilical blood flow and the permeability of the placental membrane (87). In general 
placental transport is mediated by two different mechanisms: diffusion and transporter proteins. 
Lipophilic molecules such as respiratory gasses diffuse easily across the placental membrane, and 
therefore such diffusion is limited by concentration and blood flow (85,88). Hydrophilic molecules
as amino acids and carbohydrates do not diffuse easily through the placental membrane, and 
therefore this diffusion is less dependent on concentration gradients. Instead surface area, 
membrane thickness and molecular size play import roles (89,90). Transporter protein mediated 
transport of hydrophilic molecules is energy consuming and require ATP from the Na
+
-K
+
-pump.
This transport is dependent on the number and characteristics of transporter proteins in the 
plasma membrane, which is carefully regulated by endocrine control throughout pregnancy
(88,91).
In healthy human pregnancy the normal oxygen partial pressure (pO2) of the uterine and umbilical 
blood is as follows; uterine artery pO2=80-100mmHg (sat:98-100%); uterine vein pO2=40-45mmHg 
(sat:75-80%); umbilical vein pO2=25-35mmHg (sat:80-85%); and umbilical artery pO2=20mmHg 
(sat:40-50%) (92,93). These values demonstrate a rather inefficient placental oxygen transfer, and 
a relative hypoxic intrauterine environment of the developing fetus. This can partly be explained 
by the maternal and fetal blood flow arranged in a multivillous system (73). However, this 
arrangement should ensure the umbilical vein to equilibrate at least with the uterine vein (74,75). 
Another contributor of the inefficient placental transfer might be mismatch of maternal and fetal 
placental perfusion and arterio-venous anastomoses (92,94,94). In spite of the relative hypoxic 
intrauterine environment fetal adaptations ensure that fetal oxygen supply can be similar to that 
of extra-uterine life. One of the mechanisms is the high blood perfusion of fetal organs. Because of 
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the high FHR and the parallel working ventricles the fetal cardiac output is v(94)ery high 
(300ml/kg/min) when compared to adults (75ml/kg/min) (95). Furthermore the high fetal hgb
concentration and the high oxygen affinity of fetal hgb increase the oxygen transport capacity of 
fetal blood (96).
Placental insufficiency
A normal placentation followed by an adequate placental growth and maturation is the basis of
normal fetal growth and development. Abnormal placentation is associated with miscarriage, 
placental abruption, pre-eclampsia, FGR and intrauterine fetal death (97,98). Cordocentesis 
performed in FGR fetuses have demonstrated hypoxia, acidosis (75,99), hypoglycemia and 
reduced levels of essential amino acids (89,91,100) indicating severely impaired placental
transport function. The FGR placenta has been extensively investigated for better understanding 
of this serious condition. The characteristics of the FGR placenta are summarized in the following
section.
In cases of FGR placental bed biopsies have demonstrated impaired trophoblast migration into the 
myometrium and failure of the normal physiological transformation of spiral arteries into low 
resistance vessels (80), which leads to increased thrombosis and placental infarction. Ultrasound 
Doppler flow measurement of uterine blood flow has demonstrated increased resistance and a 
reduction in blood flow of 50% (97). It is generally believed that this maternal hypo-perfusion of 
the placenta leads to intervillous hypoxia which affects the development of the fetal villous tree 
and changes the general placental metabolism (71). Hypoxia stimulates fetal angiogenesis and 
branching of the villus. Biopsies of the FGR placenta demonstrate accelerated maturation and a
40% increase in capillary volume fraction (72). This adaptive response increases placental oxygen 
transfer, as the surface area of the villous tree is increased and the thickness of the placental 
membrane is decreased. To a certain limiting these changes prevent fetal hypoxia. If, however, the 
metabolic demands of the fetus and the placenta cannot be met fetal hypoxia and acidosis might 
develop.
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In the placenta specific hypoxic changes can be demonstrated (70). Biopsies of FGR placentas have 
demonstrated malformation of the villus tree, especially the gas-exchanging terminal villi. These 
villus trees consist of fewer branches, and the terminal villi demonstrate a reduced number of 
capillaries, increased fibrosis and accelerated trophoblast apoptosis (97,101). Furthermore the
placental stem vessels show wall hypertrophy consistent with chronic vasoconstriction and loss of 
local paracrine vascular control of maternal and fetal placental perfusion (70,102). The altered 
architecture of the villous tree and increased vasoconstriction of the stem vessels increase the 
total vascular resistance on the fetal side of the placenta, which is reflected by the resistance of 
the umbilical artery. When examined by Doppler ultrasound the diastolic blood flow of the 
umbilical artery is decreased and in severe cases it is even reversed (76).
Macroscopic examination of the FGR placenta also demonstrates certain characteristics. When 
compared to the normal placenta the FGR placenta is smaller and very often it has an abnormal 
shape with increased thickness, which is directly correlated to poor neonatal outcome (103,104).
Fetal physiology
Our knowledge about fetal physiology is based on invasive experimental animal studies mainly on 
sheep. In these studies invasive methods such as injection of radioactive microspheres (105-107)
and insertion of vascular catheters (108) can be used for investigating fetal circulation and 
oxygenation in different experimental settings. Non-invasive investigation of fetal circulation can 
be provided by the ultrasound Doppler flow measurement. And over the last three decades the 
human fetal circulation has been extensively investigated by the ultrasound Doppler technique
(109,110). Normal blood flow has been described for a great number of fetal vessels, and 
abnormal blood flow has been correlated with fetal hypoxia and acidosis (111-113). Currently
ultrasound Doppler examination of fetal and placental blood flow is one of the major tools in fetal 
monitoring, as demonstrated by Figure 9 (65,114).
Fetal circulation
The umbilical blood flow is determined mainly by the resistance of the umbilical vessels in the fetal
side of the placenta. The fetal circulation is characterized a hyperkinetic system with a low 
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resistance (115), and so it is very different from the adult circulation. The ventricles of the fetal 
heart pump in parallel circuits, and the intraventricular pressure is similar in the two ventricles
(116). The well oxygenated left ventricular blood is directed to the upper part of the fetus 
including the brain. The less oxygenated right ventricular blood is directed to the placenta as well 
as the lower part of the fetus including the lungs and the viscera. In contrast to the adult heart, 
the fetal heart exhibits right-sided dominance with approximately 60% of the total cardiac output 
going through the right ventricle (117).
Figure 12  The route of oxygen rich blood reaching the fetus via the umbilical vein. Three important 
shunts; 1)Ductus venosus, 2)Foramen ovale, and 3)Ductus arteriosus (DA) form dynamic connections 
between the two parallel circuits of the fetal circulation. (118).
Three shunts, as demonstrated in Figure 12, divert blood between the two circuits, thereby 
determining the distribution of nutrients and oxygen between the cardinal fetal organs such as the 
liver, heart and brain (109,110,118). The first fetal organ to receive blood directly from the 
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placenta is the fetal liver. The circulation of the fetal liver is rather complex as it has two main 
vascular sources: the oxygen rich umbilical vein and the less oxygenated portal vein (119). The 
blood supply of the fetal liver is shown in Figure 13 (120).
Figure 13 The blood supply of the fetal liver. The well oxygenated (red) umbilical vein (UV) and the poorly 
oxygenated (blue) portal vein (PV). Left portal vein (LPV). Ductus venosus (DV). Right portal vein (RPV).  
Spine (SP). Stomach (ST) (120).
These sources are unevenly distributed as the left side of the liver primarily receives umbilical vein 
blood, and the right side of the liver receives a mixture of the two (121). The contribution of 
umbilical vein blood to the right side of the liver is directly related to the degree of ductus venosus 
shunting, as the ductus venosus leads oxygen rich umbilical vein blood away from the fetal liver to 
the heart and brain (109). The ductus venosus is embedded in the liver parenchyma, and it is 
considered the first shunt in the fetal circulation. The degree of shunting depends on the oxygen 
supply of the fetus as shunting is increased during hypoxia (122). Ductus venosus shunting 
decreases with increasing gestational age from 30% at 20 weeks to 20% at term; this is a 
consequence of the increasing metabolic demand of the fetal liver during normal pregnancy (123). 
The next shunt in the fetal circulation is the foramen ovale – the connection between the right and 
the left atria. Guided by the crista dividens there is a preferential streaming of oxygen rich 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
30
umbilical vein blood directly through the foramen ovale to the left side of the fetal heart. This 
shunt is of critical importance for the oxygenation of the myocardium and the fetal brain. In 
normal pregnancy the degree of shunting at mid gestation is 33% of the total fetal cardiac output 
and 75% of the left ventricular output (117). The third shunt is the ductus arteriosus located 
between the pulmonary arterial trunk and the descending aorta. The ductus arteriosus diverts 
right ventricular blood directly to the lower fetal body and the placenta without entering the 
pulmonary circuit. In the second trimester 40% of the total fetal cardiac output and 90% of the 
right ventricular output is directed through the ductus arteriosus (117). The last vessel to be 
mentioned is the aortic isthmus, the segment of the fetal aorta between the origin of the left 
subclavian artery and the entry of the ductus arteriosus to the descending aorta. The aortic 
isthmus is considered the communication or a watershed area between the two parallel circuits in 
the fetal circulation. The direction of blood flow through the aortic isthmus is determined by 
cerebral and placental vascular resistance. In normal pregnancy 10% of the total cardiac output 
passes through the aortic isthmus and there is a forward flow during both systole and diastole
(124).
Fetal response to acute hypoxia
In animal models acute fetal hypoxia can be induced experimentally by reducing maternal oxygen 
supply.  It has been demonstrated that acute changes in maternal oxygenation do not alter the 
blood flow to the pregnant uterus (102,125) and the oxygen consumption of the placenta remains 
rather constant during acute changes in uterine oxygen supply (126). During acute hypoxia the 
fetus initially compensates by increasing the oxygen extraction fraction. It has been demonstrated
that fetal oxygen metabolism can be maintained even if the oxygen supply is reduced by 50%
(86,92). However, below a certain threshold fetal hypoxia will develop followed by several changes 
in the fetal circulation. Initially a chemoreceptor response stimulates parasympaticus which 
reduces FHR. In the absence of acidosis cardiac output and blood pressure are maintained or even 
increased because of a sympaticus mediated peripheral vasoconstriction (127). Furthermore 
redistribution of fetal blood tends to maintain oxygenation of vital fetal organs such as the fetal 
brain and heart (111,118). The first circulatory response to hypoxia is an increase in cerebral blood 
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flow which is caused by reduced vascular resistance of the cerebral vessels. This change, well 
known as the brain sparing mechanism, tends to maintain cerebral oxygenation in spite of 
hypoxia.  It can be identified by ultrasound Doppler flow measurements of the middle cerebral 
artery demonstrating increased diastolic blood flow (113,128,129). As cerebral vascular resistance 
is reduced there is a gradual change in the direction of the blood flow of the aortic isthmus, which 
reflects the balance between the two fetal circulatory circuits. Initially the blood flow is reversed
only in diastole with the progression towards negative flow throughout the cardiac cycle
(124,130). The next step in the redistribution of fetal blood during hypoxia is increasing degree of 
ductus venosus shunting (122,131-133). The ductus venosus shunts oxygen rich umbilical vein 
blood away from the fetal liver, through the foramen ovale, directly to the left heart and fetal 
brain. Experimental studies have demonstrated that the ductus venosus is regulated by hypoxia,
which causes the ductus venosus to dilatate (134,135). During hypoxia increasing amounts of 
oxygen rich blood is diverted away from the fetal liver to increase the oxygenation of the fetal
heart and brain. The cerebral oxygenation is maintained at the expense of the liver, especially on 
the right side of the liver which looses its supply of oxygen rich umbilical vein blood (121). The 
ductus vensus waveform has been extensively studied by Doppler ultrasound examination. The 
ductus venosus waveform reflects fetal cardiac function. Abnormalities such as increased PI,
reduced velocity or even reverse blood flow during atrial contraction (negative A-wave) are 
associated with increasing degrees of cardiac failure and fetal acidosis, and it is a gestational age 
independent predictor of adverse neonatal outcome (132,136,137). During metabolic acidosis the 
centralization of fetal blood flow cannot be maintained (138). Cardiac failure develops as a 
consequence of (1) increased afterload caused by progressive peripheral and placental resistance 
and (2) impaired myocardial contractility which is a direct effect of acidosis (108,139,140). Initially,
diastolic failure occurs with elevated central venous pressure. This is followed by systolic failure in 
which the forward function of the heart is affected, leading to fetal hypotension, vascular collapse 
and intrauterine fetal death (140-142).
Fetal response to chronic hypoxia
Chronic hypoxia develops if hypoxia is introduced gradually and thereby it can be sustained for a 
longer period before progression into deteriorating fetal metabolic acidosis. Fetuses suffering 
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from placental insufficiency are subjected to some degree of chronic hypoxia as well as reduced 
levels of nutrients such as glucose and amino acids (99). These fetuses exhibit similar 
redistribution of fetal blood flow as demonstrated during acute hypoxia. Furthermore, they are 
characterized by increased hematocrits and tachycardia probably mediated by an increased level
of chatecolamines (143). Fetal oxygen consumption is gradually reduced by complicated fetal 
adaptations such as slowing fetal growth and by altering fetal behavioral pattern (138). When fetal 
oxygen metabolism is decreased the balance between fetal oxygen supply and consumption might 
be reestablished (138). The fetal consequence of chronic hypoxia is not only intrauterine FGR but 
also re-programming of fetal metabolism and tissue development, which provides an increased 
risk of metabolic disease in adult life (144-146). The intrauterine exposure to under-nutrition 
might alter fetal metabolic set points (147). What seems adequate during intrauterine life turns 
out to be a disadvantage in nutrient-rich extrauterine life.
Fetal response to maternal hyperoxia
Maternal hyperoxia can be induced by increasing the oxygen content of the breathing air. Several 
studies have been performed with the purpose of investigating the fetal effects of maternal 
hyperoxia. In healthy sheep, monkeys and humans it has been demonstrated that maternal 
hyperoxia does increase fetal oxygenation. Different methods have been used to evaluate fetal 
oxygenation, including internal fetal electrodes and vascular catheters (148-151), transcutaneous 
pO2 measurements (152) and blood-gas analysis of umbilical blood provided by cordocentesis 
(153). The physiological explanation for this increase in fetal oxygenation is likely due to an 
increased pO2 gradient across the placental membrane, which drives the oxygen transfer.
Maternal arterial blood is already fully saturated at room air, and that is why hyperoxia does not 
increase maternal hgb saturation. This is in contrast to the saturation of fetal blood which is only 
80% (92), and therefore the increase in fetal pO2 mediates an increase in fetal hgb saturation (87).
The effect of hyperoxia on fetal circulation has been extensively studied by Doppler ultrasound 
examination. In FGR fetuses it has been demonstrated that maternal hyperoxia normalizes the
resistance of the middle cerebral artery (154-156). In FGR fetuses the circulatory hyperoxic 
response even has been suggested as a predictor of fetal outcome – with the non-responder fetus 
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having the poorer outcome (157,158). In normal fetuses, the circulatory effect of maternal 
hyperoxia is more discrete and the studies have been conflicting. A majority of studies on sheep as 
well as human fetuses have demonstrated an increase in the cerebral resistance above normal
(149,159-161). This finding led to some concern regarding the oxygenation of the fetal brain 
during hyperoxia. However, studies of fetal sheep using internal tissue pO2 sensors have 
demonstrated an increase in cerebral oxygenation during maternal hyperoxia (151,162). 
Therefore, the observed cerebral vasoconstriction should be considered harmless. Several studies 
have investigated the effects of hyperoxia on the fetal heart, but no alteration in myocardial 
function or left/right-ventricular balance could be found (154,159,160). Only one study
investigated the effect of hyperoxia on ductus venosus blood flow in normal human fetuses. The 
study demonstrated that the velocity of ductus venosus blood flow was increased which indicated 
ductus venosus constriction and a reduced degree of shunting during hyperoxia (163).
The effects of maternal hyperoxia on fetal movements and FHR have also been investigated. In 
normal fetuses no significant effects were found. In FGR fetuses, however, maternal hyperoxia did 
increase fetal movements (164), and FHR showed an increasing number of accelerations and 
increasing heart rate variability (164,165). When returning to normoxia, an increasing number of
decellations were described in one study (164). This led to concerns regarding potential adverse
fetal effects of maternal hyperoxia, with the major concern being possible oxygen mediated 
placental vasoconstriction. In-vitro studies of umbilical vessels have demonstrated 
vasoconstriction in response to hyperoxia (166,167). However, these findings could not be 
reproduced in several in-vivo studies investigating the hyperoxic response of the uterine and 
umbilical vessels by ultrasound Doppler flow measurements (125,168,169).
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Materials and methods
This section describes how we used the BOLD MRI technique in our studies. Following is a
description of the software challenge we faced, and the impact it had on our studies. Furthermore, 
the method of each study is presented separately.
General aspects
The T2* weighted BOLD MRI scan
The BOLD scans consisted of an initial basal phase of normoxia followed by episodes of altered 
maternal oxygen supply inducing fetal and placental hypoxia as well as hyperoxia. The BOLD 
response was assessed by drawing ROIs in selected fetal organs and in the placenta. Large ROIs 
covering the entire organs were drawn to assess changes in total organ oxygenation, and smaller 
ROIs were drawn in the fetal liver and the placenta to assess regional oxygenation changes within
these organs. A normalization of the BOLD signal was performed using the normoxic BOLD signal 
as a reference in each ROI.
(4) Normalized BOLD signal (x) = (SX – SNormox)/SNormox x 100%
SX indicates the absolute BOLD signal at time x and SNormox indicates the absolute BOLD signal at 
steady state level during normoxia.  For each organ the BOLD response (∆BOLD) could be 
estimated and expressed as a percentage of the normoxic reference level. The hyperoxic BOLD 
response was estimated by the following formula
(5) ΔBOLDHyperox =(SHyperox – SNormox) / SNormox x 100%
SHyperox and SNormox indicate the absolute BOLD signal at steady state level during hyperoxia and the 
normoxia, respectively. The scan parameters of the three studies are listed in the following Table 
2. The BOLD scans are T2* weighted as they use a gradient echo sequence with a long TE and a 
long TR.
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Study System TE (ms) TR(ms) Flip angle Sequence Slice thickness/gab
The sheep study Philips 40 2500 90° Gradient echo 6 mm/ 9mm
The human fetal study Philips 40 1800 30° Gradient echo 6mm/9mm
The human placental study GE 50 8000 90 Gradient echo 6mm/9mm
Tabel 1 The scan parameters used in the three studies
Placental T2* measurement
In the human placental study, placental T2* relaxation time was estimated during normoxia and 
hyperoxia. Multiple gradient echo sequences were performed with 16 echo-times between 3.0 
and 67.5 ms, and T2* relaxation curves were drawn by plotting the mean MRI signal of the 
placental ROI for each echo-time during normoxia and hyperoxia (Figure 14). 
Figure 14 Placental T2* decay curves obtained during normoxia (blue) and hyperoxia (red) by plotting the 
mean MRI signal of the placental ROI for each echo time (TE).  A number of MRI images obtained at 
different echo times are included in the figure.
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The normoxic and hyperoxic placental T2* relaxation time was calculated by fitting the 
exponential T2* decay curve (Formula 1) using a non-linear least squares fitting algorithm, and the 
hyperoxic increase in placental T2* value (∆T2*) was estimated. The optimal echo-time for the T2* 
weighted BOLD scan was derived from the T2* relaxation curves of normoxic and hyperoxic 
placental tissue (Figure 14), as the BOLD response reflects the difference between the curves at 
each echo-time. The T2* curves indicate that by increasing the echo-time the hyperoxic BOLD 
response could be increased. However, if the TE is too long, the MRI signal intensity is decreased
below the background noise level. On the basis of the placental T2* decay curves the scan 
parameters of the BOLD scan was changed in the placental study. In order to optimize the 
placental BOLD response, TE was increased from 40 to 50 ms (Figure 14).
The software problem
In the sheep and the human fetal studies the raw data was analyzed using unpatented software 
developed in California by Fernando Barrio, M.Sc, more than 15 years ago. For several years this 
software was used for research in the Department of MRI at Aarhus University Hospital; however,
a detailed knowledge was lacking about the exact processes of the software. When the MRI 
system was upgraded I 2009, the raw data was no longer compatible with the old software. We 
tried to contact the developer of the software, but unfortunately this person was retired and not 
available for support. It was not possible to change the old software, so MATLAB-based software 
was developed. The new software deals with DICOM data instead of raw data, and it includes no 
filtering or transformation of data. The difference between the old and new software is
demonstrated in Figure 15, by showing the same data from one patient processed by the two 
different softwares. 
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Figure 15 The same set of data processed by either old software (top) or new MATLAB software (bottom).
When using the MATLAB software, the BOLD signal of the fetal liver is interrupted by artifacts; 
however, the BOLD signal of the fetal brain and the placenta remains intact. This finding can be 
explained by fetal movements. The fetal head is fixed in the maternal pelvis and the placenta is 
only moving according to maternal breathing movements; however, the fetal liver is subject to 
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movement artifacts caused by fetal rotation and kicking movements. During fetal movements the 
distance between the fetal organs and the coil is altered, which influences the absolute BOLD 
signal. When using the MATLAB software the changes in the BOLD signal caused by movements
outweigh the change in the BOLD signal induced by altered tissue oxygenation.
Because of the limitations of the MATLAB software, the future focus of our study became the 
placenta rather than the fetal organs. However, biomedical engineers at Aalborg University (Peter 
Brønnum Nielsen M.Sc, Ph.D and Lasse Riis Østergaard, Associate professor, M.Sc, Ph.D) leads a 
student project in which an additional motion correction tool for the MATLAB software including a 
bias field correction will be developed.
The method of each study
The sheep study: Papers 1 + 2
This study was performed at the Department of Clinical Medicine and the MRI Research Center at 
Aarhus University Hospital in Skejby. Eight ewes carrying singleton fetuses at gestation 125 days 
(term=145 days) were included in this study. One animal was excluded because of cardiac arrest 
during induction of anesthesia. Another fetus demonstrated a hepatic hematoma following 
insertion of the oxygen sensor and this fetus was excluded from the regional examination of fetal 
liver oxygenation.
Animal preparation: The animals were sedated with Rompune 2.5mg and transported to the 
hospital unit. Anesthesia was induced by Ketamine 2 mg/kg and Dormicum 0.25mg/kg.
Orotracheal intubation was performed followed by artificial ventilation, and anesthesia was 
maintained by Isoflurane 1.5% in an O2 /N2O mixture. Maternal arterial blood gas analysis was 
provided by catheters in the left common carotid artery. Ruminants develop a considerable 
amount of gas in the digestive tract; therefore, a gastic probe was installed to reduce the 
accumulation of intra abdominal gas. To ensure adequate ventilation in spite of the increasing 
intraabdominal pressure, the expiratory CO2 was monitored throughout the anesthesia, and pCO2
was kept below 7.0 kPa. Internal oxygen sensitive optodes were inserted for direct measurement 
of fetal oxygenation. The optodes were inserted into the fetal organs guided by ultrasound.
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Initially, we aimed to insert optodes in several fetal organs for simultaneous oxygenation 
measurements. However, because of technical difficulties the optodes were only inserted and well 
functioning in the fetal liver of 4 out of 7 animals. The optode consisted of a 0.9 mm thin fiber-
optic cable coated with fluorescent sensor material at the tip. The principle of measurement is
dynamic luminescence quenching, which is directly proportional to the local tissue pO2 (170). 
When compared to conventional oxygen sensitive electrodes, this optode has the advantage of 
not consuming oxygen during measurements.
BOLD MRI scan: The ewe was transported to the MRI suite for the BOLD MRI scan. The 
anesthetized ewe was placed in a left lateral position with a phased array abdominal radio-
frequency coil placed over the uterus for optimal fetal imaging. Initially fast axial and coronal T2 
weighted scans were performed for anatomic location of the fetus and for planning the BOLD MRI 
scan to follow. This fetal BOLD MRI scan was performed using varying levels of maternal oxygen 
content of the ventilated gas (14% O2 – 100% O2). The scan parameters are presented in Table 1.
Data handling: The raw MRI data was transferred to an external workstation and filtered using 
dedicated software. ROIs were drawn corresponding to the fetal liver, spleen, kidney and brain
and motion correction was performed manually in each frame in order to keep the ROI inside the 
selected fetal organ. Due to the experimental setup which included general anesthesia, the fetal 
movements were greatly reduced. For each ROI the absolute BOLD signal versus time curve was 
calculated. Mean curves were drawn for each organ based on the data from each of the 7 fetuses. 
Furthermore, in the fetal liver the regional oxygenation was investigated by several smaller ROIs 
distributed from the right to the left side of the liver. By comparing the BOLD signal of the very left 
and the very right ROI of the fetal liver the left-right oxygenation difference was estimated. In the 
investigation of regional liver oxygenation, a normalization of the BOLD response was performed 
using the normoxic BOLD signal as a reference in each ROI (Formula 5).
The human fetal study (Paper 3)
The human fetal study was performed at the Department of Obstetrics and Gynecology and the 
MRI Research Center at Aarhus University Hospital in Skejby. Eight healthy women carrying 
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singleton fetuses at gestational week 28 to 34 were included in the study. Prior to the BOLD MRI 
scan a comprehensive fetal ultrasound examination was performed including fetal weight 
estimation, amniotic fluid index, and Doppler blood flow examination of the following vessels: 
uterine artery, umbilical artery, middle cerebral artery and ducus venosus. For each fetus all
measurements were within the normal range.
BOLD MRI scan: The pregnant women were placed in a left lateral position to avoid vena cava 
compression during the MRI scan, and a multi-receiver cardiac surface coil was placed over the 
abdomen. Initially fast coronary and axial T2 weighted scans were performed for the anatomic 
location of the fetus and for planning the following BOLD MRI scan. The scan parameters are 
presented in Table 1. Maternal hyperoxia was induced by breathing in a Hudson non-rebreathing 
facial mask with the oxygen supply of 100%O2 at 12 liter/minute. Because the facial mask was not 
perfectly tight, the actual maternal oxygen supply was approximately 70%. 
Figure 16 The maternal oxygen supply during the BOLD MRI scan in the human fetal study.
As indicated by Figure 16 each scan lasted a total of 25 minutes, including three consecutive 
oxygenation episodes: (1) normoxia: 21% O2 lasting 5 minutes, (2) hyperoxia: 70% O2 lasting for 10 
minutes and finally (3) normoxia: 21% O2 lasting 10 minutes. The facial mask was applied and 
removed from the womens’ faces without interference with the BOLD scan and maternal position
inside the magnet.
Data handling: The MRI raw data were transferred to an external workstation and processed by 
dedicated software equivalent to the software previously used by our group in the sheep study. 
ROIs were drawn according to the fetal liver, spleen, kidney brain and the placenta, and motion 
correction was performed manually in each frame. In this study no anesthesia was included, and 
Maternal
normoxia
5 minutes
Maternal
hyperoxia
10 minutes
Maternal
normoxia
10 minutes
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
41
the fetal movements were greatly increased when compared to the sheep study. In each ROI a
normalization of the BOLD signal was performed using the normoxic starting BOLD signal as a 
reference (Formula 4) and normalized BOLD versus time curves were drawn. The calculation of the 
hyperoxic BOLD response (ΔBOLD) was based on the mean BOLD signal of the last 5 minutes of the 
hyperoxic episode in each individual (Formula 5). Mean ΔBOLD values were calculated for each 
organ base based on data from all eight individuals, and ∆BOLD was tested using a paired t-test, in 
which a p-value < 0.05 was considered statistically significant.
The human placental study (Papers 4+5)
This study was performed in the Department of Obstetrics and Gynecology and the Department of 
Radiology at Aalborg University Hospital. A total of 24 healthy pregnant women carrying singleton 
fetuses at gestational weeks 24 to 40 were included in this study. Paper 4 is based on the first 8 
women included, and paper 5 is based on all 24 women. At inclusion a comprehensive fetal 
ultrasound examination (equivalent to the human fetal study), and all measurements were within 
normal range. 
Placental BOLD MRI: The pregnant woman was placed in a left lateral position, and the cardiac 
surface coil was placed over the abdomen. T2 weighted scan was performed for the anatomic 
position of the fetus. The scan parameters are presented in Table 1. As shown in figure 17 the 
BOLD MRI scan lasted a total of 10 minutes including 2 consecutive oxygenation levels: normoxia 
21% O2 (5min.) and hyperoxia 70% O2 (5min.). Maternal hyperoxia was induced by using a Hudson 
non-rebreathing facial mask.
Figure 17 The protocol of the maternal oxygen supply during the BOLD MRI scan in the human placental study.
Placental T2* measurement: The placental T2* relaxation time was estimated during normoxia
and hyperoxia by fitting the mono-exponential placental T2* decay curve (Formula 1) of each 
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oxygenation level. Furthermore, the reproducibility of placental T2* was investigated on three 
levels: 1) Slice-to-slice reproducibility (n=24), 2) Scan-to-scan reproducibility: repeat scan within a 
few minutes (n=17) and 3) Session-to-session reproducibility; repeat scan session within 45 
minutes (n=8). Bland-Altman plots were performed and 95% limits of agreement were calculated
for each level. The relation between placental T2* and gestational age was investigated and tested 
using a linear regression analysis. Furthermore, the increase in placental T2* value during 
hyperoxia (∆T2*) was estimated and tested using a paired t-test. In each test a p-value < 0.05 was 
considered statistically significant.
Data handling: The DICOM data were transferred to a computer equipped with the new MAT-LAB
software. Initially the appearance of placenta in the BOLD image, and the visual hyperoxic changes 
were described. The total placental oxygenation was estimated by one ROI covering the entire 
placenta. Furthermore, the regional placental oxygenation was investigated by two smaller ROIs 
drawn in the bright and dark placental region. Normalization of the BOLD signal was performed
using the normoxic BOLD signal as a reference in each ROI (Formula 4). For each ROI the hyperoxic 
BOLD response (∆BOLD) was calculated (Formula 5), using the mean BOLD signal of last 2 minutes 
of the hyperoxic episode in each fetus. ΔBOLD was calculated in each individual and mean ∆BOLD 
was calculated for the total and regional placenta, respectively.
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Summary of results
In the following section the main results of the three studies are summarized. For detailed 
information references are made to the five publications forming the basis of this thesis.
The sheep study (Papers 1+2)
In four fetuses the changes in fetal liver oxygenation were estimated directly by the oxygen 
optodes. In these fetuses a close relationship between changes in fetal liver oxygenation and
changes in the BOLD signal of the fetal liver was demonstrated (Figure 18); though, it could be 
concluded, that changes in the BOLD signal reflect changes in fetal tissue oxygenation (25).
Figure 18 Left: The association between changes in the BOLD signal of the fetal liver (A), the direct 
measurement of fetal liver oxygenation (B) and maternal arterial pO2 (C) in one fetus. Top right: BOLD 
image of the sheep fetus. The fetal liver is selected as the region of interest. Bottom right: The 
association between the BOLD signal of the fetal liver and direct measurement of fetal liver oxygenation 
in 4 sheep fetuses (25).
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At varying oxygenation levels the corresponding changes in the BOLD signal of the placenta and 
the fetal spleen, liver, kidney and brain were investigated. The findings in one fetus are shown in
Figure 19.
Figure 19 The timeline of changes in the BOLD signal of the fetal brain, spleen, liver and kidney in one fetus during maternal 
hypoxia (10%  O2)  and hyperoxia (70% O2) (25).
During hypoxia the BOLD signal of the fetal liver, spleen and kidneys was decreased and during 
hyperoxia it was increased. In contrast, the BOLD signal of the fetal brain did not change during 
the experiment. This was a consistent finding in all of our seven fetuses (25).
The BOLD signal of 7 smaller regions of the fetal liver was investigated. The distribution of the ROIs 
in the fetal liver and the changes in BOLD signal of each ROI are demonstrated in Figure 20.
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Figure 20  Right: BOLD image of the fetal liver with 7 ROIs placed at regular intervals from the left to the 
right side of the liver. Left: The changes in BOLD signal of the 7 ROIs during maternal hypoxia and 
hyperoxia. The blue bars indicate the values included to calculate the BOLD response (ΔBOLD) presented 
in Figure 21 (171).
During hypoxia the BOLD signal of each region was reduced, and during hyperoxia it was 
increased. However, during hypoxia a remarkable difference between the regions was 
demonstrated. The BOLD signal of the right-sided regions was reduced to a lower level than the 
left-sided regions. Figure 21 demonstrates the BOLD signal of the very left and the ve ry right ROI 
of each fetus. The left-right difference is calculated during hyperoxia and hypoxia in each fetus, 
and the mean values are calculated for the total group during each oxygenation level.
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Fetus
ID-
number
Reference
(Normoxia)
Hyperoxia Hypoxia
BOLDReference
Entire fetal liver
Arbitrary units
(100%)
BOLDLeft
ROI 1
Arbitrary units
(%)
BOLDRight
ROI 7
Arbitrary units
(%)
ΔBOLDLeft-right
ROI 7 - ROI 1
BOLDLeft
ROI 1
Arbitrary units
(%)
BOLDRight
ROI 7
Arbitrary units
(%)
ΔBOLDLeft-
right
ROI 7 – ROI 1
1 517
627 ± 26
(121,2)
631 ± 27
(122,0)
-0.8 %
407 ± 65
(78,7)
390 ± 70
(75,4)
3.3 %
3 401
439
(109,5)
458
(114,2)
-4.7 %
364
(90,8)
339
(84,5)
6.2 %
5 477
606
(127,0)
598
(125,3)
1.7 %
247
(51,8)
216
(48,3)
6.5 %
6 440
636
(144,5)
641
(145,7)
-1.1 %
382
(86,8)
365
(82,9)
3.9 %
7 443
494
(111,5)
516
(116,5)
-5.0 %
368
(83,1)
355
(80,1)
2.9 %
8 431
478
(110,9)
458
(106,3)
4.6 %
348
(80,7)
312
(72,4)
8.4 %
Mean -0.9 % 5.2 %
SD 3.7 % 2.2 %
Paired t-
test
P=0.002
Figur 21 The BOLD signal (arbitrary units) of the very left ROI (BOLDleft) and the very right ROI (BOLDright)
of the fetal liver. The left-right difference is estimated during hyperoxia and hypoxia in each fetus and for 
the group as a total using the normoxic BOLD signal of the total liver as a reference (BOLDReference) in each 
ROI (171).
During hyperoxia the mean left-right difference (ΔBOLDLeft-right) was -0.9% ± 3.7 (mean ± SD), and 
during hypoxia it was 5.2% ± 2.2 (mean ±SD). The left-right difference was significantly increased 
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during hypoxia (p=0.002) (171). Furthermore, a significant linear correlation between the hypoxic 
left-right oxygenation difference and the degree of hypoxia was found (Figure 22).
Figure 22 The correlation between the left-right difference in fetal liver oxygenation and the degree of 
hypoxia indicated by maternal arterial pO2. Linear regression is performed and Pearson correlation 
coefficient (R) and the corresponding p-value are presented in the figure (171) .
The human fetal study (Paper 3)
In the human fetus the changes in the BOLD signal in a number of fetal organs was investigated 
during maternal hyperoxia. In the BOLD images the ROI was drawn in different locations according 
to the fetal organs as demonstrated in Figure 23. 
Figure 23 BOLD images of the human fetus and the placenta (axiale planes). The ROIs are drawn 
according to several fetal organs and the placenta. (A) Placenta (red) and fetal liver (green). (B) Fetal 
kidney (red). (C) Fetal brain (green) (28).
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For each ROI the changes in the normalized BOLD signal can be investigated during maternal 
hyperoxia as shown in Figure 24. The normalization of the BOLD signal is performed in each ROI 
using the initial normoxic BOLD signal as a reference.
Figure 24 Changes in normalized BOLD signal during maternal hyperoxia. Each organ is identified by the 
color of the curve. The blue bars indicate the value obtained for calculation of the hyperoxic BOLD 
response (ΔBOLD) (28).
During hyperoxia the BOLD signal of the fetal liver, spleen and kidney as well as the placenta was 
increased. However, the BOLD signal of the fetal brain remained co nstant. A consistent pattern 
was demonstrated in the 8 individuals as the BOLD signal of the fetal liver and spleen was doubled 
when compared to the placenta, and the fetal kidney. In all individuals the BOLD signal of the fetal 
brain did not change during hyperoxia.
The hyperoxic BOLD response (ΔBOLD) was calculated for the fetal organs and the placenta and
data are shown in Figure 24.
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Fetus
Number
Gestational 
age
(weeks + 
days)
Fetal 
weight
UL  
estimated
(gram)
ΔBOLD
Fetal
Liver
(%)
ΔBOLD
Fetal
Spleen
(%)
ΔBOLD
Fetal
Kidney
(%)
ΔBOLD
Placenta
(%)
ΔBOLD
Fetal
Brain
(%)
1 28+2 1381 14.6 15.3 5.2 5.5 -0.3
2 28+0 1350 -0.6 2.2 0.5 0.5 -0.01
3 28+6 1555 33.3 33.2 14.4 13.1 0.8
4 27+4 1038 13.9 16.0 5.3 4.7 0.7
5 34+1 2227 22.9 23.2 12.7 12.9 -0.3
6 33+6 2392 4.8 5.6 0.3 2.2 0.1
7 33+2 2190 9.1 9.0 3.8 4.6 1.5
8 33+6 2273 16.0 17.4 7.3 8.5 0.3
Mean 
(±SEM)
14.3
(±3.7)
15.2 
(±3.5)
6.2
(±1.8)
6.5
(±1.6)
0.3
(±0.2)
P-value 0.006 0.003 0.006 0.005 n.s.
Figure 25 The hyperoxic BOLD response (ΔBOLD) of the fetal organs and the placenta in each individual 
and organ specific mean. For each organ the increased in BOLD signal is tested by a paired t-test, and the 
p-value is demonstrated in the Figure (28).
During maternal hyperoxia the BOLD signal was significantly increased in the placental and all fetal 
organs except for the fetal brain. 
The human placental study (Papers 4+5)
In this study the placental response to maternal hyperoxia was investigated by the BOLD MRI 
technique. During hyperoxia a rather dramatic visual change occurred in the BOLD image (Figure 
26)
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Figure 26 BOLD image demonstrating a cross section of the placenta and fetus during normoxia (A) and 
hyperoxia (B). White arrows indicate the placenta (27).
During normoxia the placenta appeared heterogeneous. Dark areas were located to the fetal side 
of the placenta and brighter areas were located to the maternal side. During hyperoxia however, 
placenta became brighter. The tissue appeared homogeneous, and the dark areas were no longer 
visible.
The visual changes were quantified by estimating the increase in BOLD signal of the total placenta 
during hyperoxia. ROIs were drawn covering the entire placenta, and the absolute BOLD signal was
normalized using the normoxic BOLD signal as a reference in each ROI.  The normalized BOLD 
signal versus time curves were drawn for each ROI (Figure 27).
A B
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Figure 27 The normalized BOLD signal versus time curves the total placenta. The ROI is demonstrated in 
the BOLD image in the lower right corner. Three central slices within the same placenta are
demonstrated (27).
Data from one individual is shown in Figure 27. The three curves represent three different slices 
within the same placenta. The curves are very similar, indicating a high reproducibility of the 
hyperoxic BOLD response within the same placenta. Data from the 8 individuals are presented in 
Table 1.
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Table 1 The hyperoxic BOLD response of the total placenta (ΔBOLDtot), the fetal placenta (ΔBOLDfet), and 
the maternal placenta (ΔBOLDmat) for the eight individuals included in paper 4.
ID number
Gestational 
age
(weeks + 
days)
Total placenta
ΔBOLDtot (%)
Mean±SD (3 
slices)
Dark placental area
Fetal side
ΔBOLDfet (%)
Mean±SD (3 slices)
Bright placental 
area
Maternal side
ΔBOLDmat (%)
Mean±SD (3 slices)
1 30+5 19.4 ± 5.4 48.3 ± 19.2 10.9 ± 0.8
2 28+2 12.6 ± 2.2 30.6 ± 15.6 4.4 ± 1.4
3 32+1 19.1 ± 2.5 43.1 ± 16.4 6.8 ± 8.4
4 35+1 12.9 ± 3.4 27.5 ± 8.5 3.2 ± 6.4
5 35+5 12.3 ± 4.4 27.9 ± 11.1 1.8 ± 3.3
6 33+0 12.1 ± 1.3 34.4 ± 20.9 2.1 ± 5.5
7 36+3 17.9 ± 3.6 23.2 ± 12.5 4.3 ± 8.6
8 35+2 15.4 ± 1.0 22.2 ± 7.8 10.0 ± 6.5
Mean± SD 15.2 ± 3.2 32.1 ± 9.3 5.4 ± 3.5
P-value p<0.0001 p<0.0001 p<0.003
For the total group of 8 individuals the mean hyperoxic increase in the placental BOLD signal was 
significantly increased 15.2% ± 3.2 (mean ± SD), (p<0.0001). A curve demonstrating the mean 
normalized BOLD signal ± SD of the total placenta can be drawn as shown in Figure 28.
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Figure 28 The mean value of the normalized placental BOLD signal of the 8 individuals. Error bars indicate 
the standard deviation. (Unpublished)
Within each placenta, the hyperoxic response of the dark and the bright regions were investigated 
separately by drawing a small ROI in the bright and the dark placental regions.
Figure 29 Changes in the normalized BOLD signal of two different placental regions during maternal 
hyperoxia in one case. The placenta ROIs are demonstrated by the BOLD image in the lower right corner. 
Blue bar indicated the values of the 2 last minutes of the hyperoxic episode included for calculation of 
ΔBOLD (27).
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The hyperoxic BOLD response of the two regions was quite different; the hyperoxic increase in the 
BOLD signal was predominantly seen in the darker region of the placenta. This difference between 
the two regions was a consistent finding in each of the 8 individuals. Based on all individuals mean
values were calculated for both regions; ΔBOLDdark=32.1% ± 9.3 and ΔBOLDbright=5.4% ± 3.5 (mean 
±SD). The difference between ΔBOLD of the two regions was highly significant, when tested by a 
paired t-test, p<0.0001.
After the publication of paper 4, 16 more women were included. Because of difficulties in 
identifying the steady state level of the hyperoxic placental BOLD signal three individuals were 
excluded from the calculation of ΔBOLD. In total the group of 21 individuals ΔBOLD was 14.4% ± 
6.0, which is very similar to the findings of the first 8 individuals. Figure 30 shows the relation 
between the placental ΔBOLD and gestational age and a significant linear correlation was found as 
the placental BOLD response is increased by 0.6% per gestational week.
Figure 30 The relation between the hyperoxic placental response (ΔBOLD) and gestational age (n=21). A 
linear regression analysis is performed (the thick line), and Pearson coefficient (R) and p-value are 
presented in the figure. Dotted lines indicate the 95% confidence interval and dashed lines indicate the 
95% prediction interval. (Unpublished)
R
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=0.24, p=0.01
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
55
In the total group of 24 women the placental T2* relaxation time was investigated. Initially the 
reproducibility of the placental T2* measurement was assessed regarding three levels of variation: 
(1) the slice-to-slice variation, (2) the scan-to-scan variation and (3) the session-to-session 
variation. For each of the three levels the reproducibility is estimated by bar plots, Bland-Altman 
plots and identity plots as shown in Figure 31.
Figure 31 The reproducibility of placental T2* measurements demonstrated by bar plots, Bland-Altman 
plots and identity plots. Three levels of variation are investigated slice-to-slice (top), scan-to-scan 
(middle) and session-to-session (bottom).(Paper 5)
For each of the three levels, no systematic differences were demonstrated between the two 
measurements of placental T2*. The 95% limits of agreement indicates, that the reproducibility is 
best when the placental T2* is measured in two slices of the same placenta as it has the narrowest 
limits of agreement (-1.8±13.1 ms). The reproducibility between scans and between sessions is
almost the same -0.1±17.8 ms and -0.3±15.7 ms, respectively.
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The mean placental T2* value was 81.3 ms ± 28.1 (mean ± SD) and a significant linear relation was 
demonstrated between placental T2* and gestational age. The placental T2* value was found to 
decrease by 4.84 ms per gestational week (Figure 32).
Figure 32 The relation between placental T2* and gestational age. The thick line indicates the linear 
correlation and Pearsons coefficient (R) and p-value are presented in the figure. Dotted lines indicate 
95% confidence interval and dashed lines indicate 95% prediction interval. (Paper 5)
The hyperoxic placental response (ΔT2*) was investigated, and the findings are demonstrated in 
Figure 33
Placental T2*
R
2
=0.68, p<0.001
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Figure 33 Each column represents the hyperoxic placental T2* response (ΔT2*) in one individual. The 
individuals are arranged according to gestational age. The dashed line indicates the mean ΔT2* of the 24 
individuals.(Paper 5)
In the group of 24 individuals the mean ΔT2* was 14.4 ms ±12.8 (p=0.00002). The increase was 
statistically significant when tested by a paired t-test, but ΔT2* tended to vary between individuals 
as shown in Figure 33. 
14.4 ms ± 12.8
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Discussion
First, the general methodological aspects of fetal BOLD MRI are discussed. The limitations of the 
method are presented including the experience we have had working with this method over the 
years to assess fetal and placental oxygenation. Following is a discussion of the main findings of 
each of the individual studies. Possible physiological explanations are offered for the BOLD MRI 
findings, as the BOLD findings are related to previous studies based on ultrasound Doppler 
examination of fetal and placental circulation and previous studies in BOLD MRI.
General aspects
There are several general aspects of the BOLD MRI method that need to be considered when 
interpreting the BOLD findings.
The qualitative BOLD scan versus the quantitative T2* measurement
The BOLD signal provides dynamic information about changes in tissue oxygenation; however, 
absolute oxygenation cannot be estimated by the BOLD scan. The baseline BOLD signal depends
not only on tissue oxygenation but also on technical parameters and tissue physiology (172). Only 
relative changes, as estimated  by the normalized BOLD signal, can be directly compared between 
individuals. The T2* measurement is a quantitative method. It is directly comparable between 
individuals. It is tissue specific and depends on several factors such as tissue morphology and 
tissue oxygenation (173,174). In our data we observed that the distance between the placenta and 
the receiver coil had a strong influence on the absolute BOLD signal. The absolute BOLD signal of 
an anterior placenta is almost doubled when compared to a posterior placenta, however the 
normalized BOLD response and the placental T2* value is not affected by the distance to the 
receiver coil. This finding highlights the important difference between the qualitative BOLD scan 
and the quantitative T2* measurement.
The magnitude of the BOLD response
Tissue physiology
The changes in the BOLD signal reflect changes in the amount of dexohgb present in the region of 
interest. The amount of deoxyHgb present will depend on local tissue metabolism, blood 
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perfusion, blood volume and the oxygen content of the blood (10). In its traditional use BOLD MRI
provides information about brain activation by detecting changes in tissue metabolism and 
cerebral blood flow (12,13). In our studies of the fetus and placenta, we assume that the tissue 
metabolism is constant and we estimate the effect of altered maternal oxygen supply. However, 
changing the maternal oxygen supply might affect the blood volume and blood flow of the fetal 
organs and the placenta. These changes need to be taken into consideration as they influence the 
BOLD response. In previous studies, the fetal and placental circulatory changes during hypoxia and 
hyperoxia have been extensively investigated by Doppler flow measurements of fetal, umbilical 
and uterine vessels (see the background section). In our studies, we have related the fetal BOLD
MRI findings to well described circulatory changes of the fetal brain and the fetal liver based on 
previous ultrasound studies. However, we did not estimate these parameters directly in our 
experiments. The magnitude of the BOLD response also relies on baseline tissue physiology such 
as baseline tissue oxygenation, and as the BOLD response is supposed to increase when baseline 
tissue oxygenation is decreased (172). In our data we found that the hyperoxic BOLD response was 
increased with increasing gestational age. This finding might be explained by the well described 
decrease in placental oxygenation with increasing gestational age (175).
Technical factors
Furthermore, the magnitude of the BOLD response also depends on technical parameters. In our 
studies, we increased the echo time in order to increase the hyperoxic BOLD response of the 
placental tissue. This change was based on the T2* decay curves of the normoxic and the 
hyperoxic placenta. Following this change in TE the hyperoxic placental BOLD response was 
increased from 6.2% to 15.2%. However, the two studies were performed in two different 
locations and at two different MRI systems (Philips versus GE), which might also have influenced
the magnitude of the BOLD response. Shimming differences between the two MRI systems might 
contribute to some of the difference between the scans.
Fetal versus adult hemoglobin
The hgb molecule consists of 2 pairs of polypeptide globin chains and four heme groups. The 
globulin chains determine the type of hgb formed. Fetal hgb consist of two alpha chains and two 
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gamma chains, this is in contrast to adult hgb in which the gamma chains are replaced by beta 
chains (96). The paramagnetic effect of deoxyHgb depends on the electrons of the heme groups 
which are similar in fetal and adult hgb (1). Therefore it is expected, that the magnetic 
susceptibility of fetal and adult blood should be the same. Actually, the BOLD method is very 
suitable for estimating changes in the oxygenation in fetal blood in particular, because at 
normoxia fetal blood has a rather low saturation (80%) when compared to adult blood (100%)(92).
Because of the sigmoid shape of the hgb dissociation curve, the curve is steeper at lower 
saturation levels. This means that at lower hgb saturation any given increase in pO2 would make a 
more pronounced increase in hgb saturation. This explains why a stronger BOLD response would 
be expected in fetal blood when compared to maternal blood. The placenta contains a mixture of 
fetal and maternal blood, but the hyperoxic BOLD response (ΔBOLD) is predominantly derived 
from an increase in the saturation of fetal blood as maternal blood is already fully saturated at 
normoxia. Therefore the magnitude of ΔBOLD reflects placental oxygen transport capacity (27).
Fetal movement artifacts
One major limitation of the BOLD MRI method is that it is very sensitive to fetal movements. In our 
human studies we experienced a transient increase in fetal movement during the initial two or 
three minutes of each BOLD MRI scan. This finding is well known (44), and it is explained as a fetal 
response to noise during the MRI scan. Because the echo planar imaging (EPI) sequence used in 
the study the images are acquired very fast, and the quality of the BOLD image is therefore not 
severely affected by fetal movements. However, when moving the ROI in the BOLD image in order 
to keep the ROI within the selected organ during fetal movements the distance to the coil is 
influenced. As mentioned earlier, the absolute BOLD signal is decreased when the distance to the 
coil is increased. Therefore the fetal movements affect the absolute BOLD signal, and the changes 
in the BOLD signal due to moving the ROI exceeds the changes induced by oxygenation changes. In 
the sheep model, the fetal movements were reduced because of the use of anesthesia; however,
in the human studies the fetal movements were greatly increased. The first software used by our 
group was capable of reducing the movement artifacts; however, with the second MATLAB
software it was impossible for us to estimate the hyperoxic BOLD response from any fetal organs
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
61
because of movements. Because of this software problem (se the method section), we changed 
focus towards placental BOLD MRI while we are trying to develop an adequate motion correction 
tool for the new software. To date only a few papers have been published in human fetal BOLD 
MRI (16-21,28). In all of these publications the method has been limited because of fetal 
movements. The most successful study was published by our group when using the old software
(28); unfortunately, it has not been possible to reproduce these results with the MATLAB software.
The hyperoxic placental response: ΔBOLD and ΔT2*
The hyperoxic placental response was estimated by 1) the change in placental BOLD signal 
(ΔBOLD) and 2) the difference between placental T2* measured in the hyperoxic and the normoxic 
episode (ΔT2*). The mean value of placental ΔBOLD was 14.4% ± 6.0 and in placental ΔT2* was 
14.4ms ± 12.8. The inter-individual variation is quite different in the two estimates and placental 
ΔBOLD seems more robust. When looking at the corresponding BOLD scan of each individual a 
sudden dip in the placental BOLD signal was observed in some cases. One of these cases is 
demonstrated in Figure 34.
Figure 34 A sudden unexplained drop in the placental BOLD signal. Data from one case. Each curve 
represents one slice within the same placenta (Unpublished).
The depth of the drop in the BOLD signal varied between cases, however in each case the drop 
was identical in all placental slices, and the timing of the drop was independent of maternal 
hyperoxia. Any decrease in the placental BOLD signal reflects an increase in the amount of 
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deoxyHgb. A possible explanation of this sudden change could be reduced placental perfusion
caused by either maternal aorto-caval compression (176) or uterine contractions (177). In the 
dynamic BOLD scan some of these cases demonstrated signs of uterine contractions such as 
altered shape of the uterus and transient thickening of the uterine wall according to the drop in 
BOLD signal. However, this finding needs to be investigated in another study including CTG for 
monitoring uterine contractions. In some of the cases the drop in placental BOLD signal interferes
with the steady-state levels of either the normoxic or the hyperoxic episodes, which complicates 
the calculation of the ΔBOLD. When we identified this problem we increased the hyperoxic 
episode from 5 to 10 minutes for better identification of the hyperoxic placental BOLD steady 
state level. In most cases the steady state level could be identified, however 3 individuals were
excluded from the calculation of ΔBOLD. Furthermore, in 9 cases the drop in placental BOLD signal 
extended into the hyperoxic placental T2* measurements, and so the ΔT2* measurement could be 
biased. Therfore we re-analyzed placental T2* data excluding the 9 individuals. Figure 35 is a 
reproduction of Figure 33, in which the 9 individuals excluded from the analysis are marked by red 
columns.
Figure 35 The placental T2* difference (hyperoxic T2* - normoxic T2*). Figure 33 re-analyzed. The red 
columns indicate the individuals excluded from the analysis. The bright dashed line indicates the original 
mean increase in placental T2* of all individuals. The dark dashed line indicates the re-analysed mean 
increase in placental T2* value of the remaining 13 individuals. (Unpublished)
21.0 ± 7.5 ms
14.4 ± 12.8 ms
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When re-analyzing data the hyperoxic placental T2* response increased from 14.4ms ± 12.8 to 
21.0 ms ± 7.5 (mean± SD) as demonstrated in Figure 35. By excluding the 9 cases the variation was 
decreased. This finding highlight the importance of including the dynamic BOLD scan when 
estimating placental T2*measurements. Another explanation of the ΔBOLD being more robust 
than ΔT2* in estimation placental hyperoxic response is that the calculation of ΔT2* is based on 
two single measurements of placental T2*, which is in contrast to the multiple time points 
included for the calculation of ΔBOLD. 
The discussion of each study
The sheep study (Paper 1+2)
The main finding of the sheep study was the close relationship between the changes in the BOLD 
signal of the fetal liver and the direct measurements of fetal liver oxygenation. This finding is in 
accordance with other studies demonstrating a close correlation between the BOLD signal of 
several fetal organs and fetal oxygenation when estimated by the saturation of the fetal carotid 
artery blood (22-24).
Unlike most other studies we included not only maternal hypoxia, but also maternal hyperoxia, 
and we demonstrated a close relationship between maternal oxygenation and the BOLD signal of 
several fetal organs except for the fetal brain. However, we did not find a linear relationship as 
previous suggested by Wedegärtner et al (22). Our data demonstrated a flattening of the curve at 
higher oxygenation levels. This finding could be explained by the sigmoid shape of the hgb
dissociation curve. At higher oxygenation levels any given increase in pO2 leads to a less marked 
increase in hgb saturation. During maternal hyperoxia we demonstrated a consistent increase in 
the oxygenation of the fetal liver, spleen and kidney. This finding is in accordance with other
publications having demonstrated that fetal oxygenation is increased during maternal hyperoxia
(148-151)(153). A possible physiological explanation for this finding is the increase in maternal 
arterial pO2 which increases the trans-placental pO2 gradient and thereby improves the placental 
oxygen transfer to the fetus (87,128).(128)
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We demonstrated that the BOLD signal of the fetal brain did not change during varying maternal 
oxygenation levels. This finding is likely explained by the autoregulation of fetal cerebral blood 
flow – also known as the brain sparing mechanism. It is well described by ultrasound Doppler flow 
measurements that during hypoxia the blod flow to the fetal brain is increased to maintain a 
normal cerebral oxygenation (128). Interestingly, this protective brain sparing mechanism might 
also be demonstrated during hyperoxia, because the BOLD signal of the fetal brain also remained
constant during maternal hyperoxia. This mechanism is less well known; nevertheless, ultrasound 
Doppler studies of sheep (149,160) as well as of human fetuses (159,161) have demonstrated that 
the resistance of the cerebral vessels was increased during fetal hyperoxia. Our BOLD findings are
in contrast with previous studies published by Wedegärtner et al (22,178,179), in the studies 
published by Wedegärtner the BOLD signal of the fetal brain was decreased during maternal 
hypoxia. However, these studies are not directly comparable with our studies. The first study of 
Wedegärtner was performed during short extreme maternal hypoxia (179), and the following two 
studies were performed on a 3Tesla MRI system (178,179), which is expected to be more sensitive 
in measuring oxygenation changes (24). However, in both studies the BOLD signal of the fetal liver 
and heart was decreased to a greater extent than that of the fetal brain.
Another interesting finding of the sheep study was the increasing left-right difference in fetal liver 
oxygenation during hypoxia. The reason why the left-right difference is increased during hypoxia,
could be explained by increased ductus venosus shunting. During hypoxia an increasing amount of 
oxygen rich umbilical vein blood is shunted away from the fetal liver, especially the right side of 
the live, towards the fetal heart and brain to improve the oxygenation of these important central 
organs, and the degree of shunting is related to the degree of hypoxia (122). This is in accordance 
with our findings, demonstrating an increasing left-right oxygenation difference with decreasing 
maternal pO2. In this study only the relative changes in fetal liver oxygenation were estimated as 
the BOLD method provides no information about absolute oxygenation. 
A limitation of the study was that the degree of maternal and fetal hypoxia was not standardized 
in each animal experiment. The oxygen content of maternal ventilated gas was varied between 
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10% and 100% in each animal. Even at a certain level of oxygen the maternal oxygenation varied 
among individuals. These differences could be explained by maternal lung athelectasis due to the 
long duration of the experiment. Therefore, maternal oxygenation was estimated by arterial blood 
samples rather than the oxygen supply of the ventilation gas. Another limitation of the study was
the use of general anesthesia. The cardiovascular depressant effects of anesthetic drugs used for 
induction might have affected the fetal vascular reactivity transiently. However, as these drugs 
were introduced at least 90 minutes prior to the BOLD MRI scan, it is unlikely that they affected 
the BOLD findings. The anesthesia was maintained by isoflurane inhalation which has a known
cardiovascular depressant effect (180). Thus, isoflurane might have reduced the fetal vascular 
response, leading us to underestimate the effect of hypoxia on the left-right fetal liver 
oxygenation difference.
Extrapolation of data from animal to human physiology should be performed with caution. 
However, the sheep is a well known model of the human fetus and placenta (109). The sheep 
placenta has been extensively investigated, and there are known differences between the human
and the sheep placenta. First, in the sheep placenta the oxygen transport is less effective, and so 
the pO2 difference between the maternal and fetal blood is increased when compared to humans. 
This difference can be explained by the sheep placenta being epithelio-chorial and by the 
arrangement of the fetal and maternal vessels in a concurrent pattern (74). The fetal sheep 
physiology, the neuro-endocrine and cardiovascular response on altered oxygenation is well 
documented and very similar to the human fetus (24,181,182). For fetal imaging the sheep fetus 
has an appropriate size, and the number of fetuses can be restricted to singletons. However, when 
it comes to placental imaging, the sheep placenta is not a very suitable model because the sheep 
placenta consists of separate cotyledons, which is in contrast to the discoid shape of the human 
placenta. 
The human fetal study (Paper 3)
This study demonstrated a significant increase in the normalized BOLD signal of several fetal 
organs during maternal hyperoxia. According to the sheep study, an increase in the BOLD signal 
reflects an increase in fetal oxygenation (25). In agreement with the findings of the sheep study
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(25), the BOLD signal of the human fetal brain did not change during maternal hyperoxia, and this 
finding is likely explained by autoregulation of the fetal cerebral blood flow as discussed in the 
previous section.
To date, only a few studies have been published in human fetal BOLD MRI. Brain activation has 
been demonstrated following in utero visual and acoustic stimulation (16-18). Furthermore, fetal 
liver T2* was increased in 5 out of 9 fetuses during maternal hyperoxia (20); however, in a larger 
study of 80 human fetuses this finding could not be reproduced (21). A possible explanation could 
be inaccuracy of the fetal T2* measurement due to fitting inaccuracy or fetal movement artifacts
which, in accordance with our experience, is an important limitation of this method. Because of 
this problem we focused on placental rather than fetal oxygenation in the study to follow.
The magnitude of ΔBOLD varied between the eight individuals included in this study. In fetuses
number 2 and 6 ∆BOLD of all organs was decreased when compared to the rest of the group. A 
possible explanation of this finding could be differences in maternal oxygen supply by the facial 
mask as the mask is not perfectly tight. Maternal blood is already fully saturated at room air; 
therefore, maternal pulse-oximetry would not provide any information in regards to maternal 
hyperoxygenation. In a group of 5 pregnant women, the efficacy of the facial mask was 
investigated by maternal arterial blood gas analysis, and it was demonstrated that during a 10 
minute period of oxygen breathing (100%O2, 12l/min.), maternal arterial pO2 was increased to 
45.0 ±8 kPa (not published). Another explanation of the differences in ∆BOLD among individuals
could be differences in placental oxygen transport capacity. However, as these are uncomplicated 
pregnancies with documented normal fetal weight and normal Doppler flow measurements, this
explanation is rather unlikely.
In each fetus we demonstrated a fixed relationship between ∆BOLD of the different fetal organs. 
∆BOLD of the fetal liver and spleen was doubled when compared to the ∆BOLD of the placenta 
and fetal kidney. This finding might be explained by organ-specific differences such as differences 
in blood volume and blood flow. Biological differences will affect the baseline BOLD signal and, 
thus, the magnitude of the BOLD response in each organ. Furthermore, imaging parameters, 
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especially the echo-time (TE), are important determinants of the magnitude of the BOLD response. 
The TE=40 ms selected in this study might favor the BOLD contrast of the fetal liver and spleen 
over the placenta and the kidney.
The human placental study (Paper 4+5)
In a group of 8 healthy pregnant women the changes in placental oxygenation were investigated 
during maternal hyperoxia. In the BOLD image the hyperoxic placental response could be 
visualized as the darker placental regions located to the fetal side became brighter and the 
placenta appeared more homogeneous. During hyperoxia the normalized BOLD signal of the total 
placenta was significantly increased, and the increase was predominantly seen in the darker 
regions of the placenta. We hypothesize that the dark placental regions represent the fetal part of 
the placenta. This hypothesis is based on the anatomic location of the dark placental regions on
the fetal side of the placenta, and the stronger increase in ΔBOLD of the darker placental regions 
when compared to the brighter placental regions. It is expected that ΔBOLD is increased in the
fetal part of the placenta when compared to the maternal part of the placenta, because of a lower 
saturation of fetal blood (80%) when compared to maternal blood (100%). Hyperoxia increases the 
saturation predominantly in fetal blood, and this is the reason why ΔBOLD of the total placenta is
predominantly derived from the fetal blood, and therefore ΔBOLD reflects the transplacental
oxygen transport. 
In the interpretation of ΔBOLD possible changes in placental perfusion and placental blood volume 
during hyperoxia should be taken into consideration. A possible vaso-constriction of the umbilical 
vessels due to hyperoxia was suggested based on in-vitro studies (166,167); however, these 
findings were never reproduced in vivo. Furthermore, any vaso-constriction of either the umbilical 
or the uterine vessels would tend to reduce the placental BOLD response, so we would
underestimate the placental BOLD response demonstrated in this study. 
When comparing the hyperoxic BOLD response in three central slices of each placenta, the 
technical reproducibility of the method seems rather high as demonstrated by Table 3. 
Unfortunately, there are no repeated scan sessions of the same individual available; therefore, the 
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reproducibility of the placental BOLD response cannot be properly addressed by this study. The 
mean ΔBOLD among the first 8 individuals was 15.0% ± 3.2, and in a larger group of 21 individuals 
is was 14.14% ± 6.0. The variation between individuals can be explained by factors such as 
inaccurate maternal oxygen supply, uterus contractions, and differences in placental perfusion and 
blood volume. 
A positive linear correlation was demonstrated between the placental ∆BOLD and gestational age, 
with an increase in ΔBOLD of 0.6% per gestational week. The influence of the baseline oxygenation 
on the magnitude of ΔBOLD has previously been demonstrated for the cerebral cortex, showing 
that ΔBOLD decreases with higher baseline oxygenation levels (172). It is well described that 
baseline placental oxygenation decreases with gestation age (175), and this might explain our 
findings. Another explanation of the increasing ΔBOLD could be an increase in transplacental 
oxygen transport at later gestation. The normal placental maturation includes an increase in the 
total villous surface area and a thinning of the placental membrane, which increases the placental 
oxygen transport by approximately 40% (72).
In a larger group of 24 individuals the mean normoxic placental T2* was 81.3 ±28.1 ms, and the 
placental T2* was linearly correlated to gestational age with a decrease of 4.8 ms per gestational 
week. These findings are in conflict with a previous publication by Huen et al (21), who found the 
mean normoxic placental T2* value to be only 54.6 ± 15.9ms without any correlation with 
gestational age. The placental T2* values of the two studies were estimated by using the same 
fitting method. However in the study published by Huen et al. a multiple gradient–recalled echo 
sequence using only 10 echo-times (TE=5 – 50ms) was used, which, is in contrast to the protocol of
our study using 16 echo-times (TE=3 – 67.5ms). By using a higher number of echo-times including 
longer echo-times the estimate of placental T2* should be more precise. Another possible 
explanation of the difference in placental T2* value could be differences in the mean gestational 
age of the two groups of women studied. 
The correlation between the placental T2* value and gestational age is in accordance with 
previous studies investigating placental T2 value (174,183,184). In these studies a linear 
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correlation between the placental T2 and gestational age was demonstrated with a decrease in 
placenta T2 value of 4.0 ms per week in a 0.5 Tesla system (183,184) and 2.4 ms per week in a 1.5 
Tesla system (174). Furthermore it was demonstrated that placental T2 was correlated to the 
amount of fibrin deposition indicating a morphological explanation for its relation with gestational 
age (174). It is well known that specific tissue characteristics determine tissue relaxation times. In 
general T2 relaxation time is increased with increasing tissue water content (173), decreasing 
surface area, and an increasing amount of macromolecular deposition (174). The normal placental 
maturation is known to include an equivalent increase in the total volume of villi and intervillous 
space; furthermore, the total placental membrane surface area is increased (72,185). The exact 
relation between these morphological changes and the T2 relaxation time still needs to be 
investigated. The T2* relaxation time depends on the T2 relaxation time, but it is also influenced 
by the local magnetic field inhomogeneties as created by the presence of deoxyHgb. We therefore 
suggest that the decrease in placental T2* value demonstrated in our study can be explained 
partly by the morphological changes in normal placental maturation, and partly by the well 
described decrease in placental oxygenation with increasing gestational age (175).
The reproducibility of the placental T2* value was investigated on three levels: 1) the slice-to-slice 
variation, 2) the scan-to-scan variation and 3) the session-to-session variation. For all levels the 
95% limits of agreement were estimated. As expected we demonstrated that the reproducibility 
was the best between slices (-1.8 ± 13.1 ms), but surprisingly, the scan-to-scan and session-to-
session variation was only slightly lower (-0.1 ± 17.8 ms) and (-0.3 ± 15.7 ms), respectively. These 
findings suggest that the variation of the method relies mainly on technical variation (such as
fitting inaccuracy, movement artifacts and scanner calibration) rather than biological variation; 
otherwise, the variation should have been increased when comparing the two sessions. The 
reproducibility of placental T2* needs to be evaluated in a clinical perspective, taking the potential 
difference between normal and pathological placenta T2* into consideration. If the difference 
between normal and pathological placenta T2* is very small the reproducibility needs to be high, 
and likewise if the difference in placental T2* is large, then a lower reproducibility is clinically 
accepted. Currently, the difference in T2* between normal and FGR placenta is unknown, but it 
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should be revealed by future studies of the FGR placenta. The method is not very sensitive in 
detecting the hyperoxic placental ΔT2*, because the expected mean ΔT2* is only 14.4±12.8 ms,
and 21.0 ± 7.5 ms when the cases demonstrating possible contractions were excluded. 
Unfortunately, ΔT2* is only slightly larger than the 95% limits of agreement in session-to-session 
variation of -0.3 ± 15.7 ms. 
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Conclusions
The overall conclusion of this thesis is that it is feasible to estimate fetal and placental oxygenation
changes non-invasively by using the BOLD MRI method.
The main conclusions of each of the 5 papers included in the thesis are as follows
Paper 1
In the sheep fetus changes in the BOLD signal of the total fetal liver reflect changes in fetal liver 
oxygenation directly estimated by internal oxygen sensors. During hyperoxia fetal oxygenation 
was increased and during hypoxia it is decreased. However, the oxygenation of the fetal brain 
remained constant. This finding could be explained by the auto-regulation of fetal cerebral blood 
flow.
Paper 2
In the sheep fetus the left-right oxygenation difference of the fetal liver was increased during 
hypoxia. This finding could be explained by increased ductus venosus shunting.
Paper 3
Human fetal and placental oxygenation was significantly increased during hyperoxia. However, as 
demonstrated in the sheep study, the oxygenation of the fetal brain remained constant. 
Paper 4
Human placental oxygenation was increased during hyperoxia. The dark placental regions 
represent the fetal parts of the placenta. The hyperoxic BOLD response of the total placenta is 
derived predominantly from the fetal blood and it reflects the transplacental oxygen transport.
Paper 5
The reproducibility of human placental T2* is described. Placental T2* is decreased during 
pregnancy, and it is increased during hyperoxia. Placental T2* reflects placental tissue morphology 
and oxygenation. 
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Perspective
The fetal and placental findings presented in this thesis are the result of research conducted in 
healthy pregnancies. Future studies should focus on pathological pregnancies such as FGR due to 
placental insufficiency. 
The clinical perspective of the method is a non-invasive test of placental function based on a 
combination of the following two parameters
 Placental T2* measurement, which reflects placental morphology and oxygenation
 Placental hyperoxic BOLD response (ΔBOLD), which reflects the transplacental oxygen 
transport
In the growth restricted fetus assessment of the placental function is of major importance, as 
impaired placental function is associated with fetal hypoxia, acidosis and still birth. As previously 
mentioned, current methods in fetal surveillance estimate fetal well being rather than placental 
function.
Previous publications have suggested maternal oxygen challenge as a test of placental function. In 
FGR pregnancies oxygen challenge was evaluated by either an increase in umbilical pO2 (153) or a
normalization of fetal brain sparing (158). And no response was suggested as an indicator of 
severely impaired placental oxygen transport, which predicted a poor neonatal outcome. In 
accordance with these studies placental ΔBOLD might be a predictor of poor neonatal outcome.
This theory is supported by a rat model of FGR. In this model the ∆BOLD of the feto-placental unit
is reduced when compared to healthy controls (29,30).
Previous publications have demonstrated that placental T2 is reduced in FGR pregnancies when 
compared to normal pregnancies (183,184,186). Placental T2 was reduced even before clinical 
signs of FGR (186), which is very important for the clinical perspective of this method. 
Morphological changes of the FGR placenta, such as increased necrosis and infarction, might
explain the lower T2 value in the FGR placenta. T2* relaxation is the sum of T2 relaxation and the 
effect of local magnetic field inhomogeneities such as created by deoxyHgb, and therefore it is 
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expected that T2* is also reduced in the FGR placenta. Actually, T2* might be even more sensitive
than T2 to detect placental pathology because it is more sensitive to tissue hypoxia. However this 
still needs to be investigated.
There are several limitations of this method. Some limitations can be controlled in future studies. 
These limitations include inaccurate maternal oxygen supply, which can be controlled by maternal 
non-invasive transcutaneous pO2 sensors, and uterine contractions, which can be monitored by
MRI compatible CTGs. Furthermore, we hope to develop an additional software tool to deal with
the changes in BOLD signal because of varying distance between the ROI and the receiver coil
during fetal movements. By introducing these improvements, the reproducibility of the method 
should be increased. However general limitations of the method such as altered baseline tissue 
oxygenation, hyperoxic changes in placental blood volume and blood flow are difficult to control 
for. These limitations should always be considered when interpreting BOLD findings.
Several aspects of the fetal and placental BOLD MRI method need further investigation. In the 
group of normal pregnancies the reproducibility of placental ΔBOLD still needs to be addressed.
The main focus for future placental BOLD MRI is pregnancies complicated by FGR because of 
impaired placental function. Placental ∆BOLD and T2* measurements should be performed in FGR 
pregnancies, and in each case longitudinal data should be obtained to demonstrate the timeline of 
progression in placental impairment. Another interesting perspective of BOLD MRI is the 
opportunity to investigate placental oxygenation changes during uterine contractions.
Placental BOLD MRI has the potential to become an important non-invasive test of placental 
function in selected cases of FGR. In these cases, BOLD MRI might provide the obstetrician 
valuable knowledge of placental function in order to decide how to monitor and when to deliver 
extremely high-risk fetuses.
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English summary
Placental function is crucial for fetal growth and development. Fetal growth restriction (FGR) due to 
impaired placental function is associated with an increased risk of neonatal morbidity and mortality
because of reduced supply of oxygen. The aim of fetal monitoring is to identify the growth restricted 
fetus to ensure rational monitoring intervals and timely delivery. Fetal monitoring is based on various 
methods, such as CTG, biophysical profile and ultrasound Doppler measurements of fetal and umbilical 
blood flow. Current methods focus on fetal wellbeing and thus only indirectly estimate placental 
function. Today, the only method available for direct assessment of placental oxygen transport is 
cordocentesis. This invasive procedure is associated with an increased risk of fetal loss and is therefore 
not used. In neuroscience Blood Oxygen Level Dependent (BOLD) magnetic resonance imaging (MRI) 
provides non-invasive information about brain oxygenation as changes in BOLD signal reflect changes 
in the saturation of hemoglobin. Furthermore, the transversal relaxation time (T2*) reflect tissue 
morphology and tissue oxygenation. Over the last decade BOLD MRI has become the main method in 
mapping brain function in cognitive studies; however, in fetal medicine the method is only briefly 
described. In this thesis the feasibility of BOLD MR as a non-invasive method for estimating fetal and 
placental oxygenation is investigated in healthy pregnancies.
In a sheep model fetal oxygenation changes were induced by changing the oxygen content of the 
maternal breathing air, and the corresponding changes in the BOLD signal were measured in selected 
fetal organs. In the fetal liver the tissue oxygenation was estimated directly by internal oxygen sensors, 
and a close association was demonstrated between changes in the BOLD signal and changes in tissue 
oxygenation. In healthy human pregnancies fetal and placental hyperoxia was induced by increasing 
the oxygen content of maternal breathing air. In the fetus the oxygenation of the spleen, liver and 
kidney was increased. The placental oxygenation was also increased; however, this increase was 
predominantly seen in the fetal part of the placenta. Thus, from this thesis it can be concluded, that 
BOLD MRI is a feasible method to estimate fetal and placental oxygenation non-invasively.
The future perspective of this method is a non invasive test of placental function in cases of FGR.
Placental BOLD MRI might be an additional tool to support obstetricians in the very difficult decision of 
when to deliver these high risk fetuses.
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Dansk resumé
Moderkagens og fosterets oxygenering målt ved hjælp af BOLD MRI
Moderkagens funktion har afgørende betydning for fosterets vækst og udvikling. Væksthæmning på 
grund af nedsat funktion af moderkagen er forbundet med en øget risiko for permanent fosterskade 
og fosterdød på grund af nedsat ilt tilførsel via moderkagen. Fosterovervågning sigter blandt andet 
mod at identificer væksthæmning for at sikre rettidig forløsning. Overvågningen baseres primært på
ultralydsskanning inklusiv måling af blodets strømning i navlesnoren og fosterets blodkar samt 
registrering af fosterets hjertefrekvens, fostervandsmængde og fosterbevægelser. Disse metoder 
vurderer primært fosterets tilstand, og estimerer derved kun indirekte moderkagens funktion. 
Moderkagens evne til at transportere ilt kan idag udelukkende vurderes ved hjælp af en blodprøve fra 
navlesnoren. Dette invasive indgreb udføres dog ikke, idet det er fundet med en øget risko for fosteret. 
Ved Blood Oxygen Level Dependent (BOLD) MR skanning af hjernen udføres i dag non-invasive 
målinger af iltmætning til kortlægning af hjernen kognitive funktion. Ændringer i BOLD MR signalet 
afspejler ændringer i hæmoglobins iltmætning,, og den den transverselle relaxationstid (T2*) er 
relateret til både vævs struktur og vævs oxygenering. Indenfor foster overvågning er metoden endnu 
ganske lidt beskrevet, hvorfor formålet med dette PhD studie er at undersøge teknikkens evne til at 
måle ændringer i iltmætning hos fostre og i moderkagen.
Studiets første BOLD MR undersøgelser blev udført på fårefostre. Ved at ændre iltindholdet i 
moderens ventilationsluft ændredes fosterets oxygenering, og ved samtidig BOLD MR skanning kunne 
signalændringer i udvalgte fosterorganer registreres. Iltmætningen i fosterets lever blev målt direkte 
ved hjælp af invasive ilt sensorer, og der blev påvist en tæt sammenhæng mellem ændringer i BOLD 
signalet og ændringer i iltmætning. Ved BOLD MR skanning af raske humane fostre i forbindelse med 
at moderen indånder 100% ilt på maske fandtes en øget iltmætning af fosterets lever, milt og nyre. 
Ved skanning af moderkagen fandtes også en øget iltmætning dog primært i den føtale del.
Konklusionen på PhD studiet er således, at BOLD MR kan anvendes son en non-invasiv metode til at
estimere ændret iltmætning i foster og moderkage. Det fremtidige perspektiv ved denne metode er en 
non-invasiv test af moderkagens funktion i forbindelse med fostervæksthæmning. BOLD MR skanning 
af moderkagen kan herved blive et ekstra redskab, som kan støtte obstetrikeren i den svære 
beslutning om forløsningstidspunktet for ekstremt væksthæmmede fostre.
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
76
References
(1) Currie S, Hoggard N, Craven IJ, Hadjivassiliou M, Wilkinson ID. Understanding MRI: basic MR physics for 
physicians. Postgrad Med J 2013 Apr;89(1050):209-223. 
(2) Ogawa S, Lee TM. Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro 
measurements and image simulation. Magn Reson Med 1990 Oct;16(1):9-18. 
(3) Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of 
rodent brain at high magnetic fields. Magn Reson Med 1990 Apr;14(1):68-78. 
(4) Belliveau JW, Kennedy DN,Jr, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, et al. Functional 
mapping of the human visual cortex by magnetic resonance imaging. Science 1991 Nov 1;254(5032):716-
719. 
(5) Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic 
resonance imaging. Nat Rev Neurosci 2007 Sep;8(9):700-711. 
(6) Bandettini PA. Twenty years of functional MRI: the science and the stories. Neuroimage 2012 Aug 
15;62(2):575-588. 
(7) Pauling L, Coryell CD. The Magnetic Properties and Structure of Hemoglobin, Oxyhemoglobin and 
Carbonmonoxyhemoglobin. Proc Natl Acad Sci U S A 1936 Apr;22(4):210-216. 
(8) Cohen ER, Ugurbil K, Kim SG. Effect of basal conditions on the magnitude and dynamics of the blood 
oxygenation level-dependent fMRI response. J Cereb Blood Flow Metab 2002 Sep;22(9):1042-1053. 
(9) Gustard S, Williams EJ, Hall LD, Pickard JD, Carpenter TA. Influence of baseline hematocrit on between-
subject BOLD signal change using gradient echo and asymmetric spin echo EPI. Magn Reson Imaging 2003 
Jul;21(6):599-607. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
77
(10) Blockley NP, Griffeth VE, Simon AB, Buxton RB. A review of calibrated blood oxygenation level-
dependent (BOLD) methods for the measurement of task-induced changes in brain oxygen metabolism. 
NMR Biomed 2012 Sep 4. 
(11) Norris DG. Principles of magnetic resonance assessment of brain function. J Magn Reson Imaging 2006 
Jun;23(6):794-807. 
(12) Logothetis NK, Pfeuffer J. On the nature of the BOLD fMRI contrast mechanism. Magn Reson Imaging 
2004 Dec;22(10):1517-1531. 
(13) Logothetis NK. What we can do and what we cannot do with fMRI. Nature 2008 Jun 12;453(7197):869-
878. 
(14) Buxton RB, Uludag K, Dubowitz DJ, Liu TT. Modeling the hemodynamic response to brain activation. 
Neuroimage 2004;23 Suppl 1:S220-33. 
(15) Boxerman JL, Bandettini PA, Kwong KK, Baker JR, Davis TL, Rosen BR, et al. The intravascular 
contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo. Magn 
Reson Med 1995 Jul;34(1):4-10. 
(16) Hykin J, Moore R, Duncan K, Clare S, Baker P, Johnson I, et al. Fetal brain activity demonstrated by 
functional magnetic resonance imaging. Lancet 1999 Aug 21;354(9179):645-646. 
(17) Moore RJ, Vadeyar S, Fulford J, Tyler DJ, Gribben C, Baker PN, et al. Antenatal determination of fetal 
brain activity in response to an acoustic stimulus using functional magnetic resonance imaging. Hum Brain 
Mapp 2001 Feb;12(2):94-99. 
(18) Fulford J, Vadeyar SH, Dodampahala SH, Moore RJ, Young P, Baker PN, et al. Fetal brain activity in 
response to a visual stimulus. Hum Brain Mapp 2003 Dec;20(4):239-245. 
(19) Fulford J, Vadeyar SH, Dodampahala SH, Ong S, Moore RJ, Baker PN, et al. Fetal brain activity and 
hemodynamic response to a vibroacoustic stimulus. Hum Brain Mapp 2004 Jun;22(2):116-121. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
78
(20) Semple SI, Wallis F, Haggarty P, Abramovich D, Ross JA, Redpath TW, et al. The measurement of fetal 
liver T(*)(2) in utero before and after maternal oxygen breathing: progress towards a non-invasive 
measurement of fetal oxygenation and placental function. Magn Reson Imaging 2001 Sep;19(7):921-928. 
(21) Morris DM, Ross JA, McVicar A, Semple SI, Haggarty P, Gilbert FJ, et al. Changes in foetal liver T2* 
measurements by MRI in response to maternal oxygen breathing: application to diagnosing foetal growth 
restriction. Physiol Meas 2010 Sep;31(9):1137-1146. 
(22) Wedegartner U, Tchirikov M, Schafer S, Priest AN, Kooijman H, Adam G, et al. Functional MR imaging: 
comparison of BOLD signal intensity changes in fetal organs with fetal and maternal oxyhemoglobin 
saturation during hypoxia in sheep. Radiology 2006 Mar;238(3):872-880. 
(23) Wedegartner U, Kooijman H, Andreas T, Beindorff N, Hecher K, Adam G. T2 and T2* measurements of 
fetal brain oxygenation during hypoxia with MRI at 3T: correlation with fetal arterial blood oxygen 
saturation. Eur Radiol 2009 Jul 18. 
(24) Wedegartner U, Popovych S, Yamamura J, Kooijman H, Adam G. DeltaR2* in fetal sheep brains during 
hypoxia: MR imaging at 3.0 T versus that at 1.5 T. Radiology 2009 Aug;252(2):394-400. 
(25) Sorensen A, Pedersen M, Tietze A, Ottosen L, Duus L, Uldbjerg N. BOLD MRI in sheep fetuses: a non-
invasive method for measuring changes in tissue oxygenation. Ultrasound Obstet Gynecol 2009 
Dec;34(6):687-692. 
(26) Huen I, Morris DM, Wright C, Parker GJ, Sibley CP, Johnstone ED, et al. R(1) and R(2) * changes in the 
human placenta in response to maternal oxygen challenge. Magn Reson Med 2012 Dec 27. 
(27) Sorensen A, Peters D, Frund E, Lingman G, Christiansen O, Uldbjerg N. Changes in human placental 
oxygenation during maternal hyperoxia as estimated by BOLD MRI. Ultrasound Obstet Gynecol 2013 Jan 10. 
(28) Sorensen A, Peters D, Simonsen C, Pedersen M, Stausbol-Gron B, Christiansen OB, et al. Changes in 
human fetal oxygenation during maternal hyperoxia as estimated by BOLD MRI. Prenat Diagn 2013 
Feb;33(2):141-145. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
79
(29) Aimot-Macron S, Salomon LJ, Deloison B, Thiam R, Cuenod CA, Clement O, et al. In vivo MRI 
assessment of placental and foetal oxygenation changes in a rat model of growth restriction using blood 
oxygen level-dependent (BOLD) magnetic resonance imaging. Eur Radiol 2013 May;23(5):1335-1342. 
(30) Chalouhi GE, Alison M, Deloison B, Thiam R, Autret G, Balvay D, et al. Fetoplacental Oxygenation in an 
Intrauterine Growth Restriction Rat Model by Using Blood Oxygen Level-Dependent MR Imaging at 4.7 T. 
Radiology 2013 May 21. 
(31) Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG,Jr, Froelich JW, et al. ACR guidance document 
for safe MR practices: 2007. AJR Am J Roentgenol 2007 Jun;188(6):1447-1474. 
(32) International Commission on Non-Ionizing Radiation Protection. Guidelines on limits of exposure to 
static magnetic fields. Health Phys 2009 Apr;96(4):504-514. 
(33) Hoyer C, Vogt MA, Richter SH, Zaun G, Zahedi Y, Maderwald S, et al. Repetitive exposure to a 7 Tesla 
static magnetic field of mice in utero does not cause alterations in basal emotional and cognitive behavior 
in adulthood. Reprod Toxicol 2012 Aug;34(1):86-92. 
(34) Abramowicz JS, Barnett SB, Duck FA, Edmonds PD, Hynynen KH, Ziskin MC. Fetal thermal effects of 
diagnostic ultrasound. J Ultrasound Med 2008 Apr;27(4):541-59; quiz 560-3. 
(35) Ziskin MC, Morrissey J. Thermal thresholds for teratogenicity, reproduction, and development. Int J 
Hyperthermia 2011;27(4):374-387. 
(36) Schroder HJ, Power GG. Engine and radiator: fetal and placental interactions for heat dissipation. Exp 
Physiol 1997 Mar;82(2):403-414. 
(37) Gowland PA, De Wilde J. Temperature increase in the fetus due to radio frequency exposure during 
magnetic resonance scanning. Phys Med Biol 2008 Nov 7;53(21):L15-8. 
(38) Edwards MJ. Hyperthermia as a teratogen: a review of experimental studies and their clinical 
significance. Teratog Carcinog Mutagen 1986;6(6):563-582. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
80
(39) Hand JW, Li Y, Thomas EL, Rutherford MA, Hajnal JV. Prediction of specific absorption rate in mother 
and fetus associated with MRI examinations during pregnancy. Magn Reson Med 2006 Apr;55(4):883-893. 
(40) International Commission on Non-Ionizing Radiation Protection. Medical magnetic resonance (MR) 
procedures: protection of patients. Health Phys 2004 Aug;87(2):197-216. 
(41) Price DL, De Wilde JP, Papadaki AM, Curran JS, Kitney RI. Investigation of acoustic noise on 15 MRI 
scanners from 0.2 T to 3 T. J Magn Reson Imaging 2001 Feb;13(2):288-293. 
(42) Glover P, Hykin J, Gowland P, Wright J, Johnson I, Mansfield P. An assessment of the intrauterine sound 
intensity level during obstetric echo-planar magnetic resonance imaging. Br J Radiol 1995 
Oct;68(814):1090-1094. 
(43) Noise: a hazard for the fetus and newborn. American Academy of Pediatrics. Committee on 
Environmental Health. Pediatrics 1997 Oct;100(4):724-727. 
(44) Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J. Human fetal responses to vibratory acoustic 
stimulation from twenty-six weeks to term. Am J Obstet Gynecol 1987 Dec;157(6):1375-1381. 
(45) Baschat AA. Arterial and venous Doppler in the diagnosis and management of early onset fetal growth 
restriction. Early Hum Dev 2005 Nov;81(11):877-887. 
(46) Westgate JA, Wibbens B, Bennet L, Wassink G, Parer JT, Gunn AJ. The intrapartum deceleration in 
center stage: a physiologic approach to the interpretation of fetal heart rate changes in labor. Am J Obstet 
Gynecol 2007 Sep;197(3):236.e1-236.11. 
(47) Aldrich CJ, D'Antona D, Spencer JA, Wyatt JS, Peebles DM, Delpy DT, et al. Late fetal heart 
decelerations and changes in cerebral oxygenation during the first stage of labour. Br J Obstet Gynaecol 
1995 Jan;102(1):9-13. 
(48) Schifrin BS, Ater S. Fetal hypoxic and ischemic injuries. Curr Opin Obstet Gynecol 2006 Apr;18(2):112-
122. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
81
(49) Grivell RM, Alfirevic Z, Gyte GM, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane 
Database Syst Rev 2010 Jan 20;(1)(1):CD007863. 
(50) Sameshima H, Ikenoue T, Ikeda T, Kamitomo M, Ibara S. Unselected low-risk pregnancies and the effect 
of continuous intrapartum fetal heart rate monitoring on umbilical blood gases and cerebral palsy. Am J 
Obstet Gynecol 2004 Jan;190(1):118-123. 
(51) Rosen KG, Amer-Wahlin I, Luzietti R, Noren H. Fetal ECG waveform analysis. Best Pract Res Clin Obstet 
Gynaecol 2004 Jun;18(3):485-514. 
(52) Baskett TF, Liston RM. Fetal movement monitoring: clinical application. Clin Perinatol 1989 
Sep;16(3):613-625. 
(53) Yoshimura S, Masuzaki H, Gotoh H, Ishimaru T. Fetal redistribution of blood flow and amniotic fluid 
volume in growth-retarded fetuses. Early Hum Dev 1997 Feb 20;47(3):297-304. 
(54) Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk 
pregnancies. Cochrane Database Syst Rev 2008 Jan 23;(1):CD000038. doi(1):CD000038. 
(55) Cruz-Martinez R, Figueras F. The role of Doppler and placental screening. Best Pract Res Clin Obstet 
Gynaecol 2009 Dec;23(6):845-855. 
(56) Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in normal pregnancy. 
Cochrane Database Syst Rev 2010 Aug 4;(8):CD001450. doi(8):CD001450. 
(57) Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. 
Cochrane Database Syst Rev 2010 Jan 20;(1):CD007529. doi(1):CD007529. 
(58) When do obstetricians recommend delivery for a high-risk preterm growth-retarded fetus? The GRIT 
Study Group. Growth Restriction Intervention Trial. Eur J Obstet Gynecol Reprod Biol 1996 Aug;67(2):121-
126. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
82
(59) Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M, GRIT study group. Infant wellbeing at 2 
years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. 
Lancet 2004 Aug 7-13;364(9433):513-520. 
(60) Walker DM, Marlow N, Upstone L, Gross H, Hornbuckle J, Vail A, et al. The Growth Restriction 
Intervention Trial: long-term outcomes in a randomized trial of timing of delivery in fetal growth restriction. 
Am J Obstet Gynecol 2011 Jan;204(1):34.e1-34.e9. 
(61) Lees C, Baumgartner H. The TRUFFLE study--a collaborative publicly funded project from concept to 
reality: how to negotiate an ethical, administrative and funding obstacle course in the European Union. 
Ultrasound Obstet Gynecol 2005 Feb;25(2):105-107.
(62) Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, et al. Duration of persistent 
abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction. Ultrasound 
Obstet Gynecol 2011 Sep;38(3):295-302. 
(63) Bilardo CM, Wolf H, Stigter RH, Ville Y, Baez E, Visser GH, et al. Relationship between monitoring 
parameters and perinatal outcome in severe, early intrauterine growth restriction. Ultrasound Obstet 
Gynecol 2004 Feb;23(2):119-125. 
(64) Baschat AA, Gembruch U, Reiss I, Gortner L, Weiner CP, Harman CR. Relationship between arterial and 
venous Doppler and perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol 2000 
Oct;16(5):407-413. 
(65) Baschat AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum 
parameters of placental dysfunction. Ultrasound Obstet Gynecol 2011 May;37(5):501-514. 
(66) Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. 
Thromb Res 2004;114(5-6):397-407. 
(67) Everett TR, Lees CC. Beyond the placental bed: placental and systemic determinants of the uterine 
artery Doppler waveform. Placenta 2012 Nov;33(11):893-901. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
83
(68) Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, et al. Placental phenotypes of intrauterine 
growth. Pediatr Res 2005 Nov;58(5):827-832. 
(69) Enders AC, Carter AM. Review: The evolving placenta: different developmental paths to a hemochorial 
relationship. Placenta 2012 Feb;33 Suppl:S92-8. 
(70) Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its 
consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000 Sep;92(1):35-43. 
(71) Huppertz B, Peeters LL. Vascular biology in implantation and placentation. Angiogenesis 2005;8(2):157-
167. 
(72) Burton GJ, Jauniaux E. Sonographic, stereological and Doppler flow velocimetric assessments of 
placental maturity. Br J Obstet Gynaecol 1995 Oct;102(10):818-825. 
(73) Schroder HJ. Comparative aspects of placental exchange functions. Eur J Obstet Gynecol Reprod Biol 
1995 Nov;63(1):81-90. 
(74) Wilkening RB, Meschia G. Current topic: comparative physiology of placental oxygen transport. 
Placenta 1992 Jan-Feb;13(1):1-15. 
(75) Pardi G, Marconi AM, Cetin I, Baggiani AM, Lanfranchi A, Bozzetti P. Fetal oxygenation and acid base 
balance during pregnancy. J Perinat Med 1991;19 Suppl 1:139-144. 
(76) Kingdom JC, Burrell SJ, Kaufmann P. Pathology and clinical implications of abnormal umbilical artery 
Doppler waveforms. Ultrasound Obstet Gynecol 1997 Apr;9(4):271-286. 
(77) Morrow RJ, Adamson SL, Bull SB, Ritchie JW. Effect of placental embolization on the umbilical arterial 
velocity waveform in fetal sheep. Am J Obstet Gynecol 1989 Oct;161(4):1055-1060. 
(78) Morrow RJ, Adamson SL, Bull SB, Ritchie JW. Acute hypoxemia does not affect the umbilical artery flow 
velocity waveform in fetal sheep. Obstet Gynecol 1990 Apr;75(4):590-593. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
84
(79) Burrell SJ, Kingdom JC. The use of umbilical artery Doppler ultrasonography in modern obstetrics. Curr 
Opin Obstet Gynecol 1997 Dec;9(6):370-374. 
(80) Lin S, Shimizu I, Suehara N, Nakayama M, Aono T. Uterine artery Doppler velocimetry in relation to 
trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995 May;85(5 Pt 1):760-
765. 
(81) Madazli R, Somunkiran A, Calay Z, Ilvan S, Aksu MF. Histomorphology of the placenta and the placental 
bed of growth restricted foetuses and correlation with the Doppler velocimetries of the uterine and 
umbilical arteries. Placenta 2003 May;24(5):510-516. 
(82) Urban G, Vergani P, Ghidini A, Tortoli P, Ricci S, Patrizio P, et al. State of the art: non-invasive 
ultrasound assessment of the uteroplacental circulation. Semin Perinatol 2007 Aug;31(4):232-239. 
(83) Hernandez-Andrade E, Brodszki J, Lingman G, Gudmundsson S, Molin J, Marsal K. Uterine artery score 
and perinatal outcome. Ultrasound Obstet Gynecol 2002 May;19(5):438-442. 
(84) Malassine A, Cronier L. Hormones and human trophoblast differentiation: a review. Endocrine 2002 
Oct;19(1):3-11. 
(85) Carter AM. Placental oxygen transfer and the oxygen supply to the fetus. Fetal Matern Med Rev 
1999;11(3-4):151-161. 
(86) Carter AM. Placental oxygen consumption. Part I: in vivo studies--a review. Placenta 2000 Mar-Apr;21 
Suppl A:S31-7. 
(87) Carter AM. Factors affecting gas transfer across the placenta and the oxygen supply to the fetus. J Dev 
Physiol 1989 Dec;12(6):305-322. 
(88) Desforges M, Sibley CP. Placental nutrient supply and fetal growth. Int J Dev Biol 2010;54(2-3):377-390. 
(89) Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. 
A review. Placenta 2009 Mar;30 Suppl A:S77-82. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
85
(90) Cetin I, Ronzoni S, Marconi AM, Perugino G, Corbetta C, Battaglia FC, et al. Maternal concentrations 
and fetal-maternal concentration differences of plasma amino acids in normal and intrauterine growth-
restricted pregnancies. Am J Obstet Gynecol 1996 May;174(5):1575-1583. 
(91) Pardi G, Marconi AM, Cetin I. Placental-fetal interrelationship in IUGR fetuses--a review. Placenta 2002 
Apr;23 Suppl A:S136-41. 
(92) Goplerud JM, Delivoria-Papadopoulos M. Physiology of the placenta--gas exchange. Ann Clin Lab Sci 
1985 Jul-Aug;15(4):270-278. 
(93) Gregg AR, Weiner CP. "Normal" umbilical arterial and venous acid-base and blood gas values. Clin 
Obstet Gynecol 1993 Mar;36(1):24-32. 
(94) Longo LD, Meschia G. Elizabeth M. Ramsey and the evolution of ideas of uteroplacental blood flow and 
placental gas exchange. Eur J Obstet Gynecol Reprod Biol 2000 Jun;90(2):129-133. 
(95) Martin CB,Jr. Normal fetal physiology and behavior, and adaptive responses with hypoxemia. Semin 
Perinatol 2008 Aug;32(4):239-242. 
(96) Bell SG. An introduction to hemoglobin physiology. Neonatal Netw 1999 Mar;18(2):9-15. 
(97) Chaddha V, Viero S, Huppertz B, Kingdom J. Developmental biology of the placenta and the origins of 
placental insufficiency. Semin Fetal Neonatal Med 2004 Oct;9(5):357-369.
(98) Redline RW. Disorders of placental circulation and the fetal brain. Clin Perinatol 2009 Sep;36(3):549-
559. 
(99) Nicolaides KH, Economides DL, Soothill PW. Blood gases, pH, and lactate in appropriate- and small-for-
gestational-age fetuses. Am J Obstet Gynecol 1989 Oct;161(4):996-1001. 
(100) Cetin I. Placental transport of amino acids in normal and growth-restricted pregnancies. Eur J Obstet 
Gynecol Reprod Biol 2003 Sep 22;110 Suppl 1:S50-4. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
86
(101) Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 
1997 Nov;18(8):613-21; discussion 623-6. 
(102) Sebire NJ. Umbilical artery Doppler revisited: pathophysiology of changes in intrauterine growth 
restriction revealed. Ultrasound Obstet Gynecol 2003 May;21(5):419-422. 
(103) Raio L, Ghezzi F, Cromi A, Nelle M, Durig P, Schneider H. The thick heterogeneous (jellylike) placenta: 
a strong predictor of adverse pregnancy outcome. Prenat Diagn 2004 Mar;24(3):182-188. 
(104) Elchalal U, Ezra Y, Levi Y, Bar-Oz B, Yanai N, Intrator O, et al. Sonographically thick placenta: a marker 
for increased perinatal risk--a prospective cross-sectional study. Placenta 2000 Mar-Apr;21(2-3):268-272. 
(105) Rudolph AM, Heymann MA. The circulation of the fetus in utero. Methods for studying distribution of 
blood flow, cardiac output and organ blood flow. Circ Res 1967 Aug;21(2):163-184. 
(106) Edelstone DI, Rudolph AM. Preferential streaming of ductus venosus blood to the brain and heart in 
fetal lambs. Am J Physiol 1979 Dec;237(6):H724-9. 
(107) Edelstone DI, Rudolph AM, Heymann MA. Effects of hypoxemia and decreasing umbilical flow liver 
and ductus venosus blood flows in fetal lambs. Am J Physiol 1980 May;238(5):H656-63. 
(108) Junno J, Bruun E, Gutierrez JH, Erkinaro T, Haapsamo M, Acharya G, et al. Fetal sheep left ventricle is 
more sensitive than right ventricle to progressively worsening hypoxemia and acidemia. Eur J Obstet 
Gynecol Reprod Biol 2012 Dec 21. 
(109) Kiserud T. Physiology of the fetal circulation. Semin Fetal Neonatal Med 2005 Dec;10(6):493-503. 
(110) Brezinka C. Fetal hemodynamics. J Perinat Med 2001;29(5):371-380. 
(111) Arbeille P. Fetal arterial Doppler-IUGR and hypoxia. Eur J Obstet Gynecol Reprod Biol 1997 
Dec;75(1):51-53. 
(112) Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol 2004 
Feb;28(1):67-80. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
87
(113) Bonnin P, Guyot B, Bailliart O, Benard C, Blot P, Martineaud JP. Relationship between umbilical and 
fetal cerebral blood flow velocity waveforms and umbilical venous blood gases. Ultrasound Obstet Gynecol 
1992 Jan 1;2(1):18-22. 
(114) Baschat AA. Doppler application in the delivery timing of the preterm growth-restricted fetus: 
another step in the right direction. Ultrasound Obstet Gynecol 2004 Feb;23(2):111-118. 
(115) DAWES GS. The umbilical circulation. Am J Obstet Gynecol 1962 Dec 1;84:1634-1648. 
(116) Johnson P, Maxwell DJ, Tynan MJ, Allan LD. Intracardiac pressures in the human fetus. Heart 2000 
Jul;84(1):59-63. 
(117) Mielke G, Benda N. Cardiac output and central distribution of blood flow in the human fetus. 
Circulation 2001 Mar 27;103(12):1662-1668. 
(118) Baschat AA. The fetal circulation and essential organs-a new twist to an old tale. Ultrasound Obstet 
Gynecol 2006 Apr;27(4):349-354. 
(119) Haugen G, Kiserud T, Godfrey K, Crozier S, Hanson M. Portal and umbilical venous blood supply to the 
liver in the human fetus near term. Ultrasound Obstet Gynecol 2004 Nov;24(6):599-605. 
(120) Kessler J, Rasmussen S, Kiserud T. The fetal portal vein: normal blood flow development during the 
second half of human pregnancy. Ultrasound Obstet Gynecol 2007 Jul;30(1):52-60. 
(121) Kessler J, Rasmussen S, Godfrey K, Hanson M, Kiserud T. Fetal growth restriction is associated with 
prioritization of umbilical blood flow to the left hepatic lobe at the expense of the right lobe. Pediatr Res 
2009 Jul;66(1):113-117. 
(122) Tchirikov M, Eisermann K, Rybakowski C, Schroder HJ. Doppler ultrasound evaluation of ductus 
venosus blood flow during acute hypoxemia in fetal lambs. Ultrasound Obstet Gynecol 1998 Jun;11(6):426-
431. 
(123) Kiserud T, Rasmussen S, Skulstad S. Blood flow and the degree of shunting through the ductus 
venosus in the human fetus. Am J Obstet Gynecol 2000 Jan;182(1 Pt 1):147-153. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
88
(124) Acharya G, Tronnes A, Rasanen J. Aortic isthmus and cardiac monitoring of the growth-restricted 
fetus. Clin Perinatol 2011 Mar;38(1):113-25, vi-vii. 
(125) Makowski EL, Hertz RH, Meschia G. Effects of acute maternal hypoxia and hyperoxia on the blood 
flow to the pregnant uterus. Am J Obstet Gynecol 1973 Mar 1;115(5):624-631. 
(126) Wilkening RB, Meschia G. Fetal oxygen uptake, oxygenation, and acid-base balance as a function of 
uterine blood flow. Am J Physiol 1983 Jun;244(6):H749-55. 
(127) Bennet L, Gunn AJ. The fetal heart rate response to hypoxia: insights from animal models. Clin 
Perinatol 2009 Sep;36(3):655-672. 
(128) Wladimiroff JW, Tonge HM, Stewart PA. Doppler ultrasound assessment of cerebral blood flow in the 
human fetus. Br J Obstet Gynaecol 1986 May;93(5):471-475. 
(129) Wladimiroff JW, vd Wijngaard JA, Degani S, Noordam MJ, van Eyck J, Tonge HM. Cerebral and 
umbilical arterial blood flow velocity waveforms in normal and growth-retarded pregnancies. Obstet 
Gynecol 1987 May;69(5):705-709. 
(130) Makikallio K, Jouppila P, Rasanen J. Retrograde aortic isthmus net blood flow and human fetal cardiac 
function in placental insufficiency. Ultrasound Obstet Gynecol 2003 Oct;22(4):351-357. 
(131) Kiserud T, Kessler J, Ebbing C, Rasmussen S. Ductus venosus shunting in growth-restricted fetuses and 
the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol 2006 Aug;28(2):143-149. 
(132) Kiserud T. The ductus venosus. Semin Perinatol 2001 Feb;25(1):11-20. 
(133) Reuss ML, Rudolph AM. Distribution and recirculation of umbilical and systemic venous blood flow in 
fetal lambs during hypoxia. J Dev Physiol 1980 Feb-Apr;2(1-2):71-84. 
(134) Kiserud T. Hemodynamics of the ductus venosus. Eur J Obstet Gynecol Reprod Biol 1999 
Jun;84(2):139-147. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
89
(135) Tchirikov M, Schroder HJ, Hecher K. Ductus venosus shunting in the fetal venous circulation: 
regulatory mechanisms, diagnostic methods and medical importance. Ultrasound Obstet Gynecol 2006 
Apr;27(4):452-461. 
(136) Makikallio K, Acharya G, Erkinaro T, Kavasmaa T, Haapsamo M, Huhta JC, et al. Ductus venosus 
velocimetry in acute fetal acidemia and impending fetal death in a sheep model of increased placental 
vascular resistance. Am J Physiol Heart Circ Physiol 2010 Apr;298(4):H1229-34. 
(137) Hecher K, Campbell S, Doyle P, Harrington K, Nicolaides K. Assessment of fetal compromise by 
Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow 
velocity studies. Circulation 1995 Jan 1;91(1):129-138. 
(138) Richardson BS, Bocking AD. Metabolic and circulatory adaptations to chronic hypoxia in the fetus. 
Comp Biochem Physiol A Mol Integr Physiol 1998 Mar;119(3):717-723. 
(139) Rizzo G, Capponi A, Rinaldo D, Arduini D, Romanini C. Ventricular ejection force in growth-retarded 
fetuses. Ultrasound Obstet Gynecol 1995 Apr;5(4):247-255. 
(140) Cohn HE, Sacks EJ, Heymann MA, Rudolph AM. Cardiovascular responses to hypoxemia and acidemia 
in fetal lambs. Am J Obstet Gynecol 1974 Nov 15;120(6):817-824. 
(141) Bahtiyar MO, Copel JA. Cardiac changes in the intrauterine growth-restricted fetus. Semin Perinatol 
2008 Jun;32(3):190-193. 
(142) Godfrey ME, Messing B, Cohen SM, Valsky DV, Yagel S. Functional assessment of the fetal heart: a 
review. Ultrasound Obstet Gynecol 2012 Feb;39(2):131-144. 
(143) Kitanaka T, Alonso JG, Gilbert RD, Siu BL, Clemons GK, Longo LD. Fetal responses to long-term 
hypoxemia in sheep. Am J Physiol 1989 Jun;256(6 Pt 2):R1348-54. 
(144) Barker DJ. The developmental origins of well-being. Philos Trans R Soc Lond B Biol Sci 2004 Sep 
29;359(1449):1359-1366. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
90
(145) Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and 
cardiovascular disease in adult life. Lancet 1993 Apr 10;341(8850):938-941. 
(146) Morrison JL, Duffield JA, Muhlhausler BS, Gentili S, McMillen IC. Fetal growth restriction, catch-up 
growth and the early origins of insulin resistance and visceral obesity. Pediatr Nephrol 2010 Apr;25(4):669-
677. 
(147) Neerhof MG, Thaete LG. The fetal response to chronic placental insufficiency. Semin Perinatol 2008 
Jun;32(3):201-205. 
(148) Myers RE, Stange L, Joelsson I, Huzell B, Wussow C. Effects upon the fetus of oxygen administration to 
the mother. A study in monkey. Acta Obstet Gynecol Scand 1977;56(3):195-203. 
(149) Sonesson SE, Fouron JC, Teyssier G, Bonnin P. Effects of increased resistance to umbilical blood flow 
on fetal hemodynamic changes induced by maternal oxygen administration: a Doppler velocimetric study 
on the sheep. Pediatr Res 1993 Dec;34(6):796-800. 
(150) VASICKA A, QUILLIGAN EJ, AZNAR R, LIPSITZ PJ, BLOOR BM. Oxygen tension in maternal and fetal 
blood, amniotic fluid, and cerebrospinal fluid of the mother and the baby. Am J Obstet Gynecol 1960 
Jun;79:1041-1047. 
(151) Tomimatsu T, Pena JP, Longo LD. Fetal cerebral oxygenation: the role of maternal hyperoxia with 
supplemental CO2 in sheep. Am J Obstet Gynecol 2007 Apr;196(4):359.e1-359.e5. 
(152) Willcourt RJ, King JC, Queenan JT. Maternal oxygenation administration and the fetal transcutaneous 
PO2. Am J Obstet Gynecol 1983 Jul 15;146(6):714-715. 
(153) Nicolaides KH, Campbell S, Bradley RJ, Bilardo CM, Soothill PW, Gibb D. Maternal oxygen therapy for 
intrauterine growth retardation. Lancet 1987 Apr 25;1(8539):942-945. 
(154) Rizzo G, Arduini D, Romanini C, Mancuso S. Effects of maternal hyperoxygenation on atrioventricular 
velocity waveforms in healthy and growth-retarded fetuses. Biol Neonate 1990;58(3):127-132. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
91
(155) Caforio L, Caruso A, Testa AC, Pompei A, Ciampelli M. Short-term maternal oxygen administration in 
fetuses with absence or reversal of end-diastolic velocity in umbilical artery: pathophysiological and clinical 
considerations. Acta Obstet Gynecol Scand 1998 Aug;77(7):707-711. 
(156) Arduini D, Rizzo G, Mancuso S, Romanini C. Short-term effects of maternal oxygen administration on 
blood flow velocity waveforms in healthy and growth-retarded fetuses. Am J Obstet Gynecol 1988 
Nov;159(5):1077-1080. 
(157) Arduini D, Rizzo G, Romanini C, Mancuso S. Doppler assessment of fetal blood flow velocity 
waveforms during acute maternal oxygen administration as predictor of fetal outcome in post-term 
pregnancy. Am J Perinatol 1990 Jul;7(3):258-262. 
(158) Arduini D, Rizzo G, Romanini C, Mancuso S. Hemodynamic changes in growth retarded fetuses during 
maternal oxygen administration as predictors of fetal outcome. J Ultrasound Med 1989 Apr;8(4):193-196. 
(159) Almstrom H, Sonesson SE. Doppler echocardiographic assessment of fetal blood flow redistribution 
during maternal hyperoxygenation. Ultrasound Obstet Gynecol 1996 Oct;8(4):256-261. 
(160) Sonesson SE, Fouron JC, Teyssier G, Bonnin P. Doppler echocardiographic assessment of changes in 
the central circulation of the fetal sheep induced by maternal oxygen administration. Acta Paediatr 1994 
Oct;83(10):1007-1011. 
(161) Simchen MJ, Tesler J, Azami T, Preiss D, Fedorko L, Goldszmidz E, et al. Effects of maternal hyperoxia 
with and without normocapnia in uteroplacental and fetal Doppler studies. Ultrasound Obstet Gynecol 
2005 Oct;26(5):495-499. 
(162) Tomimatsu T, Pereyra Pena J, Hatran DP, Longo LD. Maternal oxygen administration and fetal 
cerebral oxygenation: studies on near-term fetal lambs at both low and high altitude. Am J Obstet Gynecol 
2006 Aug;195(2):535-541. 
(163) Soregaroli M, Rizzo G, Danti L, Arduini D, Romanini C. Effects of maternal hyperoxygenation on ductus 
venosus flow velocity waveforms in normal third-trimester fetuses. Ultrasound Obstet Gynecol 1993 Mar 
1;3(2):115-119. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
92
(164) Bekedam DJ, Mulder EJ, Snijders RJ, Visser GH. The effects of maternal hyperoxia on fetal breathing 
movements, body movements and heart rate variation in growth retarded fetuses. Early Hum Dev 1991 
Dec;27(3):223-232. 
(165) Bartnicki J, Saling E. Influence of maternal oxygen administration on the computer-analysed fetal 
heart rate patterns in small-for-gestational-age fetuses. Gynecol Obstet Invest 1994;37(3):172-175. 
(166) Mildenberger E, Siegel G, Versmold HT. Oxygen-dependent regulation of membrane potential and 
vascular tone of human umbilical vein. Am J Obstet Gynecol 1999 Sep;181(3):696-700. 
(167) McGrath JC, MacLennan SJ, Mann AC, Stuart-Smith K, Whittle MJ. Contraction of human umbilical 
artery, but not vein, by oxygen. J Physiol 1986 Nov;380:513-519. 
(168) Battaglia FC, Meschia G, Makowski EL, Bowes W. The effect of maternal oxygen inhalation upon fetal 
oxygenation. J Clin Invest 1968 Mar;47(3):548-555. 
(169) Polvi HJ, Pirhonen JP, Erkkola RU. The hemodynamic effects of maternal hypo- and hyperoxygenation 
in healthy term pregnancies. Obstet Gynecol 1995 Nov;86(5):795-799. 
(170) Mahutte CK. On-line arterial blood gas analysis with optodes: current status. Clin Biochem 1998 
Apr;31(3):119-130. 
(171) Sorensen A, Holm D, Pedersen M, Tietze A, Stausbol-Gron B, Duus L, et al. Left-right difference in fetal 
liver oxygenation during hypoxia estimated by BOLD MRI in a fetal sheep model. Ultrasound Obstet 
Gynecol 2011 Dec;38(6):665-672. 
(172) Lu H, Zhao C, Ge Y, Lewis-Amezcua K. Baseline blood oxygenation modulates response amplitude: 
Physiologic basis for intersubject variations in functional MRI signals. Magn Reson Med 2008 Aug;60(2):364-
372. 
(173) Cameron IL, Ord VA, Fullerton GD. Characterization of proton NMR relaxation times in normal and 
pathological tissues by correlation with other tissue parameters. Magn Reson Imaging 1984;2(2):97-106. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
93
(174) Wright C, Morris DM, Baker PN, Crocker IP, Gowland PA, Parker GJ, et al. Magnetic resonance imaging 
relaxation time measurements of the placenta at 1.5 T. Placenta 2011 Dec;32(12):1010-1015. 
(175) Soothill PW, Nicolaides KH, Rodeck CH, Campbell S. Effect of gestational age on fetal and intervillous 
blood gas and acid-base values in human pregnancy. Fetal Ther 1986;1(4):168-175. 
(176) Lee SW, Khaw KS, Ngan Kee WD, Leung TY, Critchley LA. Haemodynamic effects from aortocaval 
compression at different angles of lateral tilt in non-labouring term pregnant women. Br J Anaesth 2012 
Dec;109(6):950-956. 
(177) Li H, Gudmundsson S, Olofsson P. Uterine artery blood flow velocity waveforms during uterine 
contractions. Ultrasound Obstet Gynecol 2003 Dec;22(6):578-585. 
(178) Wedegartner U, Tchirikov M, Schafer S, Priest AN, Walther M, Adam G, et al. Fetal sheep brains: 
findings at functional blood oxygen level-dependent 3-T MR imaging--relationship to maternal oxygen 
saturation during hypoxia. Radiology 2005 Dec;237(3):919-926. 
(179) Wedegartner U, Tchirikov M, Koch M, Adam G, Schroder H. Functional magnetic resonance imaging 
(fMRI) for fetal oxygenation during maternal hypoxia: initial results. Rofo 2002 Jun;174(6):700-703. 
(180) Okutomi T, Whittington RA, Stein DJ, Morishima HO. Comparison of the effects of sevoflurane and 
isoflurane anesthesia on the maternal-fetal unit in sheep. J Anesth 2009;23(3):392-398. 
(181) Kiserud T, Jauniaux E, West D, Ozturk O, Hanson MA. Circulatory responses to maternal hyperoxaemia 
and hypoxaemia assessed non-invasively in fetal sheep at 0.3-0.5 gestation in acute experiments. BJOG 
2001 Apr;108(4):359-364. 
(182) Gudmundsson S, Gunnarsson GO, Hokegard KH, Ingemarsson J, Kjellmer I. Venous Doppler 
velocimetry in relationship to central venous pressure and heart rate during hypoxia in the ovine fetus. J 
Perinat Med 1999;27(2):81-90. 
(183) Duncan KR, Gowland P, Francis S, Moore R, Baker PN, Johnson IR. The investigation of placental 
relaxation and estimation of placental perfusion using echo-planar magnetic resonance imaging. Placenta 
1998 Sep;19(7):539-543. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
94
(184) Gowland PA, Freeman A, Issa B, Boulby P, Duncan KR, Moore RJ, et al. In vivo relaxation time 
measurements in the human placenta using echo planar imaging at 0.5 T. Magn Reson Imaging 1998 
Apr;16(3):241-247. 
(185) Mayhew TM, Wadrop E. Placental morphogenesis and the star volumes of villous trees and 
intervillous pores. Placenta 1994 Feb-Mar;15(2):209-217. 
(186) Derwig I, Barker GJ, Poon L, Zelaya F, Gowland P, Lythgoe DJ, et al. Association of placental T2 
relaxation times and uterine artery Doppler ultrasound measures of placental blood flow. Placenta 2013 
Jun;34(6):474-479. 
(187) Girsh E, Plaks V, Gilad AA, Nevo N, Schechtman E, Neeman M, et al. Cloprostenol, a prostaglandin 
F(2alpha) analog, induces hypoxia in rat placenta: BOLD contrast MRI. NMR Biomed 2007 Feb;20(1):28-39. 
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
95
Appendix
The Review Table
Paper 1
Sørensen A, Pedersen M, Tietze A, Ottosen L, Duus L, Uldbjerg N.
BOLD MRI in sheep fetuses: a non-invasive method for measuring changes in tissue oxygenation.
Ultrasound Obstet Gynecol. 2009 Dec;34(6):687-92.
Paper 2
Sørensen A, Holm D, Pedersen M, Tietze A, Stausbøl-Grøn B, Duus L, Uldbjerg N.
Left-right difference in fetal liver oxygenation during hypoxia estimated by BOLD MRI in a fetal sheep model.
Ultrasound Obstet Gynecol. 2011 Dec;38(6):665-72
Paper 3
Sørensen A, Peters D, Simonsen C, Pedersen M, Stausbøl-Grøn B, Christiansen OB, Lingman G, Uldbjerg N.
Changes in human fetal oxygenation during maternal hyperoxia as estimated by BOLD MRI..
Prenat Diagn. 2013 Feb;33(2):141-5
Paper 4
Sørensen A, Peters D, Fründ E, Lingman G, Christiansen O, Uldbjerg N.
Changes in human placental oxygenation during maternal hyperoxia as estimated by BOLD MRI.
Ultrasound Obstet Gynecol. 2013 Sep;42(3):310-4
Paper 5
Peters D, Sørensen A, Simonsen C, M. Sinding, Uldbjerg N.
The reproducibility of human placental T2* measurements and the hyperoxic response.
Radiology 2013 (Submitted)
Fetal and placental oxygenation estimated by BOLD MRI
PhD thesis
Anne Sørensen
96
Review Table
First Author 
(Reference)
Year
Studied cases
Number
MRI 
system
Reference of 
fetal saturation
Stimulus Target organ
Hykin
(16)
1999
Human fetus
n=4 (14)
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Moore
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Wedegärtner 
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Fetal 
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saturation.
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(Bruker)
Hypoxia
(Prostaglandin F2α)
ΔBOLD placenta
Wedegärtner
(23)
2009
Sheep fetus
n=5
3T 
(Philips)
Fetal 
hemoglobin 
saturation
(Carotid artery)
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right)
Huen
(26)
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ABSTRACT
Objective The purpose of this descriptive study was to
correlate changes in the blood oxygen level-dependent
(BOLD) magnetic resonance imaging (MRI) signal with
direct measurements of fetal tissue oxygenation.
Methods Seven anesthetized ewes carrying singleton
fetuses at 125 days’ gestation (term 145 days) under-
went BOLD MRI, covering the entire fetus in a mul-
tislice approach. The fetuses were subjected to nor-
moxic, hypoxic and hyperoxic conditions by changing
the O2/N2O ratio in the maternal ventilated gas sup-
ply. The partial pressure of oxygen (pO2) in the fetal liver
was measured using an oxygen-sensitive optode. Maternal
arterial blood samples were simultaneously withdrawn for
blood gas analysis. These measurements were compared
with BOLD MRI signals in the fetal liver, kidney, spleen
and brain.
Results We demonstrated a consistent increase in the
BOLD MRI signal with increasing tissue pO2. For the
fetal liver, spleen and kidney we observed a clear asso-
ciation between changes in maternal arterial blood pO2
and changes in BOLD MRI signal. Interestingly, we
found that the BOLD signal of the fetal brain remained
unchanged during hypoxic, normoxic and hyperoxic con-
ditions.
Conclusions This experimental study demonstrated that
BOLD MRI is a reliable non-invasive method for
measuring changes in tissue oxygenation in fetal sheep.
The unchanged signal in the fetal brain during altered
maternal oxygen conditions is probably explained by the
brain-sparing mechanism. Copyright  2009 ISUOG.
Published by John Wiley & Sons, Ltd.
INTRODUCTION
Monitoring fetal well-being, identifying fetuses at high
risk of poor perinatal outcome and timing of delivery are
the main challenges in obstetrics. Doppler ultrasonogra-
phy and cardiotocography are the preferred diagnostic
tools for this purpose, providing immediate information
about the fetal heart rate and blood flow1. These meth-
ods, however, do not offer direct information about the
oxygen supply to the fetus nor the oxygen levels in the
fetal organs. The only current method for obtaining this
direct information is cordocentesis, which is a procedure
associated with a risk of miscarriage. In this experimental
study we introduce a non-invasive method for the direct
measurement of changes in fetal tissue oxygenation.
The blood oxygen level-dependent (BOLD) effect in
magnetic resonance imaging (MRI) is based on the
magnetic properties of hemoglobin. Oxyhemoglobin
has diamagnetic properties whereas deoxyhemoglobin
has paramagnetic properties2. Changes in the blood
saturation level will therefore affect the apparent
transversal relaxation time (T2*) of the surrounding
water molecules, providing a measurable change in the
MRI signal using a T2*-weighted sequence. The content
of deoxyhemoglobin is inversely related to T2*3, and
a signal reduction in T2*-weighted images therefore
corresponds to an increased deoxyhemoglobin content.
Thus, assuming that the pO2 of capillary blood is in
equilibrium with the pO2 in tissue, changes in BOLD
signal relate to changes in tissue oxygenation4.
BOLD MRI provides an opportunity to monitor
tissue oxygenation in vivo. This technique has allowed
investigation of the fetal response following maternal
hyperoxygenation5 as well as audio and visual fetal
stimuli6–8. In an experimental study in pregnant sheep,
Wedega¨rtner et al. showed a reduced BOLD signal in
fetal organs suffering from hypoxia9–11. Although these
observations justify the use of BOLD MRI as a novel
diagnostic tool to identify critical changes in the fetal
oxygenation level, the exact tissue oxygen content cannot
be established. Hence, the aim of this study was to
investigate the relationship between changes in BOLD
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MRI signal and direct tissue oxygen measurements in
the fetal liver during hyperoxic, normoxic and hypoxic
conditions. In addition, BOLD MRI signals in fetal organs
were compared to maternal arterial pO2 in response to
changes in the ventilated oxygen supply.
METHODS
Seven healthy ewes (Gotland sheep) carrying singleton
fetuses at 125 days’ gestation (term 145 days) were
included in the study. Prior to the experimental
procedures, the ewes were cared for at our animal farm
(Pa˚skehøjga˚rd, Aarhus University Hospital, Denmark),
where they had free access to water and food. On the day
of the experiment the ewe was sedated with atropine
(Nycomed, Taastrup, Denmark) 2 mg and Rompun
(Bayer Schering Pharma, Berlin, Germany) 2.5 mg and
transported to the surgical unit. Anesthesia was induced
with Ketamine (Pfizer, New York, NY, USA) 2 mg/kg
and Dormicum (Roche, Basel, Switzerland) 0.25 mg/kg
and maintained by Isoflurane (Baxter, Deerfield, IL,
USA) 1.5% in an O2/N2O mixture. Orotracheal
intubation (tube diameter 9 mm) was followed by
artificial ventilation using a servoventilator (Abott, Solna,
Sweden; tidal volume 600–800 mL, 18 breaths/min).
Catheterization of the left common carotid artery
was performed for withdrawal and blood gas analysis
(Radiometer, Brønshøj, Denmark), a pulse oximeter
sensor was attached to an ear, and a capnograph was
used for end-tidal CO2 measurement.
By changing the O2/N2O ratio in ventilated gas, the
fetus was subjected to normoxic, hypoxic and hyperoxic
conditions. The oxygen content varied between 10%
and 100%. Each ventilation level was maintained for
30 min to allow steady-state oxygenation conditions. In
four ewes, the tissue oxygenation in the fetal liver was
successfully measured using an oxygen sensitive optode.
The experimental protocol was approved by the local
animal ethics committee.
The invasive tissue oxygenation measurements were
performed with an MRI-compatible optical oxygen-
sensitive optode (Presens, Regensburg, Germany). The
optodes used in this study consisted of a 15-m long,
0.9-mm thick fiber-optic cable, exposed and coated
with oxygen-sensitive fluorescent sensor material at the
tip, which was 0.1 mm in diameter. The principle
of measurement is based on the effect of dynamic
luminescence quenching of the fluorescent sensor material
by molecular oxygen. The dynamic quenching is directly
related to the local tissue pO2 and is measured in real time.
The 90% response time of the optode was approximately
10 s12. Compared to conventional oxygen-sensitive
(Clark-type) electrodes, optodes have the advantage of
not consuming oxygen during measurements, such that
long-term pO2 measurements in vivo can be performed
in tissue, without depleting oxygen around the optode
tip, even in regions where oxygen supply is mainly
limited to molecular diffusion. One previous study has
been published applying this fluorescent technique to fetal
tissue oxygen measurement in vivo13. In this study a 1.2-
mm diameter trocar was placed in the fetal liver using
sonographic guidance and the optode was firmly inserted
through it.
MRI was performed with a 1.5 T clinical system
(Philips Medical Systems, Best, The Netherlands). The
anesthetized ewe was examined in a left lateral position.
The acquisitions were obtained with a phased-array
abdominal radio-frequency coil. Fast axial and coronal
scans of the fetus were initially performed to locate organs
of interest. Next, a sequence was employed, sensitive
to changes in magnetic susceptibility using strong T2*-
weighting, allowing one to assess changes in the BOLD
contrast. This was performed as a dynamic sequence,
in which T2*-weighting was accomplished using a two-
dimensional gradient-echo sequence with sequential echo-
planar encoding. The sequence parameters included: eight
slices with 3 mm of thickness; field of view 250 × 250
mm2; acquired spatial resolution 256 × 256 voxels;
repetition time (TR) 1500 ms; flip angle 90◦; and an
echo time of 40 ms optimized for the average T2* value
in vivo. Six transients were acquired for optimal signal-
to-noise ratio, giving a single-frame scan time of 300 s.
A total of 150 dynamic frames were recorded with an
interval of 112 s.
The MRI data were transferred to an external
workstation equipped with the Mistar software (Apollo
Imaging Technology, Melbourne, Australia). All images
displayed an adequate signal-to-noise ratio and did not
show substantial artifacts. The signal intensity of the T2*-
weighted images was examined in regions of interest
(ROIs) as shown in Figure 1. Placement of ROIs in
the fetal kidney, liver, spleen and brain was performed
by a clinical radiologist, and movements were adjusted
manually in each dynamic image. For each ROI, the mean
(± SD) signal versus time curve was calculated.
From a theoretical point of view the local magnetic
susceptibility is the degree of magnetization of a material
in response to a magnetic field, but the inherent differences
Figure 1 Blood oxygen level-dependent magnetic resonance image
showing an axial view of the fetus with the fetal liver selected as the
region of interest (ROI).
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in local magnetic field mean that it is not possible to
directly compare the acquired BOLD signal between
animals. Furthermore inter-animal variations are expected
in hydration, fetal size, temperature, distance to the
receiver coil etc. Owing to these expected inter-animal
variations and the modest size of the dataset, we have
taken a descriptive approach to data analysis.
Optode measurements of fetal pO2 were compared with
levels of BOLD MRI of the fetal liver during different
maternal ventilation oxygenation levels, and the BOLD
MRI signals of all fetal organs were compared with
maternal arterial pO2 levels and graphically presented.
RESULTS
All the animals underwent BOLD MRI during normoxic,
hyperoxic and hypoxic conditions. In four out of seven
animals an oxygen-sensitive optode was successfully
inserted into the fetal liver for direct measurement of
tissue oxygen. For the fetal liver, changes in the BOLD
signal were associated with changes in the direct optode
measurements of tissue pO2 (Figures 2 and 3). Within
a few min after changing the maternal oxygen supply
(performed by changing the ventilated O2/N2O ratio),
we observed a corresponding response in the optode
measurements as well as in the acquired BOLD signal
of the fetal liver. Because of progressive lung atelectasis,
the maternal arterial pO2 did not return to the starting
level when the maternal ventilation was returned to
normoxic conditions (O2/N2O ratio = 1.0) at the end
of the experiment, and consequently the BOLD signal of
the fetal liver and the optode measurements also remained
at a lower level in the last period of the experiment.
Figure 4 demonstrates a linear relationship between
maternal arterial pO2 and optode measurements of tissue
oxygen levels, justifying the use of maternal arterial pO2
as a reference for organs without optode measurements.
Figure 5 illustrates the BOLD signal in one of the seven
fetuses during periods of different maternal arterial pO2
level. The BOLD signal of the fetal kidney and the spleen
changed in patterns similar to the one seen in the liver. In
contrast to this, the signal of the brain remained constant
during normoxic, hypoxic and hyperoxic conditions.
In all the animals we observed that changes in the BOLD
signal of the fetal spleen, kidney and liver were closely
associated with changes in maternal arterial oxygenation
(Figure 6). As shown in Figures 3 and 6, the BOLD MRI
data from each organ in relation to optode/maternal
arterial measurements seem to describe a curved graph,
which is steeper at lower oxygen levels and flattens at
higher oxygen levels. The only exception to this pattern is
the BOLD response from the brain, the BOLD signal of
which remained constant.
The BOLD MRI signal response was expected to vary
between the animals. However, as shown in Figures 3
and 6 there was only a small amount of variation
between the different animals, thus the data seem to
be reproducible.
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Figure 2 Changes in fetal liver blood oxygen level-dependent
(BOLD) magnetic resonance signal (a), fetal liver optode oxygen
measurement (b) and maternal arterial pO2 (c) over time for one
sheep (Animal 8) during varying oxygen levels (14–100%) in
maternal ventilated gas.
DISCUSSION
This experimental study in pregnant sheep demonstrated
that changes in the BOLD MRI signal of the fetal liver
were closely related to changes in tissue oxygenation
determined by an oxygen-sensitive fluorescence optode.
We also observed that changes in BOLD MRI signal
were reproducible among animals. Thus, BOLD MRI
seems to constitute a reliable non-invasive technique for
the determination of short-term changes in fetal tissue
oxygenation.
The sensitivity of BOLD MRI is enhanced by the
relative hypoxic conditions of the normal fetus. Despite
the left shift of the dissociation curve of fetal hemoglobin,
as compared to adult hemoglobin, the hemoglobin
saturation in the umbilical vein is only 80%14. The fetal
arterial, mid-capillary and venous oxygen concentrations
Copyright  2009 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2009; 34: 687–692.
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Figure 3 Association between the blood oxygen level-dependent
(BOLD) magnetic resonance imaging (MRI) signal of the fetal liver
and the direct optode measurements from the fetal liver in four
animals. ♦, Animal 2; , Animal 3; , Animal 5; ×, Animal 8.
correspond with the steeper part of the hemoglobin
dissociation curve. Therefore, with any given change in
oxygen concentration, a more pronounced change in the
BOLD signal is expected in the fetus as compared to the
adult. Keeping the sigmoidal shape of the dissociation
curve in mind, one should expect a more pronounced
change in BOLD signal during lower oxygen levels and
the opposite effect for higher oxygen levels. Our work
supports this theory, as the BOLD data from each organ
in relation to optode/maternal arterial measurements seem
to describe a curved graph that is steep at lower oxygen
levels and flattens at higher levels. This is in conflict with
a study by Wedega¨rtner et al.9 that suggested a linear
association between maternal arterial saturation and the
BOLD signal of selected fetal organs. This difference is
probably explained by the different experimental designs
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Figure 4 Association between optode measurements of pO2 in the
fetal liver and pO2 measured in maternal arterial blood samples in
four animals. ♦, Animal 2; , Animal 3; , Animal 5;
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of the two studies, as we, unlike Wedega¨rtner et al., also
performed experimental measurements during hyperoxic
conditions.
Another variable of importance is the ‘fractional
blood volume’. As the BOLD MRI signal reflects the
deoxyhemoglobin concentration, it depends not only on
hemoglobin saturation but also on the fractional blood
volume, i.e. if the vessels dilate the amounts of both
oxyhemoglobin and deoxyhemoglobin increase within the
voxel even in case of unchanged hemoglobin saturation15.
The oxygen-sensitive optodes used in this study, however,
operate independently of changes in fractional blood
volume. This indicates that the changes in BOLD MRI
signal truly reflect oxygenation changes.
As we only succeeded in inserting oxygen-sensitive
optodes into the fetal liver of four animals, we used
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one animal (Animal 5) during varying oxygen levels in maternal ventilated gas (10–100%).
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the maternal arterial pO2 as a reference for the remaining
fetal organs. This was justified by the observed linear
relationship between the optode measurements and the
maternal arterial pO2. In the fetal liver, spleen and kidney
we found a clear association between changes in the BOLD
signal and changes in maternal arterial pO2. In contrast
to this, the BOLD signal of the fetal brain remained
unchanged during the normoxic, hypoxic and hyperoxic
conditions – a consistent finding in all our experiments.
We explain this interesting phenomenon as a result of
the brain-sparing mechanism, characterized by increased
blood flow to the brain during hypoxic conditions, thus
compensating for the reduced oxygen content of the
circulating blood. This autoregulation is very efficient, and
protects the brain from extreme conditions. Our results
indicate that the brain was also spared from hyperoxic
conditions.
Apart from the fetal brain, fetal oxygenation increased
during hyperoxic maternal conditions. This consistent
finding is supported by other studies. Semple et al.5
performed BOLD MRI during hyperoxia in normal preg-
nancies, showing an increase in BOLD signal in five
out of nine pregnancies. The lack of response in four
pregnancies was probably due to fetal movements inter-
fering with the MRI signal5. In growth-restricted fetuses
maternal hyperoxygenation seems to improve umbilical
pO2 as determined by cordocentesis16, normalize brain
sparing demonstrated by Doppler flow17 and increase
fetal movements18. The ‘oxygen test’ was introduced by
Arduini et al.19; if fetal brain sparing is normalized by
maternal hyperoxygenation the test is positive, and if
brain sparing remains unaffected the oxygen test is neg-
ative. A negative test has been reported to be a strong
predictor of adverse perinatal outcome19,20. A positive
oxygen test cannot be explained by increased oxygena-
tion of maternal hemoglobin as the arterial saturation is
close to 100% even during normoxic conditions. There-
fore, an increased oxygen partial pressure gradient across
the placental membrane is likely to be of importance, as
the hemoglobin saturation of venous umbilical blood is
only 80%14.
Differences between the human placenta and the sheep
placenta complicate extrapolation of our experimen-
tal findings to the human situation. The histological
Copyright  2009 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2009; 34: 687–692.
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structure of the human placenta can be represented by
the multivillous model, in contrast to the sheep pla-
centa, which is represented by the venous equilibration
exchange model21. The sheep placenta is less effective
at transporting oxygen to the fetus than is the human
placenta. As a consequence of the reduced O2 extrac-
tion coefficient the sheep fetus is slightly more hypoxic
(umbilical vein, 4.7 kPa; umbilical artery, 2.7 kPa) com-
pared to the human fetus (umbilical vein, 5.5 kPa;
umbilical artery, 3.9 kPa). The neuroendocrine and car-
diovascular responses in hypoxia are very similar in
sheep and human fetuses, including the brain-sparing
mechanism22. The long duration of anesthesia might have
affected our results, but not the conclusions drawn from
them.
In conclusion, BOLD MRI is a reliable non-invasive
method for measuring regional changes in tissue
oxygenation in fetal organs in vivo. This method provides
new opportunities for fetal monitoring and fetal testing.
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ABSTRACT
Objective The purpose of this study was to measure
differences in oxygenation between the left and right sides
of the fetal liver during varying oxygenation levels.
Methods Eight ewes carrying singleton fetuses at gesta-
tional age 125 days (term, 145 days) were included in the
study. Under anesthesia the ewes were ventilated with gas
containing different levels of oxygen, thereby subjecting
the fetuses to hyperoxia (mean ± SD maternal arterial
partial pressure of oxygen (pO2), 23.2 ± 8.2 kPa) and
hypoxia (mean maternal arterial pO2, 7.1 ± 0.5 kPa).
Changes in oxygenation within the fetal liver were
assessed by blood oxygen level-dependent (BOLD) mag-
netic resonance imaging (MRI).
Results During hyperoxia there was no difference
between the BOLD signal in the left and right sides of
the fetal liver; mean change in BOLD (BOLD)hyperox,
−0.9 ± 3.7%. During hypoxia, however, the decrease in
the BOLD signal wasmore pronounced in the right side as
compared with the left side, thereby creating a significant
increase in the left–right difference in the BOLD signal;
mean BOLDhypox, 5.2 ± 2.2% (P = 0.002, paired
t-test). The left–right difference was directly proportional
to the degree of hypoxia (R2 = 0.86, P = 0.007).
Conclusions To our knowledge, this is the first study
demonstrating differences in oxygenation between the
left and right sides of the fetal liver during hypoxia,
a difference that can be explained by increased ductus
venosus shunting. Thus, the BOLD MRI technique is a
promising non-invasive tool that might be useful for the
future monitoring of the human fetus. Copyright  2011
ISUOG. Published by John Wiley & Sons, Ltd.
INTRODUCTION
The fetal liver has a privileged position in the fetal
circulation, as it is the first organ to receive blood directly
from the placenta. Therefore the oxygen supply to this
organ is better than to that of any other fetal organ.
The fetal liver plays an important role in regulating fetal
growth1 and in programming adult metabolism2. The
fetal circulation has been intensively investigated, initially
using a radioactive microsphere technique3,4 and later by
ultrasound Doppler flow measurements5–7. The fetal liver
has two main vascular sources. It receives about 75% of
its blood supply from the well-oxygenated umbilical vein
and 20% from the less-well-oxygenated portal vein8. The
contributions of these sources are unevenly distributed
in the fetal liver, as the left side receives primarily the
well-oxygenated umbilical vein blood, while the right side
receives an equal mixture from the two vascular sources9.
The remainder is supplied by the hepatic artery, which
makes a modest contribution of < 10% that is evenly
distributed in the fetal liver10. The left portal vein has
been identified as the means of communication between
the umbilical vein and the portal circulation, as this vessel
carries umbilical venous blood to the right side of the
liver11,12 (Figure 1). The contribution of umbilical vein
blood to the right side of the liver is highly dependent on
the ductus venosus shunting fraction, which in the third
trimester is 20% in the healthy fetus. However, during
acute hypoxia13 and in the growth-restricted fetus14–17
ductus venosus shunting is increased; consequently, blood
flow in the left portal vein is reduced or even reversed14.
This redistribution of umbilical vein blood increases the
oxygen supply to the fetal heart and brain at the expense
of the fetal liver, especially the right side of the fetal liver.
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Figure 1 Main blood supply of the sheep fetal liver seen in
transverse view. Red represents well-oxygenated and blue
represents poorly oxygenated blood. DV, ductus venosus; LPV, left
portal vein; PV, portal vein; RPV, right portal vein; SP, spine; ST,
stomach; UV, umbilical vein. (Reproduced with permission9.)
We hypothesized that during hypoxia the redistribution
of umbilical vein blood would lead to lower oxygenation
in the right side of the fetal liver than in the left side. The
aim of this study was to evaluate the left–right difference
in fetal liver oxygenation during hypoxia.
METHODS
Animal handling
Eight healthy ewes (Gotland sheep) carrying singleton
fetuses at 125 days’ gestation (term, 145 days, equivalent
to 34 weeks’ gestation in humans) were included in
the study. Prior to the experimental procedures, the
ewes were cared for at our animal farm (Pa˚skehøjga˚rd,
Aarhus University Hospital, Denmark), with free access
to water and food. On the day of the experiment,
each ewe was sedated with atropine 2 mg (Nycomed,
Taastrup, Denmark) and Rompun
TM
2.5 mg (Bayer
Schering Pharma, Berlin, Germany) and transported to
the surgical unit. Anesthesia was induced with ketamine
2 mg/kg (Pfizer, New York, USA) and Dormicum
TM
0.25 mg/kg (Roche, Basel, Switzerland) and maintained
by isoflurane (Baxter, Deerfield, USA), 1.5% in an
oxygen/nitrous oxide (O2/N2O) mixture. Orotracheal
intubation (tube diameter, 9 mm) was followed by
artificial ventilation using a servo-ventilator (Abott, Solna,
Sweden) with a tidal volume of 600–800 mL at a rate
of 18 breaths/min. Catheterization of the left common
carotid artery was performed for withdrawal of blood
and blood gas analysis (Radiometer, Brønshøj, Denmark).
A pulse oximeter sensor was attached to an ear, and a
capnograph was used for end-tidal carbon dioxide (CO2)
measurement. By sonographic guidance oxygen-sensitive
optodes were placed in the fetal liver in four fetuses;
these measurements were used for other purposes18. By
changing the O2/N2O ratio in the maternal ventilated gas,
the fetus was subjected to varying oxygenation levels. The
oxygen content in the ventilated gas varied between 10%
(hypoxia) and 100% (hyperoxia), and the corresponding
mean maternal arterial partial pressure of oxygen (pO2)
was 7.1 ± 0.5 kPa (mean ± SD) during hypoxia and
23.2 ± 8.2 kPa during hyperoxia. In this study, we
monitored maternal oxygenation not only by the oxygen
content of the ventilation gas but also by maternal arterial
blood samples. As a result, we discovered a discrepancy
between the two, probably due to varying degrees of
lung atelectasis in the ewes during our experiments. The
experimental protocol was approved by the local animal
ethics committee.
Anesthetics
The anesthetics used in this experiment and their potential
effects on fetal circulation are discussed here. Rompun is
an α2-adrenoceptor agonist with known oxytocin-like
effects on the uterus. In goat fetuses increased intrauterine
pressure has been observed for 5–15 min following
Rompun injection, thereby causing a mild and transient
decrease in fetal pH and pO219. Ketamine has known
sympathomimetic effects. In sheep fetuses a mild decrease
in fetal pH has been noted following ketamine injection;
however, no significant effects on fetal mean arterial blood
pressure, fetal heart rate or uterine blood flow were
seen20. Atropine is a non-selective muscarine receptor
antagonist. In sheep fetuses near term a transient increase
in heart rate and blood pressure has been seen following
atropine injection, however no effects were seen on fetal
arterial pH, pO2 and partial pressure of CO2 (pCO2)21.
Dormicum is a benzodiazepine derivate with sedative
effects. In sheep fetuses a transient increase in heart rate
has been noted following Dormicum injection, but no
effects were seen on fetal blood pressure, uterine blood
flow or fetal arterial pH, pO2 or pCO222. By reducing fetal
pH transiently Rompun and ketamine might have affected
the ductus venosus shunting fraction initially. But as
the magnetic resonance imaging (MRI) experiments were
carried out at least 90 min after induction of anesthesia,
these effects are unlikely to have influenced our results.
Isoflurane, used for maintaining anesthesia in this
experiment, is a halogenated ether with known analgesic
and muscle-relaxing effects. In fetal sheep reduced blood
pressure has been noted following administration of
isoflurane23. This cardiovascular depressant effect of
isoflurane might have reduced the vascular response in the
fetal liver, hence decreasing the changes in the right–left
difference in fetal liver blood oxygen level-dependent
(BOLD) signal–BOLD – during hypoxia. Thus, we may
have underestimated the effect of hypoxia on BOLD in
this study.
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BOLD MRI
The absolute BOLD MRI signal is not a direct
measure of fetal tissue oxygenation, but changes in
the BOLD signal reflect changes in the proportion of
oxygenated hemoglobin molecules in a given region.
The BOLD effect is based on the magnetic properties
of hemoglobin; oxyhemoglobin is diamagnetic whereas
deoxyhemoglobin is paramagnetic. Changes in the
oxygenation of hemoglobin, therefore, provide a change in
the local magnetic field, and this leads to a corresponding
change in the BOLD signal in the same region24. The
BOLD MRI technique is now widely used in neuroscience,
and it is the most important method for investigating
brain function during cognitive and sensory stimuli25.
BOLD MRI is also used for the non-invasive evaluation
of changes in tissue oxygenation during physiological
challenges such as hyperoxia and hypoxia in the following
organs: the brain26, the kidney27 and the liver28–30. In fetal
MRI the BOLD technique has been used for measuring
changes in fetal oxygenation in the sheep fetus18,31–33
during maternal hypoxia and the human fetus34,35 during
maternal hyperoxia. It has been shown that changes
in the fetal BOLD MRI signal are closely related to
changes in fetal arterial saturation33 and changes in fetal
tissue oxygenation as estimated by internal fetal oxygen
sensors18. According to these studies BOLD MRI provides
a reliable method for measuring changes in the overall
oxygenation of selected fetal organs.
During our experiments BOLD scans were performed
continuously at varying levels of maternal and fetal
oxygenation. The BOLD signal inside certain regions
of interest (ROIs) was obtained, and the changes in
BOLD signal inside these ROIs reflected the changes in
fetal oxygenation in these particular regions. One large
ROI covering the entire liver was selected for overall
oxygenation measurements (Figure 2a) and seven smaller
ROIs, which were equidistantly distributed throughout
the liver from the left to the right side, were used for
regional oxygenation measurements (Figure 3a).
BOLD MRI was performed with a 1.5-T clinical
system (Philips Medical Systems, Best, The Netherlands).
The anesthetized ewe was examined in a left lateral
position. Acquisitions were obtained with a phased-array
abdominal radiofrequency coil. Fast axial and coronal
scans of the fetus were initially performed to locate the
fetal organ of interest. Next, a T2*-weighted sequence
was performed, allowing assessment of changes in the
BOLD signal. This was done using a dynamic multishot
2D-gradient-echo sequence with sequential echo-planar
encoding. The sequence parameters included 10–17 slices
6 mm thick with an interslice gap of approximately 9 mm
(depending on the orientation and position of the fetus);
the field of view was 460 × 460 mm, acquired using a
256 × 256 matrix, resulting in an in-plane resolution of
approximately 1.8 × 1.8 mm, TR = 2500 ms, flip angle
= 90◦, and an effective echo time of 40 ms optimized for
the average T2* value in vivo. Each frame was averaged
three times for the optimal signal-to-noise ratio. A total
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Figure 2 Change in overall fetal liver oxygenation in a sheep fetus
(Fetus 1). (a) Blood oxygen level-dependent (BOLD) image of the
fetal liver (transverse view) with one region of interest (ROI; red
line) covering the entire fetal liver for overall fetal liver oxygenation
assessment. (b) Changes in BOLD signal within the ROI during
varying oxygenation levels presented as a signal/time curve. Such
changes reflect changes in overall fetal liver oxygenation. , Signal
values used for calculating mean value (see Table 1).
of 150 dynamic frames were recorded with an interval of
112 s.
Data analysis
MRI data were transferred to an external workstation
equipped with Mistar software (Apollo Imaging Tech-
nology, Melbourne, Australia). All images displayed ade-
quate signal-to-noise ratio and did not show substantial
artifacts. The signal intensity of the T2*-weighted BOLD
images was obtained in the ROI as shown in Figures 2a
and 3a. Placement of the ROIs within the fetal liver was
performed by clinical radiologists (B.S.-G. and A.T.), and
errors due to fetal movement were corrected by manu-
ally moving the ROI in each dynamic image. For each
ROI, the mean signal vs. time curve was calculated. The
BOLD signals from different regions were compared at
different oxygenation levels. As we wanted to include
only steady-state measurements, only the last 10 min of
each oxygenation level were included. In each fetus the
Copyright  2011 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2011; 38: 665–672.
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Figure 3 Change in regional fetal liver oxygenation in a sheep fetus
(Fetus 1). (a) Blood oxygen level-dependent (BOLD) image of the
fetal liver (transverse view), showing seven small regions of interest
(ROIs) within the fetal liver for regional oxygenation assessment.
ROIs are placed at regular intervals from left to right, with the
blue-colored ROI (ROI-7) placed at the furthest right side and the
red-colored ROI (ROI-1) placed at the furthest left side in the fetal
liver. (b) Changes in BOLD signal within the seven ROIs during
varying oxygenation levels presented as signal/time curves, each
representing change in oxygenation in a different region of the fetal
liver, identified by color. , Signal values obtained for calculation
of mean values (see Table 2) in each fetus. , ROI 1;
, ROI 2; , ROI 3; , ROI 4; , ROI 5;
, ROI 6; , ROI 7.
left–right difference in fetal liver oxygenation (BOLD)
was defined as the difference between the BOLD signal of
the furthest left ROI (ROI-1) and the furthest right ROI
(ROI-7) of the fetal liver. Using the starting normoxic
overall BOLD signal as a reference (BOLDref) the relative
BOLD was calculated for each fetus during hyperoxia
and hypoxia.
Statistical analysis
Absolute BOLD signal values were normalized, using
the normoxic starting level as a reference in each
fetus. Mean ± SD were calculated for the hyperoxic
and hypoxic levels, reflecting changes in overall and
regional fetal liver oxygenation (Tables 1 and 2). Using
the paired t-test, we tested paired values of the BOLD
signal from the left and the right regions of the fetal
liver during hyperoxia as well as hypoxia. Our null
hypothesis was that there was no left–right difference
(BOLD = 0). The relationship between BOLD and
the degree of hypoxia was tested using linear regression
analysis, and for all tests P < 0.05 was considered
statistically significant. Statistical analysis was performed
using the Stata11 (StataCorp LP, TX, USA) statistical
package.
RESULTS
Eight animals were originally included in the study, but
two were excluded from the analysis because fetus number
2 had a hepatic hematoma when the oxygen sensor was
installed and animal number 4 had a cardiac arrest when
anesthesia was induced, thus final data were only available
for six animals.
For measuring changes in overall fetal liver oxygenation
one ROI covering the entire fetal liver was drawn
(Figure 2a). The corresponding changes in BOLD signal
during different oxygenation levels are presented for
one fetus (Fetus 1) in Figure 2b. Using the BOLD MRI
technique we found the overall oxygenation of the fetal
liver to be reduced to a mean ± SD of 75 ± 13%
during hypoxia and increased to 121 ± 16% during
hyperoxia when using the normoxic starting BOLD
signal (BOLDref) as a reference (100%) for each fetus
(Table 1).
Changes in regional oxygenation of the fetal liver
were investigated using seven smaller ROIs, as shown
in the BOLD image in Figure 3a. The red-colored ROI-
1 was placed at the furthest left side of the liver,
and the blue-colored ROI-7 was placed at the furthest
right side of the liver. The corresponding changes in
the BOLD signal at different oxygenation levels are
presented for one fetus (Fetus 1) in Figure 3b. During
hyperoxia the BOLD signal of every ROI increased to
the same level. During hypoxia, however, the BOLD
signal of the blue-colored ROIs of the right side was
reduced to a lower level than the BOLD signal of the
red-colored ROIs of the left side. This finding reflects
lower oxygenation on the right side of the fetal liver
as compared with the left side during hypoxia. Table 2
presents the absolute and normalized BOLD signals of
the furthest left and furthest right ROIs in the fetal
liver, and the calculated BOLD during hyperoxia and
hypoxia. BOLD was significantly increased from a mean
of −0.9 ± 3.7% during hyperoxia to 5.2 ± 2.2% during
hypoxia (P = 0.002, paired t-test) (Table 2). For each
fetus BOLD increased during hypoxia, as illustrated in
Figure 4.
Figure 5 illustrates the correlation between BOLD
and the maternal arterial pO2 during hypoxia. BOLD is
directly proportional to the degree of hypoxia (R2 = 0.86,
P = 0.007). This correlation was not apparent during
hyperoxia.
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Table 1 Changes in overall liver oxygenation of sheep fetuses during hyperoxia and hypoxia
Hyperoxia Hypoxia
Fetus BOLDref BOLDhyperox BOLDhyperox/BOLDref (%) BOLDhypox BOLDhypox/BOLDref (%)
1 517 ± 18 678 ± 20 131 384 ± 22 74
3 401 ± 14 455 ± 25 113 344 ± 50 86
5 477 ± 16 563 ± 41 118 237 ± 48 50
6 440 ± 17 658 ± 16 150 375 ± 13 85
7 443 ± 23 492 ± 26 111 363 ± 31 82
8 431 ± 20 450 ± 57 104 315 ± 22 73
Mean (SD) 121 (16) 75 (13)
Only the last 10 min in each oxygenation episode were included. Values are given as mean ± SEM in arbitrary units except where indicated.
BOLD, blood oxygen level-dependent magnetic resonance signal; BOLDref, BOLD of normoxic fetuses; BOLDhyperox, BOLD of hyperoxic
fetuses; BOLDhypox, BOLD of hypoxic fetuses.
Table 2 Changes in regional liver oxygenation presented as blood oxygen level-dependent (BOLD) magnetic resonance signal and the
left–right difference (BOLD) of sheep fetuses during hyperoxia and hypoxia
Hyperoxia Hypoxia
Fetus BOLDref BOLDleft BOLDright BOLDhyperox BOLDleft BOLDright BOLDhypox
1 517 ± 18 627 ± 26 (121.3) 631 ± 27 (122.0) −0.8 407 ± 65 (78.7) 390 ± 70 (75.4) 3.3
3 401 ± 14 439 ± 20 (109.5) 458 ± 25 (114.2) −4.7 364 ± 31 (90.8) 339 ± 46 (84.5) 6.2
5 477 ± 16 606 ± 30 (127.0) 598 ± 28 (125.4) 1.7 247 ± 36 (51.8) 216 ± 20 (45.3) 6.5
6 440 ± 17 636 ± 53 (144.5) 641 ± 48 (145.7) −1.1 382 ± 29 (86.8) 365 ± 41 (83.0) 3.9
7 443 ± 23 494 ± 41 (111.5) 516 ± 27 (116.5) −5.0 368 ± 24 (83.1) 355 ± 32 (80.1) 2.9
8 431 ± 20 478 ± 38 (110.9) 458 ± 50 (106.3) 4.6 348 ± 18 (80.7) 312 ± 32 (72.4) 8.4
Mean (SD) −0.9 (3.7) 5.2 (2.2)
P 0.6 0.002
For each fetus the absolute BOLD signal in arbitrary units was obtained from different regions of interest (ROIs) of the fetal liver during
hyperoxia as well as hypoxia. Only the last 10 min in each oxygenation episode were included. Data are given as mean ± SEM in arbitrary
units, mean ± SEM (%) or %. BOLDref, BOLD of normoxic fetuses; BOLDleft, BOLD of left side of liver i.e. region of interest (ROI)-1;
BOLDright, BOLD of right side of liver i.e. ROI-7; BOLDhyperox, difference between ROI-1 and ROI-7 for hyperoxic fetuses; BOLDhypox,
difference between ROI-1 and ROI-7 for hypoxic fetuses. P according to paired t-test.
DISCUSSION
In this study we measured the difference in oxygenation
between the left and right sides of the fetal liver
(BOLD) using the BOLD MRI technique. During
hypoxia BOLD was significantly increased and was
found to be directly proportional to the degree of
hypoxia. To our knowledge, this is the first study to
describe changes in regional oxygenation within the fetal
liver.
A limitation of the BOLD MRI technique is that the
absolute BOLD signal depends not only on the proportion
of paramagnetic deoxyhemoglobin but also on other
variables including blood flow, blood volume in the
fetal tissue, hematocrit and the hemoglobin concentration
within fetal erythrocytes36. This could explain some of
the interanimal variation in the normoxic BOLDref signal
presented in Table 1. Because of these variables only
relative changes and not the absolute BOLD signal can be
compared between animals.
Another limitation of this study involves the use of
anesthesia. The possible fetal effects of the anesthetics
used in this experiment are listed in the methods section.
The cardiovascular depressant effect of isoflurane23 might
have reduced the vascular response in the fetal liver, hence
decreasing the changes in BOLD during hypoxia. Thus,
we may have underestimated the effect of hypoxia on
BOLD in this study. The anesthetics used for induction
of anesthesia might have affected the ductus venosus
shunting fraction transiently, but as the MRI experiments
were carried out at least 90 min after induction of
anesthesia, these effects are unlikely to have influenced
our results.
Our findings are in accordance with well-established
theories about fetal liver circulation and fetal physiology
based on Doppler ultrasound flow measurements. The
increase in BOLD in the fetal liver during hypoxia can
be explained by increased ductus venosus shunting37. The
direct proportion between BOLD and the degree of
hypoxia agrees with the results of a study by Kiserud
et al.16 showing increased ductus venosus shunting with
an increasing degree of umbilical vein flow impairment
in the growth-restricted fetus. The variation in maternal
arterial pO2 during hypoxia can be explained by varying
degrees of lung atelectasis among the ewes during the
experiment.
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Figure 5 Correlation between difference in left–right oxygenation
of the fetal sheep liver during hypoxia (BOLDhypox) (see Table 1)
and maternal arterial partial pressure of oxygen (pO2). R2 = 0.86.
According to our hypothesis, during hypoxia one
would expect an increased BOLD; this was confirmed
by our experiment. During hyperoxia, however, we
found no left–right difference in oxygenation. This was
not expected. During hyperoxia the portal vein still
contributes to the blood supply of the right side of
the liver. Therefore, a left–right oxygenation difference
should be expected at any oxygenation level, even during
hyperoxia.
An explanation for this finding could be that the
left–right oxygenation difference during hyperoxia was
below the sensitivity for this method. A way to improve
the sensitivity of the BOLD technique in fetal MRI
would be to increase the magnetic field strength, as
noted by Wedega¨rtner et al.38. When the magnetic field
strength is doubled from 1.5 to 3 T the BOLD signal is
more affected by the presence of deoxyhemoglobin, as
the susceptibility effects are higher at 3 T than they
are at 1.5 T. This leads to a higher signal-to-noise
ratio for the BOLD response and a higher sensitivity
in detecting signal changes. A negative aspect will be
increased artifacts caused by fetal movements. From a
clinical perspective 1.5 T is of greater interest because
3-T systems, as a safety precaution, are not currently
used for human fetal MRI, although no harmful short-
or long-term effects of prenatal MRI have ever been
reported39. Further data about prenatal MRI in higher
magnetic fields will probably change clinical practice in
this field.
Fetal movements are known to interfere with MRI,
causing artifacts on the images, thereby producing
inaccuracy in measuring signal changes within selected
fetal organs. In this study, however, the ewes and fetuses
underwent general anesthesia, and fetal movements were
therefore greatly reduced. A recent paper described no
effects of maternal hyperoxia on human fetal liver
oxygenation using quantitative T2* measurements in
80 human pregnancies (involving both healthy and
growth-restricted fetuses)35. This might be caused by
fetal movements between the acquisition of images at
the different echo times or because the T2* mapping
was not accurate or sensitive enough. The BOLD
technique might not show the same susceptibility
to fetal movements, and it might provide higher
sensitivity to changes in susceptibility (T2*). This needs
to be investigated by further human studies in this
field.
A study similar to this could not be conducted in
human fetuses as it would not be ethical to induce acute
hypoxia. However, fetuses subjected to chronic hypoxia,
for example growth-restricted fetuses, might exhibit the
same left–right differences in fetal liver oxygenation as
seen during acute hypoxia. Examination of this group of
human fetuses could provide the clinical protocol for this
method. Moreover, in this particular group of fetuses we
would not expect significant artifacts because of reduced
fetal movements.
Before introducing BOLD of the fetal liver for
evaluating fetal wellbeing it should be remembered that
the ductus venosus shunting fraction is influenced not
only by hypoxia. Other factors such as fluid dynamics40,
neural and endocrine factors37 and maternal diet41 also
play important roles. Furthermore, there are differences
between the sheep and the human fetus regarding the fetal
circulation and especially the ductus venosus shunting
fraction. In the human fetus the ductus venosus shunting
fraction is 20% in the third trimester42 compared with
50% in the near-term sheep fetus3,6. However, during
hypoxia the sheep fetus exhibits the same redistribution
of umbilical vein blood as seen in the human fetus3.
Therefore, changes in fetal liver oxygenation during
hypoxia should be comparable in sheep and human
fetuses.
In this study the BOLD MRI technique proved its
potential as a non-invasive method for investigating
changes in regional fetal oxygenation. Further research is
needed in this field in healthy as well as growth-restricted
human fetuses.
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ABSTRACT
Objective Changes in blood oxygen level dependent (BOLD) magnetic resonance imaging (MRI) signal are closely
related to changes in fetal oxygenation. In this study, we aimed to investigate the changes in human fetal oxygenation
during maternal hyperoxia by using the non-invasive BOLD MRI technique.
Method Eight healthy pregnant women in gestational week 28 to 34 were included. With the use of a facial oxygen
mask, we induced maternal hyperoxia and measured changes in the BOLD MRI signal of selected fetal organs.
Results In a number of fetal organs, the BOLD MRI signal increased signiﬁcantly (P< 0.01) during maternal hyperoxia
(mean change in % SEM): liver (14.3 3.7%), spleen (15.2 3.5%) and kidney (6.2 1.8%) as well as the placenta
(6.5 1.6%). In the fetal brain, however, the BOLD MRI signal remained constant (0.3 0.2%).
Conclusion During maternal hyperoxia, we demonstrated an increased oxygenation in a number of human fetal organs
by using the non-invasive BOLD technique. The oxygenation of the fetal brain remained constant, thus a ‘reversed’ brain
sparing mechanism could be considered in healthy fetuses subjected to hyperoxia. © 2012 John Wiley & Sons, Ltd.
Funding sources: None
Conﬂicts of interest: None declared
INTRODUCTION
The fetal effects of antepartum maternal hyperoxia in
uncomplicated third trimester pregnancies havebeen investigated
in several studies.1–4 Cordocentesis performed during maternal
hyperoxia showed the pO2 in the umbilical vein to increase above
the normal range.1 Unfortunately, cordocentesis is associatedwith
an increased risk of fetal mortality of 1%; therefore, it is not
justiﬁed to perform it unless clinically indicated.5 Furthermore,
the oxygen content of the umbilical vein reﬂects the total oxygen
supply to the fetus, but it does not provide information about
the tissue oxygenation in individual fetal organs. By using the
non-invasive blood oxygen level dependent (BOLD) technique, it
is now possible to investigate oxygenation changes in different
fetal organs.
BOLD magnetic resonance imaging (MRI) is widely used in
clinical neuroimaging as it links brain anatomy and cognitive
function.6,7 This technique is based on the magnetic properties
of hemoglobin. Deoxyhemoglobin is paramagnetic in contrast
to oxyhemoglobin, which is diamagnetic. During hyperoxia, the
concentration of deoxyhemoglobin decreases. Consequently,
the local magnetic ﬁeld changes thereby increasing the T2*
relaxation time of the neighboring protons. This produces a
measurable increase in the local BOLD MRI signal.8 Studies in
sheep fetuses have shown that changes in fetal BOLDMRI signal
are closely related to changes in fetal oxygenation estimated by
fetal arterial hemoglobin saturation9,10 and by ﬂuorescent
oxygen sensors inserted into the fetal liver.11
The purpose of this present study was to investigate
oxygenation changes in a number of fetal organs during
maternal hyperoxia by using the non-invasive BOLD technique.
METHODS
The study was approved by the regional Committee on
Biomedical Research Ethics (Journal number M-20090006).
Oral and written informed consent was obtained from all
Prenatal Diagnosis 2013, 33, 141–145 © 2012 John Wiley & Sons, Ltd.
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participating women. Eight healthy pregnant women carrying
uncomplicated singleton pregnancies were included in the
study. On the day of the examination, the fetal weight was
estimated by ultrasound, and Doppler ﬂow measurements of
the umbilical artery, the middle cerebral artery and maternal
uterine arteries were performed. All measurements were within
the normal range. During the BOLD MRI scan, the maternal
oxygen supply was controlled by a non-rebreather facial
mask (Hudson Respiratory Care, Durham, NC, USA). Three
consecutive maternal oxygenation episodes were induced: (1) a
normoxic level (room air: 21% O2) lasting 5min, followed by (2)
a hyperoxic level (12LO2/min corresponding to approximately
60% O2) lasting 10min, and ﬁnally (3) a normoxic level (air:
21% O2) lasting10min. The facial mask was applied without
interfering with the BOLD MRI scan while the pregnant woman
remained in the bore magnet in the left lateral position.
The BOLD MRI scan was performed with a 1.5 Tesla MRI
System (Philips Medical Systems, Best, The Netherlands). A
multi-receiver cardiac surface coil was placed over the
abdomen covering the entire fetus. Data were acquired with
a gradient echo-planar-imaging sequence with the following
parameters: repetition time= 1800ms, echo-time (effective) =
39.4ms, number of averages = 3, ﬂip angle = 30 and 15 slices
of 6mm with varying slice gap depending on the size of the
fetus. The acquisition matrix was adjusted accordingly
resulting in an in-plane spatial resolution of 2.8 2.8mm,
and spectral fat saturation was applied.
The BOLD MRI raw data were streamed to an external
workstation and ﬁltered by using dedicated custom software.
Regions of interest (ROIs) were plotted in each dynamic BOLD
image corresponding to the selected fetal organs and the
placenta as presented in Figure 1. The ROI size depended on
the size and shape of the investigated organ. In each organ,
the ROI was drawn as big as possible, which meant that the
placenta ROI was the biggest (approximately 670 pixels), and
the kidney ROI was the smallest (approximately 45 pixels).
The ROI was moved manually in each dynamic image to adjust
for fetal movements, and less than 5% of the images were
discarded because of severe movement artifacts. The change
in BOLD signal during the entire 25-min BOLD MRI scan was
obtained for each organ. For each ROI, the average BOLD
signal of the initial normoxic episode (5min) was used as a
reference. The increase in BOLD signal was calculated as the
average BOLD signal during the last 5min of the hyperoxic
episode. The values obtained for calculation are marked with
blue bars in Figure 2.
The increase in the BOLD MRI signal during hyperoxia
(ΔBOLD) was tested against the initial normoxic BOLD signal
level for each organ by using a paired t test. A P-value <0.05
was considered statistically signiﬁcant. The statistical analysis
was performed with STATAW11 (StataCorp LP, College Station,
TX, USA) statistical package.
RESULTS
Changes in the BOLD MRI signal during hyperoxia in one case
(fetus number ﬁve) are shown in Figure 2. In Figure 3, data
from the eight cases are pooled together, and each graph
represents changes in BOLD signal (mean SEM) values of
one fetal organ. During maternal hyperoxia, we observed an
abrupt increase in the BOLD MRI signal of the fetal liver,
spleen and kidney as well as the placenta; and within a few
minutes, the MRI signal reached a steady-state plateau. During
normoxia, the BOLD MRI signal returned to the initial
reference level at a markedly slower pace. In contrast to the
organs just mentioned, the BOLD MRI signal of the fetal brain
remained constant during all three oxygenation periods.
Table 1 presents the eight cases and the ΔBOLD in all
selected organs. The ΔBOLD was calculated for each organ.
During hyperoxia, we found a signiﬁcant increase in the BOLD
MRI signal (ΔBOLD) of the three fetal organs (mean SEM):
liver (14.3 3.7%), spleen (15.2 3.5%), kidney (6.2 1.1%)
and the placenta (6.5 1.6%). Interestingly, the BOLD MRI
signal of the fetal brain did not change during hyperoxia
(0.3 0.2%). We found, that the observed ΔBOLD in response
to maternal hyperoxia varied among organs. For example, the
Figure 1 BOLD images of the fetus and the placenta (axial plane). Regions of interest (ROIs) are drawn in different locations. (A) the placenta
(blue) and in the fetal liver (turquoise). (B) the fetal kidney, (C) the fetal brain
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Figure 2 Changes in BOLD signal during maternal hyperoxia. Each fetal organ is represented by a different color. (Fetus number 5). The blue
bars indicate the values obtained for calculation of ΔBOLD
Figure 3 Data are pooled for the eight participants and each graph represents the BOLD signal changes (mean SEM) for one fetal organ.
The gray box marks the hyperoxic episode
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ΔBOLD of the liver and spleen were approximately twice the
ΔBOLD of the kidney and the placenta.
DISCUSSION
This present study demonstrated that duringmaternal hyperoxia,
oxygenation changes in a number of human fetal organs could
be estimated by using the non-invasive BOLD technique.
The BOLDMRI technique provides information about changes
in the fetal oxygenation status, as previously demonstrated in
a study using oxygen sensitive optodes as a reference.11
Furthermore, this technique allows real-time assessment of
oxygenation changes in a number of fetal organs simultaneously.
It is considered safe when performed in the second and third
trimester at a magnetic ﬁeld strength of 1.5 Tesla.12
One limitation of BOLD MRI is that oxygenation is measured
in relative hence not in absolute values. The acquired BOLD
MRI signal depends not only on the proportion of paramagnetic
deoxyhemoglobin but also on physical parameters such
as the distance to the radiofrequency coil, the magnetic
shimming, sequence parameters (especially the echo-time)
and physiological conditions including the blood ﬂow, the
volume fraction of blood in the fetal tissue, the hematocrit,
and the hemoglobin concentration within fetal erythrocytes
and so forth.13 Therefore, the absolute BOLD MRI signal is
expected to vary not only between individuals but also from
day to day in the same individual.
Reducing the movement artifacts and keeping the ROI in the
exact same position in the fetal organs during the BOLD MRI
acquisition are important for acquiring accurate assessment.
In this study, the pregnant woman remained inside the magnet
bore during the entire BOLD MRI scan. No interruption was
made for application of the facial mask. In case of fetal
movements, the ROI position was adjusted by hand in each
BOLD image.
In this present study, we did not include assessment of
maternal arterial pO2. Previously, however, in unpublished
data, we have demonstrated an increased maternal arterial
pO2 to (mean SD) 45.0 7.6 kPa (data not shown) when
using the exact same facial mask for maternal hyperoxia. The
differences in pO2 were mainly due to inaccurate maternal
oxygen supply. The facial mask administered oxygen at a ﬂow
rate of 12 L per minute. However, the mask was not completely
tight; and therefore, some inhalation of room air was
allowed. This variation in maternal pO2 might to some extent
explain the observed differences in ΔBOLD MRI signals
among the fetuses.
The graphs in Figures 2 and 3 all showed a rapid increase in
BOLD signal during hyperoxia and a decrease at a much slower
pace when the oxygen was reduced to normoxia. The oxygen
binding capacities of fetal hemoglobin might explain the shape
of the graphs. Fetal hemoglobin has high oxygen afﬁnity when
compared with maternal hemoglobin, which facilitates fetal
tissue oxygenation and hampers fetal hemoglobin unloading
of oxygen.
Another interesting observation was that the oxygenation of
the fetal brain remained unaffected by maternal hyperoxia. It is
well known from Doppler ﬂow measurements that cerebral
blood ﬂow is subjected to autoregulation.14 During hypoxia, a
compensatory increase in the cerebral blood ﬂow is seen, known
as the brain sparing mechanism.15 The fetal hemodynamic
response during hyperoxia is sparsely described, but a few
studies have shown a decrease in the cerebral blood ﬂow16–18
during maternal hyperoxia, which could be considered as a
‘reversed’ brain sparing mechanism. The lack of oxygenation
changes in the fetal brain observed in our study may therefore
support the view that the cerebral blood ﬂow is reduced
during hyperoxia.
In addition, we found a ﬁxed relationship between theΔBOLD
signals of the different organs in each individual. In each fetus,
the ΔBOLD signal of the fetal spleen and liver were similar, and
it was nearly doubled when compared with the ΔBOLD signal
of the fetal kidney and placenta. These observations are likely
explained by biological variations among organs, for example,
different fractions of blood volume. As mentioned earlier, the
imaging parameters, especially the echo-time, are important
for the magnitude of the BOLD MRI signal, and the echo-time
chosen in this studymight favor an increasedΔBOLD in the fetal
liver and spleen.
Two previous studies using BOLD MRI, a pilot study of
nine fetuses19 and a larger study including 41 growth restricted
Table 1 The eight participants are presented and the average BOLD for each organ (mean SEM) are calculated. The P-values are
based on a paired t test, and P<0.05 is considered signiﬁcant
Fetus
number
Gestational age
(weeks + days)
Fetal weight UL
estimated (gram)
ΔBOLD fetal
liver (%)
ΔBOLD fetal
spleen (%)
ΔBOLD fetal
kidney (%)
ΔBOLD
placenta (%)
ΔBOLD fetal
brain (%)
1 28+2 1381 14.6 15.3 5.2 5.5 0.3
2 28+0 1350 0.6 2.2 0.5 0.5 0.01
3 28+6 1555 33.3 33.2 14.4 13.1 0.8
4 27+4 1038 13.9 16.0 5.3 4.7 0.7
5 34+1 2227 22.9 23.2 12.7 12.9 0.3
6 33+6 2392 4.8 5.6 0.3 2.2 0.1
7 33+2 2190 9.1 9.0 3.8 4.6 1.5
8 33+6 2273 16.0 17.4 7.3 8.5 0.3
Mean (SEM) 14.3 (3.7) 15.2 (3.5) 6.2 (1.8) 6.5 (1.6) 0.3 (0.2)
P-value 0.006 0.003 0.006 0.005 n.s.
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fetuses and 39 normal fetuses,20 have investigated the human
fetal liver oxygenation during maternal hyperoxia. The later
study demonstrated no changes in BOLD signal in fetal liver
during hyperoxia. The discrepancy between these ﬁndings
and our present results could be due to differences in
experimental design, MRI protocol and in handling of the
pregnant woman during the BOLD MRI procedure.
A clinical perspective of this method could be BOLD MRI
scans of growth restricted fetuses with impaired placental
function. Two previous studies have investigated the potential
of maternal hyperoxia as a test of placental function and fetal
outcome.1,21 Cordocentesis in growth restricted fetuses during
maternal hyperoxia showed that no increase in fetal
oxygenation was associated with severe placental dysfunction
and adverse fetal outcome.1 Another study investigated the
changes in fetal cerebral resistance by Doppler ultrasound
during maternal hypoxia. In a group of growth restricted
fetuses with brain sparing normalization of cerebral ﬂow
was associated with better fetal outcome, and no change
of cerebral blood ﬂow was associated with adverse fetal
outcome.21 These ﬁndings suggest that fetuses with seriously
impaired placental function do not respond to maternal
hyperoxia; and therefore, fetal non-responsiveness could be a
predictor of poor fetal outcome. However, this needs to be
tested further. To our knowledge, this is the ﬁrst study to
successfully demonstrate oxygenation changes in a number
of human fetal organs during maternal hyperoxia. The BOLD
MRI technique provides new possibilities in observing normal
fetal physiology, and it introduces a new tool to the ﬁeld of
fetal monitoring and fetal testing. Further research should be
conducted in healthy as well as growth retarded fetuses
suffering from impaired placental function.
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WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• The BOLD MRI signal depends upon the magnetic properties of
hemoglobin.
• In the sheep fetus, changes in the BOLD MRI signal reﬂect changes
in fetal tissue oxygenation.
• Maternal hyperoxia increases the fetal oxygen supply when
estimated by cordocentesis.
WHAT DOES THIS STUDY ADD?
• In the human fetus, the BOLD technique is capable of measuring
changes in tissue oxygenation in various fetal organs.
• Maternal hyperoxia increases fetal tissue oxygenation in a number
of fetal organs.
• The oxygenation of the fetal brain is unaffected by maternal
hyperoxia, this could be caused by autoregulation of fetal cerebral
bloodﬂow – reversed brain sparing.
REFERENCES
1. Nicolaides KH, Campbell S, Bradley RJ, et al. Maternal oxygen therapy
for intrauterine growth retardation. Lancet 1987;1(8539):942‐5.
2. Haydon ML, Gorenberg DM, Nageotte MP, et al. The effect of maternal
oxygen administration on fetal pulse oximetry during labor in fetuses
with nonreassuring fetal heart rate patterns. Am J Obstet Gynecol
2006;195(3):735‐8.
3. Bartnicki J, Saling E. The inﬂuence of maternal oxygen administration
on the fetus. Int J Gynaecol Obstet 1994;45(2):87‐95.
4. Battaglia FC,Meschia G,Makowski EL, et al. The effect ofmaternal oxygen
inhalation upon fetal oxygenation. J Clin Invest 1968;47(3):548‐55.
5. Srisupundit K, Wanapirak C, Piyamongkol W, et al. Comparisons of
outcomes after cordocentesis at mid-pregnancy between singleton and
twin pregnancies. Prenat Diagn 2011;31(11):1066‐9
6. Logothetis NK. What we can do and what we cannot do with fMRI.
Nature 2008;453(7197):869‐78.
7. Blatow M, Nennig E, Durst A, et al. fMRI reﬂects functional connectivity
of human somatosensory cortex. Neuroimage 2007;37(3):927‐36.
8. Thulborn KR, Waterton JC, Matthews PM, et al. Oxygenation
dependence of the transverse relaxation time of water protons in whole
blood at high ﬁeld. Biochim Biophys Acta 1982;714(2):265‐70.
9. Wedegartner U, Tchirikov M, Schafer S, et al. Functional MR imaging:
comparison of BOLD signal intensity changes in fetal organs with fetal
and maternal oxyhemoglobin saturation during hypoxia in sheep.
Radiology 2006;238(3):872‐80.
10. Wedegartner U, Kooijman H, Andreas T, et al. T2 and T2* measurements
of fetal brain oxygenation during hypoxia with MRI at 3T: correlation with
fetal arterial blood oxygen saturation. Eur Radiol 2010;20(1):121‐7
11. Sorensen A, Pedersen M, Tietze A, et al. BOLD MRI in sheep fetuses: a
non-invasive method for measuring changes in tissue oxygenation.
Ultrasound Obstet Gynecol 2009;34(6):687‐92.
12. Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR
practices: 2007. AJR Am J Roentgenol 2007;188(6):1447‐74.
13. Lu H, Zhao C, Ge Y, et al. Baseline blood oxygenation modulates
response amplitude: physiologic basis for intersubject variations in
functional MRI signals. Magn Reson Med 2008;60(2):364‐72.
14. Kiserud T, Acharya G. The fetal circulation. Prenat Diagn 2004;24
(13):1049‐59.
15. Baschat AA. Fetal responses to placental insufﬁciency: an update. BJOG
2004;111(10):1031‐41.
16. Almstrom H, Sonesson SE. Doppler echocardiographic assessment of
fetal blood ﬂow redistribution during maternal hyperoxygenation.
Ultrasound Obstet Gynecol 1996;8(4):256‐61.
17. Hsu YY, Kuan WC, Lim KE, et al. Breathhold-regulated blood
oxygenation level-dependent (BOLD) MRI of human brain at 3 Tesla. J
Magn Reson Imaging 2010;31(1):78‐84.
18. Simchen MJ, Tesler J, Azami T, et al. Effects of maternal hyperoxia with
and without normocapnia in uteroplacental and fetal Doppler studies.
Ultrasound Obstet Gynecol 2005;26(5):495‐9.
19. Semple SI, Wallis F, Haggarty P, et al. The measurement of
fetal liver T(*)(2) in utero before and after maternal oxygen
breathing: progress towards a non-invasive measurement of fetal
oxygenation and placental function. Magn Reson Imaging 2001;19
(7):921‐8.
20. Morris DM, Ross JA, McVicar A, et al. Changes in foetal liver T2*
measurements by MRI in response to maternal oxygen breathing:
application to diagnosing foetal growth restriction. Physiol Meas
2010;31(9):1137‐46.
21. Arduini D, Rizzo G, Romanini C, et al. Hemodynamic changes in growth
retarded fetuses during maternal oxygen administration as predictors of
fetal outcome. J Ultrasound Med 1989;8(4):193‐6.
Changes in human fetal oxygenation 145
Prenatal Diagnosis 2013, 33, 141–145 © 2012 John Wiley & Sons, Ltd.
Fetal and placental oxygenation estimated by BOLD MRI 
PhD thesis 
Anne Sørensen 
 
 
 
 
 
 
 
 
 
 
Paper 4 
  
Ultrasound Obstet Gynecol 2013; 42: 310–314
Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.12395
Changes in human placental oxygenation during maternal
hyperoxia estimated by blood oxygen level-dependent
magnetic resonance imaging (BOLD MRI)
A. SØRENSEN*, D. PETERS†, E. FRU¨ND*, G. LINGMAN‡, O. CHRISTIANSEN* and
N. ULDBJERG§
*Department of Obstetrics and Gynecology, Aalborg University Hospital, Aalborg, Denmark; †Department of Clinical Engineering, Aarhus
University Hospital, Aarhus, Denmark; ‡Department of Obstetrics, Lund University Hospital, Lund, Sweden; §Department of Obstetrics
and Gynecology, Aarhus University Hospital, Aarhus, Denmark
KEYWORDS: BOLD; hyperoxia; MRI; oxygen; placenta
ABSTRACT
Objectives To investigate changes in human placental
oxygenation during maternal hyperoxia using non-
invasive blood oxygen level-dependent (BOLD) magnetic
resonance imaging (MRI).
Methods Eight healthy pregnant women with uncompli-
cated singleton pregnancies at gestational weeks 28–36
were examined with BOLD MRI, over two consecutive
5-min periods of different oxygenation: first normoxia
(21% O2) and then hyperoxia (12 L O2/min), achieved
by controlling the maternal oxygen supply with a non-
rebreather facial mask. Selecting three slices showing
cross-sections of the central part of the placenta, we inves-
tigated total placental oxygenation by drawing regions of
interest (ROIs) covering the entire placenta, and regional
placental oxygenation by drawing smaller ROIs in the
darker and brighter areas of the placenta. For each ROI,
the difference in BOLD signal between the two episodes
was determined and the percentage increase in BOLD
signal during hyperoxia (BOLD) was calculated.
Results In the BOLD image, the normoxic placenta
appeared heterogeneous, with darker areas located to the
fetal side and brighter areas to the maternal side. During
hyperoxia, the placenta became brighter and the structure
more homogeneous, and the BOLD signal of the total
placenta increased (BOLDtot, 15.2 ± 3.2% (mean ±
SD), P < 0.0001). The increase was seen predominantly in
the dark areas in the fetal part of the placenta (BOLDfet,
32.1 ± 9.3%) compared with in the bright areas in the
maternal part of the placenta (BOLDmat, 5.4 ± 3.5%).
Conclusion During hyperoxia, placental oxygenation
was increased predominantly in the darker placental
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areas, which, given their anatomical location, represent
the fetal circulation of the placenta. To our knowledge,
this is the first study to successfully visualize changes in
placental oxygenation using BOLD MRI. Copyright 
2013 ISUOG. Published by John Wiley & Sons Ltd.
INTRODUCTION
An adequate supply of oxygen is crucial in fetal growth
and development. The oxygen supply to the fetus is
determined by the maternal uterine blood flow and oxygen
content, placental diffusion of oxygen and umbilical
venous blood flow1,2. Oxygen molecules, which are
small and lipophilic, diffuse easily across the placental
membrane3,4, driven by the partial pressure gradient of
oxygen5,6. In the normal placenta the efficiency of oxygen
transfer is dependent more on blood flow and oxygen
content than on diffusion1. Impaired placental function
is associated with fetal growth restriction7,8, hypoxia9,10
and adverse perinatal outcome11.
Placental oxygen transport can be estimated by
cordocentesis, which provides information about the
oxygen content of the umbilical cord vessels. This invasive
procedure is not used routinely because of the procedure-
related risk of fetal loss of approximately 1%12. The
major tools in fetal monitoring are ultrasound Doppler
flow measurements and cardiotocography, including
ST waveform analysis of the fetal electrocardiogram.
However, these methods are indirect, based on the
fact that specific changes in umbilical blood flow13,
fetal cerebral blood flow14 and fetal electrocardiogram
findings15 are associated with fetal hypoxia and acidosis9.
It is now possible, using the non-invasive blood oxygen
level-dependent (BOLD) magnetic resonance imaging
Copyright  2013 ISUOG. Published by John Wiley & Sons Ltd. ORIGINAL PAPER
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(MRI) technique, to estimate changes in oxygenation
directly in specific areas of placental and fetal tissue. The
technique is based on the fact that the magnetic properties
of hemoglobin and deoxyhemoglobin are different16;
deoxyhemoglobin induces local field inhomogeneities,
which leads to a reduction in the BOLD signal17. During
hyperoxia, the amount of deoxyhemoglobin is reduced,
and therefore the BOLD signal is expected to increase.
The BOLD MRI technique is used widely in neuroscience,
linking brain anatomy and cognitive function through
brain activation studies18. A few studies have been
published using this technique for estimating changes in
oxygenation in the sheep fetus19–24. To our knowledge,
this is the first BOLD MRI study focusing on human
placental oxygenation.
In this study, we aimed to investigate changes in human
placental oxygenation during maternal hyperoxia using
the non-invasive BOLD MRI technique. Furthermore, we
discuss the potential of the BOLD MRI technique as a
tool for future placental testing.
METHODS
The study was approved by the regional Committee
on Biomedical Research Ethics (Journal number M-
20090006). Oral and written informed consent was
obtained from all participating women.
We included in the study eight healthy women with
uncomplicated singleton pregnancies at gestational weeks
28–36 and with normal estimated fetal weight and
normal Doppler flow in the umbilical artery, middle
cerebral artery and maternal uterine arteries. During
the BOLD MRI procedure, the maternal oxygen supply
was controlled by a non-rebreather facial mask (Hudson
Respiratory Care, Durham, NC, USA). We investigated
two consecutive episodes of different oxygenation, each
lasting 5 min: an initial normoxic episode (21% O2)
followed by a hyperoxic episode (12 L O2/min). The facial
mask was applied without interfering with the BOLD MRI
examination, while the pregnant woman remained within
the bore magnet in the left lateral position.
The BOLD MRI examination was performed with a GE
Discovery MR450 1.5-Tesla MRI system (GE Healthcare,
Milwaukee, WI, USA). An eight-channel cardiac coil was
placed over the maternal abdomen, covering the uterus.
Data were acquired with a gradient echo planar imaging
sequence with the following parameters: repetition time,
8000 ms; echo-time (effective), 50 ms; flip angle, 90◦;
number of slices, 22; slice thickness, 6 mm with a slice
gap of 6 mm; matrix 128 × 128 pixels; field-of-view,
36 × 36 cm, resulting in an in-plane spatial resolution of
3.6 × 3.6 mm. A total of 75 dynamics was acquired in
each 10-min BOLD scan.
The BOLD MRI DICOM (Digital Imaging and Com-
munications in Medicine) data were processed using a
program, developed in-house, written in MATLAB (The
MathWorks Inc, Natick, MA, USA). From the BOLD MRI
images we selected three slices showing cross-sections of
the central part of the placenta, with a minimum distance
between slices of 30 mm, and further calculations were
based on the mean of the three slices. To investigate
total placental oxygenation, a region of interest (ROI)
was drawn covering the entire placenta in each slice (see
Figure 2). To investigate regional placental oxygenation,
smaller ROIs were drawn in two different areas of the pla-
centa in each slice; one ROI was placed in the darker area
located on the fetal side and the other ROI was placed in
the brighter area on the maternal side of the placenta (see
Figure 3). The location of the ROI was adjusted in each
dynamic image, correcting for maternal breathing move-
ments. All ROIs were drawn by a single examiner (A.S.).
The BOLD signal of each ROI was recorded at
75 time points during the entire 10-min BOLD scan
and for each ROI the BOLD signal at each time
point was normalized using the mean BOLD signal
of the initial 3 min of normoxia (BOLDNormoxia) as a
reference. Furthermore, BOLD was calculated using
the following equation: BOLD = (BOLDHyperoxia −
BOLDNormoxia) × 100%, where BOLDHyperoxia was the
mean BOLD signal of the last 2 min of the BOLD scan.
BOLD was calculated for the total placenta (BOLDtot)
and for the dark (BOLDfet) and the bright (BOLDmat)
placental areas. In every patient BOLD was calculated
as a mean value of the three slices.
The hyperoxic BOLD signal was tested against the ini-
tial normoxic BOLD signal using a paired Student’s t-test.
P < 0.05 was considered statistically significant. Statistical
analysis was performed with the Stata11 (StataCorp
LP, College Station, TX, USA) statistical package.
RESULTS
In the normoxic BOLD image the placenta appeared het-
erogeneous. Dark areas were scattered along the fetal
surface of the placenta, stretching towards the maternal
surface as thin finger-like structures (Figure 1a). The sur-
rounding placental tissue looked brighter, increasing in
brightness towards the maternal side. During hyperoxia,
a clear visual change occurred in the BOLD image; the pla-
cental structure now appeared brighter and homogeneous
and the dark areas were no longer visible (Figure 1b).
Figure 1 Blood oxygen level-dependent (BOLD) images:
cross-section through uterus showing an axial plane through fetal
abdomen and central part of placenta (arrow) during maternal
normoxia (a) and hyperoxia (b).
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The total placental oxygenation was investigated using
ROIs covering the entire placenta (Figure 2) in three
different slices from each patient. In each ROI the
BOLD signal was obtained at 75 consecutive time-points
during the 10-min scan, and the normalized BOLD
signal vs time curves for one participant (Case 3) are
presented in Figure 2. The three curves in Figure 2
are very similar, indicating that BOLDtot is highly
reproducible in different slices within the same placenta.
For all eight participants in our study, the BOLD
signal for the total placenta was significantly increased
during maternal hyperoxia: BOLDtot = 15.2 ± 3.2%
(mean ± SD). Individual findings are shown in Table 1.
Regional placental oxygenation was investigated by
drawing smaller ROIs in both the darker and the
brighter areas of the placenta. The normalized BOLD
signal vs time curves for the two regions in one
participant (Case 3) are presented in Figure 3. These
two curves are very different; the one representing the
dark fetal part of the placenta increases to a higher level
during maternal hyperoxia when compared with that
representing the bright maternal part of the placenta. For
all eight participants the hyperoxic increase in BOLD
signal was seen predominantly in the dark fetal parts
of the placenta (BOLDfet, 32.1 ± 9.3% (mean ± SD))
when compared with the brighter maternal parts of
the placenta (BOLDmat, 5.4 ± 3.5% (mean ± SD)).
Individual findings are presented in Table 1.
DISCUSSION
This study based on BOLD MRI of the normal human
placenta demonstrated a significant increase in total
placental oxygenation (BOLDtot, 15.2 ± 3.2%) during
maternal hyperoxia. The increase was seen predominantly
in the darker areas located close to the fetal side of the
placenta (BOLDfet: 32.1 ± 9.3%). In the BOLD MR
image the changes in oxygenation were visualized clearly
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Figure 2 Normalized blood oxygen level-dependent (BOLD) signal vs time curves of total placenta during 10-min BOLD scan: three curves
represent three slices within the same placenta (Case 3). Region of interest is shown in inset BOLD image. Slice 1, Slice 2, Slice 3.
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Figure 3 Normalized blood oxygen level-dependent (BOLD) signal vs time curves of two different placental regions: dark placental area on
fetal side of placenta ( ) and bright placental area on maternal side of placenta ( ). Regions of interest are shown in inset BOLD image
(Case 3).
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Table 1 Increase in blood oxygen level-dependent (BOLD) signal of total placenta (BOLDtot) and different regions of placenta
(BOLDfet and BOLDmat) during maternal hyperoxia in eight healthy women with uncomplicated singleton pregnancies
Case GA (weeks)
Total placenta
BOLDtot (%)
Dark placental area:
fetal side BOLDfet (%)
Bright placental area:
maternal side BOLDmat (%)
1 30 + 5 19.4 ± 5.4 48.3 ± 19.2 10.9 ± 0.8
2 28 + 2 12.6 ± 2.2 30.6 ± 15.6 4.4 ± 1.4
3 32 + 1 19.1 ± 2.5 43.1 ± 16.4 6.8 ± 8.4
4 35 + 1 12.9 ± 3.4 27.5 ± 8.5 3.2 ± 6.4
5 35 + 5 12.3 ± 4.4 27.9 ± 11.1 1.8 ± 3.3
6 33 + 0 12.1 ± 1.3 34.4 ± 20.9 2.1 ± 5.5
7 36 + 3 17.9 ± 3.6 23.2 ± 12.5 4.3 ± 8.6
8 35 + 2 15.4 ± 1.0 22.2 ± 7.8 10.0 ± 6.5
1–8 (overall) 15.2 ± 3.2 32.1 ± 9.3 5.4 ± 3.5
P < 0.0001 < 0.0001 0.003
Data are mean ± SD of three slices in each case and of the eight cases overall. P-values are based on paired t-test. GA, gestational age.
as the placenta became brighter and more homogeneous
during hyperoxia.
A strength of the BOLD MRI technique is that
it has been evaluated in sheep fetuses with oxygen-
sensitive optodes inserted into the fetal liver23. That
study demonstrated a very close correlation between
changes in organ tissue oxygenation and changes in
the BOLD signal. However, the absolute BOLD signal
depends not only on the proportion of paramagnetic
deoxyhemoglobin but also on other variables, including
the hemoglobin concentration, hematocrit, blood flow
and blood volume within the tissue25,26. Nevertheless,
we found the reproducibility of BOLDtot in different
slices within the same placenta to be very high (Figure 2).
The lower reproducibility of BOLDmat and BOLDfet
within the same placenta might depend on difficulties in
the complete separation of maternal and fetal parts when
drawing the ROIs. The small inter-individual differences
in BOLDtot could be due to physiological differences
between individuals; however, we cannot exclude minor
differences in the maternal oxygen supply as another
possible explanation for these differences.
Maternal hyperoxia is known to increase fetal oxygen
supply provided there is normal placental function27.
This has been demonstrated in the human fetus by
cordocentesis28, pulse oximetry29 and postpartum umbil-
ical cord blood sampling30. Furthermore, using the BOLD
MRI technique in the sheep fetus we have demonstrated
that maternal hyperoxia increases fetal tissue oxygenation
in a number of fetal organs23. This effect is probably medi-
ated by increased partial pressure of oxygen in the mater-
nal blood of the intervillous space, which improves the
diffusion of oxygen across the placental membrane from
the mother to the fetus5. During normoxia the maternal
blood is already fully saturated; this is in contrast to
fetal blood, which is only 70% saturated31. This means
that the fetus is situated at a lower and steeper part
of the hemoglobin dissociation curve when compared
to the mother. Therefore, the same increase in oxygen
partial pressure generates a larger increase in saturation
in the fetus. As the changes in the BOLD MRI signal
are dependent on changes in hemoglobin saturation, the
BOLD MRI response to hyperoxia is expected to be
more pronounced in fetal blood. A precise conclusion
concerning the heterogeneous pattern of the placenta
observed in the normoxic BOLD MR image cannot be
drawn from the present study. However, according to
the anatomical location of the dark areas, their size and
their response to maternal hyperoxygenation, it seems
reasonable to hypothesize that the darker areas represent
the villous trees dominated by fetal blood. A histopatho-
logical examination of these normal placentae would
not have determined the origin of the dark and bright
areas of the placenta on the BOLD image. However,
in future studies based on pregnancies complicated by
placental insufficiency, histopathological examination of
the placenta will be of great interest as an altered oxygen
response might have a histopathological explanation.
To our knowledge, this is the first BOLD MRI
study of the human placenta. Previous BOLD MRI
studies published in sheep models19–24 did not focus on
placental oxygenation. This is because the sheep placenta
is very different from the human placenta in both shape
and structure. The sheep placenta consists of separate
cotyledons scattered on the amniotic sac; in contrast, the
human placenta is discoid in shape and therefore more
suitable for imaging and drawing of ROIs. Furthermore,
the sheep placenta is considered a concurrent system,
which is less efficient than the multivillous system in the
human placenta3,32. However, in individual cotyledons
of the sheep placenta, the BOLD signal was reduced
during maternal hypoxia20. Comparable findings were
reported in rat experiments, in which the BOLD signal of
the total placenta was reduced during hypoxia induced
by prostaglandin33.
The clinical perspective of these results might be that
the BOLD MRI technique provides a new tool in the
difficult field of testing placental function. In particular,
BOLDtot seems like a robust measurement. Testing of
pathological pregnancy with impaired placental function,
as seen in the growth-restricted fetus, would be an
obvious target for this method. Because of the high cost
and limited availability of BOLD MRI, the method is
only suitable for selected cases.
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Cordocentesis in severely growth-restricted fetuses has
demonstrated three different types of fetal response to
maternal hyperoxia: 1) increase in fetal oxygen partial
pressure (pO2) above normal, indicating unimpaired
placental function; 2) increase in fetal pO2 below normal,
indicating some degree of impaired placental function;
and 3) no response, indicating severely impaired placental
function. Non-responding fetuses have poor neonatal
prognosis and they require immediate delivery28. This
is known as the non-responder hypothesis. According to
this hypothesis reduced or no increase in placental BOLD
signal during maternal hyperoxia might be associated with
impaired placental function and poor neonatal outcome.
Further research should be performed in healthy as well
as pathological pregnancies.
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Abstract 
Purpose
The aim of this study was to investigate placental T2* from normal pregnancies 
with regards to the reproducibility, dependence on gestational age, and the 
response to maternal oxygen breathing. 
Materials and Methods
Twenty-four pregnant women with confirmed normal pregnancies between 
gestational week 24 and 40 underwent MRI examination. T2* measurement 
were performed using a gradient recalled echo sequence with multiple readouts 
at 16 different echo times. T2* value was calculated using a non-linear least 
squares fitting algorithm.
T2* measurement were repeated during 10 minutes of maternal oxygen 
breathing through a Hudson mask (12 litre O2/min).
Results
The mean placental T2* was 81.3±28.1 ms and a negative linear correlation 
between placental T2* and gestation age was found with a decline of 4.8 ms per 
week. 
The reproducibility of placental T2* was tested
1. Slice-to-slice (N=24) comparing two separate slices of each placenta
(95%-limits of agreement -1.8±13.1 ms)
2. Scan-to-scan (N=16) comparing repeat scans within two minutes (95%-
limits of agreement -0.1±17.8 ms).
3. Session-to-session (N=8) comparing repeat scan sessions within 45 
minutes (95%-limits of agreement -0.3±15.7 ms)
During hyperoxia a statistically significant increase of 14.4±12.8 ms in placental 
T2* was demonstrated.
Conclusion
We have estimated the reproducibility of placental T2* measurements, and
demonstrated that placental T2* decreases with gestational age. Thereby, we 
have established a normal material that may be useful for future investigation of 
placental pathology. We have further demonstrated that T2* of the placenta 
increases during maternal hyperoxia. 
Introduction
In the developing fetus the oxygen supply from the placenta is essential to 
maintain normal growth. Therefore a non-invasive method to detect the oxygen 
concentration in the placenta would be of huge benefit, as it could be used as a 
tool in the diagnosis and surveillance of growth-retarded fetuses.
As deoxyhemoglobin is paramagnetic it decreases the transversal relaxation time
in MRI (T2*), while oxyhemoglobin is diamagnetic and has no affect on T2*, 
therefore the amount of oxygen bound to hemoglobin affects the MR signal(1).
This effect can be monitored using heavily T2* weighted imaging (Blood oxygen 
level dependent – BOLD) or by measuring T2* directly(2,3). As opposed to 
conventional structural MR imaging, this method assess tissue function, and 
therefore it is termed functional MR imaging.
The very first functional MRI studies of pregnancies were performed using the 
BOLD method and focused on detecting changes in fetal brain activity during 
visual and acoustic fetal stimulation in utero (4-7). These studies were followed 
by studies in sheep fetuses estimating the fetal response on altering maternal 
oxygen supply in the ventilating gas(8-11). Good correlation between changes in 
fetal oxygenation and changes in BOLD signal were shown (9,10). As the MR 
signal is not quantitative, BOLD weighted imaging is only able to detect changes 
in oxygenation and cannot be used to evaluate the absolute oxygenation status of 
the fetus. The first step towards absolute quantification of oxygenation is 
therefore to switch to quantitative imaging. Previously, only one study has
reported human placental T2* (12), however the precision and reproducibility of 
the method has not been investigated. In this study we aim to assess the 
reproducibility of human placental T2* measurements.
A further aim of the study is to establish a normal material against which 
pathological pregnancies could be compared. 
Lastly the effect of maternal oxygen breathing on the placental T2* values is 
investigated.
Materials and Methods
The study was approved by the regional Committee on Biomedical Research 
Ethics (Journal number M-20090006). Oral and written informed consent was 
obtained from all participating women.
Subjects
Twenty-four pregnant women carrying uncomplicated singleton pregnancies in 
gestational week 24 - 40 with normal fetal weight estimated by ultrasound and 
normal Doppler flow in the umbilical artery; the middle cerebral artery and the 
maternal uterine arteries were included in the study.
MRI
All measurements were performed in a GE Discovery MR450 1.5 Tesla MRI 
System (GE Healthcare, Milwaukee, USA). An eight channel cardiac coil was 
placed over the abdomen covering the uterus.
T2* was measured using a gradient recalled echo sequence with multiple 
readouts with the following parameters: TR=70.9 ms, TE=3.0 to 67.5 ms in steps 
of 4.3 ms (16 echoes), FOV 350x350 mm, Matrix 256x128 resulting in an inplane 
resolution of 1.37x2.73mm, Two eight mm thick slices with a distance of at least
three cm were acquired within a single breath hold. 
Study design
The study design is shown in figure 1. Following initial localizer and T2 weighted 
reference scans one (N=8) or two (N=16) normoxic placental T2* measurements 
were performed. A 10-minute BOLD weighted EPI sequence was then performed
(results from the first eight subjects are reported in (13)). Halfway through the 
BOLD sequence the scanning was paused and the maternal facial Hudson oxygen
mask (Hudson Respiratory Care, Durham, NC) receiving 12 liters of oxygen per 
minute was applied. The pregnant women stayed in the bore in the left lateral 
position while the mask was fitted and care was taken that to avoid maternal 
movements
After the 10 minute BOLD scan hyperoxic placental T2* measurements were 
performed, while the mother was still breathing oxygen. In a subset of women
(N=8) the protocol was repeated in separate scanning session after a 45-minute
break. 
MRI analysis
The BOLD MRI DICOM images were processed using an in-house developed 
program written in MATLAB (The MathWorks Inc, Natick, MA, USA).
Regions of interest (ROIs) were drawn for each echo time in each scan covering 
the entire placenta by a single examiner (A.S). In case of severe placental 
movement due to maternal breathing the ROI was either moved according to the 
new position of the placenta or in cases of severe movement artifacts the given 
echo time was discarded. Placental T2* values were obtained by fitting the 
average signal from each ROI as a function of echo time with a mono-
exponentially decaying function having M0 and T2* as free parameters (Figure 
2). Fitting was performed with a non linear least squares method (14).
Reproducibility was assessed in three different ways. 
(1) The slice-to-slice reproducibility: comparing the measured placental T2*
value in two different slices which were at least 3 cm apart. (N=24). 
(2) The scan-to-scan reproducibility: comparing two normoxic placental T2* 
measurements performed within a few minutes (N=16). Each measurement was 
performed in two slices and the average value for the two was used.
(3) The session-to-session reproducibility: comparing the normoxic T2* 
measurement performed within a 45 minute break (N=8). Each measurement 
was performed in two slices and the average value for the two was used.
Statistics
Bland-Altman plotting (15) was used to investigate the reproducibility of the 
studies and to estimate 95% limits of agreement between repeat measurements. 
The relation between the normoxic placental T2* and gestational age was 
estimated using an ordinary linear regression in Stata®11 (StataCorp LP, College 
Station, TX, USA). 95% confidence and prediction intervals were calculated. 
A students T-test was used to test the hyperoxic increase in placental T2*. A p-
value < 0.05 was considered statistically significant.
Results
Reproducibility
Reproducibility is demonstrated by Bland-Altman plots which show the 
difference between two placental T2* measurements on the y-axis as a function 
of the mean of the two placental T2* values on the x-axis. The mean difference 
between measurements and the 95% limits of agreement are indicated as 
horizontal lines. 
Slice to slice reproducibility (figure 3 top). The difference between placental T2* 
of slice 1 and slice 2 did not change systematically as a function of the mean 
placental T2* value. The 95% limits of agreement were -1.8±13.1 ms.
Scan to scan reproducibility (figure 3 middle). The difference between the 
placental T2* measurements of scan 1 and scan 2 did not change systematically 
as a function of the mean placental T2* value. The 95% limits of agreement were
-0.1±17.8 ms.
Session to session reproducibility: figure 3 bottom). Again the difference 
between the placental T2* measurement of session 1 and session 2 did not 
change systematically as a function of the mean placental T2* value. The 95% 
limits of agreement were -0.3±15.7 ms.
T2* as a function of gestational age
Figure 4 demonstrates the relation between the normoxic placental T2* and 
gestational age. Possible correlation was tested using ordinary least squares 
regression and a significant correlation was found. (R2 =0.68, p<0.001). Placental 
T2* decreased with 4.8 ms per gestational week.
T2* in response to oxygen
The mean normoxic placental T2* was measured to 81.3±28.1 ms, while 
hyperoxic T2* was measured to 95.7±26.3 ms.
The hyperoxic increase in placental T2* after oxygen inhalation is shown in 
figure 5. The change in placental T2* range from a 19.0 ms decrease to a 35.3 ms 
increase. On average the hyperoxic increase in placental T2* was 14.4±12.8 ms
and this increase was statistically significant with a p-value less than 0.00002. 
No correlation could be demonstrated between the gestational age and the 
change in placental T2* (Spearmans rho=0.21, p=0.34).
Discussion
Reproducibility
In this study we have investigated several aspects of placental T2* 
reproducibility
The technical reproducibility of the method was tested by comparing two 
different slices of each placenta acquired in the same scan (slice-to-slice 
variability) as well as comparing two baseline scans performed within a couple 
of minutes (scan-to-scan variability). In eight women the experiment was 
repeated after a break of 45 minutes (session-to-session variability). The 
variation between sessions would be expected to come from technical as well as 
biological variations. The 95 % limits of agreement for scan-to-scan and session-
to-session variability were very similar (-0.1±17.8 ms and -0.3±15.7 ms 
respectively) while the slice-to-slice limits were more narrow (-1.8±13.1 ms). 
This finding suggests that the variation seen in this study mainly relies on
technical variations (such as fitting inaccuracy, movement artefacts and 
differences in scanner calibration) and not biological variation.
The scan-to-scan variability was higher than the slice-to-slice variability. The 
additional preparation steps, which are performed when starting a new scan, for 
instance adjustment of gain and frequency and the acquisition of parallel 
imaging sensitivity maps, might explain this finding.
The reproducibility of this method needs to be evaluated in a clinical perspective. 
This is difficult as the difference in placental T2* measurement between normal 
and pathological placentas are not known. The studies of placental T2 
measurement indicate, that placental T2* should be reduced in the IUGR 
placenta (16-18). However placental T2* needs to be investigated in the human 
IUGR placenta.
Normoxic T2* as a function of gestational age
We found a mean normoxic T2* in the placenta of 81.3±28.1 ms which is higher 
than the 54.6±15.9 ms reported by A possible explanation could be that Huen et 
al. (12) used 10 echo-times (TE=5-50 ms), while this study used 16 echo-times 
(TE=3-67.5 ms) to estimate T2*. Increasing the number of echo times should 
increase the precision of measuring especially long T2* values. 
A negative linear correlation between placental T2* and gestational age was 
demonstrated with a decrease in placental T2* value of 4.8 ms per gestational 
week. This finding is in conflict with data previously published by Huen et al, as 
they failed to demonstrate any relation between placental T2* and gestational 
age (12). However, previously a negative linear correlation between placental T2 
and gestational age has been demonstrated with a decrease in placenta T2 value 
of 4.0 ms/week in a 0.5T MRI system(16) and 2.4 ms/week in a 1.5T system(19)
respectively. Furthermore it was demonstrated that placental T2 was correlated 
to the amount of fibrin deposition thereby suggesting an morphological 
explanation for this relation(19). It is well known, that specific tissue 
characteristics are important determinants of tissue relaxation times. In general 
T2 relaxation time is increased with increasing tissue water content(20),
increasing surface area and increasing amount of macromolecular 
deposition(19). The T2* relaxation time depend on the T2 relaxation time, but it 
is also influenced by the local magnetic field inhomogeneities as created by the 
presence of deoxyhemoglobin (21).
It is well know, that the oxygenation of the intervillous placental blood is 
decreased with increasing gestational age, probably as a consequence of the 
increasing metabolic demand of the placenta and the fetus(22).
We therefore suggest, that the decrease in placental T2* value demonstrated in 
our study could be explained partly by morphological changes in the maturation 
of the normal placenta, and partly by the well known decrease in placental 
oxygenation with increasing gestational age(22).
T2* in response to oxygen
We demonstrated a significant hyperoxic increase in placental T2* of 14.4±12.8
ms, which is in agreement with the 18.4±30.2 ms previously reported by Huyen 
(12). 
The hyperoxic placental T2* response varied between subjects and in three cases 
placental T2* even decreased. Apart from the placental T2* measurements a
dynamic T2* weighted (BOLD) scan was acquired in each subject. In the majority 
of subjects with poor T2* response demonstrated a corresponding drop in the 
placental BOLD signal.. Uterine contractions could be responsible for the 
observed drops in BOLD signal. However, this particular finding needs to be
investigated in another study including cardiotocographs for monitoring uterine 
contractions. However, this finding highlights the importance of following the 
placenta dynamically when studying the effects of oxygen inhalation. 
Another possible explanation of the variation in the hyperoxic placental T2* 
response would be the rather limited reproducibility of the method. As 
previously demonstrated the session to session 95% limits of agreement are -
16.0 – 15.5 ms. Therefore this method is not perfectly suitable for detecting 
increases in T2* value of only 14.4 ms. Furthermore, differences in maternal 
oxygen delivery could explain some of the variation. The facial mask was not 
perfectly tight, and therefore some variation could rely on differences in
maternal oxygen supply.
Previous publications by our group have demonstrated a significant increase in 
placental BOLD signal of 15.2 ± 3.2% (mean±SD) during maternal hyperoxia(13).
During hyperoxia, the placenta BOLD response seems more robust than the 
placental T2* response, and this might rely on technical inaccuracy in the 
calculation of T2*. Furthermore, in contrast to the single measurements of 
placental T2* value, the dynamic BOLD scan measure the placental BOLD signal 
at multiple time points.
Placental T2 has been investigated in pregnancies complicated by fetal growth 
restriction, and a lower placental T2 value was found in the group of complicated 
pregnancies when compared to healthy pregnancies(16-18). Morphological 
changes of the pathological placenta, as for instance; increased necrosis and 
infarction, might explain the lower placental T2 value.  One study investigated 
the value of placental T2 performed in gestational week 26 in order to predict 
fetal growth restriction (18). It was demonstrated that low placental T2 value 
already in the second trimester was a strong predictor of fetal growth restriction 
later in pregnancy, even when fetal growth was normal at the time of MRI scan. 
As T2* is more sensitive to changes in oxygenation than T2(21) it is likely that 
T2* will be able to further separate the groups. These findings are very 
interesting as they suggest placental relaxation time (T2 and T2*) measurements 
as a future non-invasive test of placental function. Placental relaxation time may
not only be capable of detecting differences between healthy and pathological 
pregnancies; it may also predict pregnancies complicated by fetal growth 
restriction. Thereby suggesting, that alterations in placental relaxation time 
might precede the clinical signs of disease, which is very important for the 
clinical perspective of this method.
Figure 1 – Study design
Timeline of a placental MRI examination. BOLD imaging was performed for 10 
minutes (5 min normoxia, 5 min hyperoxia)
Initially a localizer was performed followed by a number of placental T2* 
measurements during normoxia (blue) and hyperoxia (red). In each patient a 10 
minute T2*-weighted BOLD scan was performed (another study)
Figure 2 – Placental T2* measurement
Normoxic (blue) and hyperoxic (red) placental T2* decay curves. The mean MRI 
signal (arbitrary units) of the placental ROI plotted at each echo-time. A number 
of MRI images obtained at different echo times are included in the figure. 
Figure 3 – Reproducibility
Reproducibility plots demonstrating (a) slice-to-slice variation, (b) scan-to-scan 
variation and (c) session-to-session variation.
Each section contains barplots of the compaired values, Bland-Altman plots 
including 95% limits of agreement and identity plot of the compared values.
Figure 4
The linear relation between placental T2* and gestational week . Thick line is 
ordinary least squares fit (P<0.001. R2=0.68). Dotted lines indicate 95% 
confidence interval while dashed lines indicate 95% prediction interval. 
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Figure 5
The hyperoxic placental T2* response. The subjects are sorted by gestational age. 
The dashed line indicates the average increase in placental T2* of 14.4±12.8 ms
during hyperoxia.
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